KSC 2026 [The 70th Annual Scientific Meeting of The Korean Society of Cardiology]

10.15 Thu.

08:30-09:45

Intervention 1

Symposium

Intervention 1

Drug-Coated Balloons in Contemporary PCI: From Evidence to Everyday Practice

Oct. 15 (Thu.) 08:30-09:45, Vista 1

Chairpersons : Hyo-Soo Kim , Eun-Seok Shin

Panel : Ji Han Kim , Yong-Joon Lee , Jong-Young Lee , Young-Hyo Lim

Learning Objective: 1. 최신 randomized trial 결과를 바탕으로 DCB의 적응증이 small vessel disease를 넘어 large vessel disease까지 확대될 수 있는지 논의합니다.
2. 해부학적 생리학적 지표를 이용하여 DCB PCI가 적합한 병변을 선택할 수 있는 방법에 대해 논의합니다.
3. Bifurcation lesion에서 DCB의 역할 및 DCB 기반 시술에 대해 이해합니다. 4. Paclitaxel과 Sirolimus의 약물학적 차이를 이해하고 최신 임상 근거를 평가합니다.

08:30-08:45	Redefining the Role of DCB in De Novo Lesions [Speaker] Dong Oh Kang / Korea Univ., Korea
08:45-09:00	Who Is the Ideal Candidate for Stentless PCI? [Speaker] Ae-Young Her / Kangwon National Univ., Korea
09:00-09:15	Can DCB Simplify Bifurcation PCI? [Speaker] Ki Hong Choi / Sungkyunkwan Univ., Korea
09:15-09:30	Paclitaxel vs. Sirolimus-Based DCB: Choosing the Right Platform [Speaker] Woohyeun Kim / Hanyang Univ., Korea
09:30-09:45	Discussion

ENG Echocardiography 1

Symposium

ENG Echocardiography 1

Echocardiography for Structural Heart Interventions

Oct. 15 (Thu.) 08:30-09:45, Vista 2

Chairpersons : Geu-Ru Hong , Dae-Hee Kim

Panel : DeaYoung Kim , Ye Chan Kim , Hyung Yoon Kim , Jong Ho Nam

Learning Objective: 1. Understand the key aspects of Mitral TEE, ranging from patient selection to stepwise TEE and clip optimization.
2. Explain the principles of integrated utilization of echo, CT, and intraprocedural imaging in pre- and post-TAVR evaluation.
3. Apply the procedural role of echo in transcatheter tricuspid intervention and alcohol septal ablation.

08:30-08:45	Mitral TEER: From Patient Selection to Clip Optimization [Speaker] Makoto Amaki / National Cerebral and Cardiovascular Center, Japan
08:45-09:00	Multi-modality Imaging for TAVR: Echo, CT, and Intraprocedural Guidance [Speaker] Jae Yeong Cho / Chonnam National Univ., Korea
09:00-09:15	Imaging for Transcatheter Tricuspid Interventions [Speaker] Eun Kyoung Kim / Sungkyunkwan Univ., Korea
09:15-09:30	Echo Guidance for Alcohol Septal Ablation in HOCM [Speaker] Dong-Hyuk Cho / Korea Univ., Korea
09:30-09:45	Discussion

Cardiogenic Shock 1

Symposium

Cardiogenic Shock 1

Basic Approach for Cardiogenic Shock

Oct. 15 (Thu.) 08:30-09:45, Vista 3

Chairpersons : In Seok Jeong , Jeong Hoon Yang

Panel : Min-Seok Kim , Jong-Hwa Ahn , Chul-Min Ahn , Woo Jin Jang , Hae chan Cho

Learning Objective: 1. Shock team에 대한 개념을 정립하여 심장성쇼크에 대한 팀접근의 중요성을 논의합니다.
2. 중환자실에서 자주 사용하는 진단 도구 및 약제들의 이론적인 배경과 적용 노하우를 공유합니다.

08:30-08:45	Evolution of Shock Team-Based Care [Speaker] Sang-Hyup Lee / Yonsei Univ., Korea
08:45-09:00	Echocardiography in Cardiogenic Shock: Beyond LVEF [Speaker] Mijoo Kim / Chungnam National Univ., Korea
09:00-09:15	Contemprary Hemodynamic Monitoring in Cardiogenic Shock [Speaker] Ah Ram Kim / Ulsan Univ., Korea
09:15-09:30	Beyond Norepinephrine: Practical Use of Inotropes and Vasopressors [Speaker] Soo Yong Lee / Pusan National Univ., Korea
09:30-09:45	Heart-Lung Interactions in Cardiogenic Shock [Speaker] In-Cheol Kim / Keimyung Univ., Korea

Main 1

Symposium

Main 1

The Lost Art of Cardiology Revived

Oct. 15 (Thu.) 08:30-09:45, Walker 1

Chairpersons : Joon-han Shin , Woo-Young Chung

Panel : In Sook Kang , Ju Youn Kim , Hyukjin Park , In-Chang Hwang

Learning Objective: 1. 검사 등이 점점 복잡해 지고 있는 심혈관학 분야에서 basic에 더 주의를 기울일 때, 제대로 된 환자 care가 가능함을 보여주는 세션입니다.
2. 교육적인 사례 또는 증례 등에 대한 소개와 함께 주어진 제목에 합당한 결말을 낼 수 있는 교육적인 강의로 구성되 세션입니다.

08:30-08:45	Pressure Tracing Never Lies [Speaker] Chan Soon Park / Ulsan Univ., Korea
08:45-09:00	When Less is More in Cardiovascular Care [Speaker] Sung Jin Hong / Yonsei Univ., Korea
09:00-09:15	The Most Expensive Test Isn't the One You Need [Speaker] Ji Hoon Kim / Hallym Univ., Korea
09:15-09:30	Can AI Understand Physiology? [Speaker] Jun Beom Park / Ewha Womans Univ., Korea
09:30-09:45	Discussion

ENG Main 2

Symposium

ENG Main 2

Beyond Secondary Prevention: PCSK9 Inhibition at the Frontier of Cardiovascular Risk Reduction

Oct. 15 (Thu.) 08:30-09:45, Walker 2

Chairpersons : Seung Hwan Han , Byung Jin Kim

Learning Objective: 1. Understand the clinical evidence for PCSK9 inhibitors in high-risk patients without a history of MI or stroke, and the background of the expanded indication for primary prevention.
2. Interpret the key results of the VESALIUS-CV study (magnitude of MACE reduction, implications for LDL-C target levels) and explain the differences from existing evidence for secondary prevention.
3. Based on the latest dyslipidemia guidelines and the VESALIUS-CV evidence, discuss the appropriate target population and actual prescribing strategies for PCSK9 inhibitors in the domestic clinical setting.

08:30-08:45	LDL-Lowering Therapy in High-Risk Patients: Where Do Guidelines Stand in 2026? [Speaker] Ji Hyun Kim / Catholic Univ., Korea
08:45-09:00	From FOURIER to VESALIUS-CV: Expanding the Scope of PCSK9 Inhibitor Therapy [Speaker] Doyeon Hwang / Seoul National Univ., Korea
09:00-09:15	Cardiovascular Outcomes in Patients at High CV Risk: Evidence From the VESALIUS-CV Study [Speaker] Jan Hein Cornel / Northwest Clinics, Netherlands
09:15-09:30	Implementing PCSK9 Inhibitors in Real-World Clinical Practice: Korean Perspective [Speaker] Oh Hyun Lee / Yonsei Univ., Korea
09:30-09:45	Discussion

ENG a Arrhythmia 1

Oral

ENG a Arrhythmia 1

Oct. 15 (Thu.) 08:30-09:45, Grand 4

08:30-08:40 No.1 [K2026F-0046]	AI-ECG Guided Risk Stratification for Atrial Fibrillation Detection After Acute Ischemic Stroke: A Real-World Prospective Cohort Operationalizing AI in the Clinical Workflow [Speaker] Yongsoo Baek / Inha Univ., Korea
08:40-08:50 No.2 [K2026F-0130]	Virtual Atrial Fibrillation Dynamics Reflect Clinical Outcomes After Catheter Ablation [Speaker] Taehyun HWANG / Yonsei Univ., Korea
08:50-09:00 No.3 [K2026F-0112]	Rhythm findings from implantable loop recorder registry in embolic stroke of undetermined source: predictors and treatment response of clinically significant atrial fibrillation - A single center, retrospective, observational study [Speaker] ohchul kwon / Seoul Univ., Korea
09:00-09:10 No.4 [K2026F-0276]	Feasibility and Safety of Intracardiac Echocardiography?Guided Zero-Fluoroscopy Pulsed-Field Ablation for Atrial Fibrillation [Speaker] Moonki Jung / Chung-Ang Univ., Korea
09:10-09:20 No.5 [K2026F-0230]	A multimodal artificial intelligence approach for atrial fibrillation subtype classification and post-ablation recurrence risk stratification [Speaker] Oh-Seok KWON / Yonsei Univ., Korea
09:20-09:30 No.6 [E2026F-0012]	Urban - Rural Differences in the Clinical Course and Outcomes of Atrial Fibrillation [Speaker] Ahtam Tolibov / Republican Specialized Scientific and Practical Medical Center of Cardiology, Uzbekistan
09:30-09:40 No.7 [E2026F-0121]	The 1-in-10 Dilemma: Real-World Bleeding Prevalence and Predictors in AHRE Patients on Anticoagulation [Speaker] Mohammad Akram M Ramli / University Malaya Medical Centre, Malaysia

ENG a Hypertension

Oral

ENG a Hypertension

Oct. 15 (Thu.) 08:30-09:45, Grand 5

08:30-08:40 No.8 [K2026F-0236]	Differential Association of Appendicular Skeletal Muscle Mass with Hypertension by Measurement Modality (DXA vs. BIA) and the Role of Adiposity : The Korea National Health and Nutrition Examination Survey 2024 [Speaker] JuneYoung YOON / Wonkwang Univ., Korea
08:40-08:50 No.9 [E2026F-0080]	Poor sleep quality, inflammation and nocturnal blood pressure burden in essential hypertension: the role of glycemic control [Speaker] Borys Shelest / Kharkiv National Medical University, Ukraine
08:50-09:00 No.10 [E2026F-0087]	The Sub-120 Era: Revisiting Systolic Blood Pressure Targets in Cardiovascular Prevention (A Systematic Review and Meta-analysis) [Speaker] Lutfi Hafiz Zunardi / Sunan Kalijaga General Hospital, Indonesia
09:00-09:10 No.11 [E2026F-0048]	CT-Based Quantitative Analysis of Cardiothoracic Structural and Pulmonary Functional Changes in Male Patients with Silicosis and Comorbid Hypertension [Speaker] Yue Lin / West China Fourth Hospital, Sichuan University, China
09:10-09:20 No.12 [E2026F-0037]	Hemodynamic Changes in a Subnephrectomized Rat Model of Concurrent Hypertension and Type 2 Diabetes Mellitus: A Pre-Clinical Experimental Study [Speaker] Reza Wahyuningsih / Universitas Islam Indonesia, Indonesia
09:20-09:30 No.13 [E2026F-0023]	Awareness and Practices of Physicians Regarding Updated European Society of Cardiology and European Society of Hypertension Guidelines [Speaker] Aiisha Tileuzhan / WKMU named after Marat Ospanov, Kazakstan
09:30-09:40 No.14 [E2026F-0116]	The Nitric Oxide Synthase 3 G894T Polymorphism is Associated with Hypertension in the Rural Melanesian Population: an Insight from Eastern Indonesia [Speaker] Widyan Putra Anantawikrama / National Cardiovascular Center Harapan Kita/ Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia

ENG a Heart Failure 1

Oral

ENG a Heart Failure 1

Oct. 15 (Thu.) 08:30-09:45, Grand 6

08:30-08:40 No.15 [K2026F-0116]	Exploratory Identification of Candidate Digital Biomarkers for Heart Failure Using Smartphone-Based Remote Photoplethysmography [Speaker] Jooyeon Lee / Yonsei Univ., Korea
08:40-08:50 No.16 [K2026F-0139]	Long-Term Prognostic Value of Artificial Intelligence Estimated Left Ventricular Systolic Function From Electrocardiography : A Nationwide Cohort Study [Speaker] DeaYoung Kim / Inha Univ., Korea
08:50-09:00 No.17 [K2026F-0258]	연구비 Effectiveness of a Family-Engaged AI Coaching Web Application for Improving Self-Management in Patients with Heart Failure [Speaker] Seung Mi Moon / Hanyang Univ., Korea
09:00-09:10 No.18 [K2026F-0268]	Artificial intelligence-enabled electrocardiography for detecting elevated left ventricular filling pressure: development and multi-cohort validation from echocardiography to point-of-care [Speaker] Minseong Kim / Yonsei University, Korea
09:10-09:20 No.19 [K2026F-0259]	Artificial intelligence-enabled Electrocardiography Reflects Serial Changes in Left Ventricular Ejection Fraction [Speaker] Minjae Yoon / Seoul Univ., Korea
09:20-09:30 No.20 [K2026F-0078]	Artificial intelligence-derived electrocardiographic aging and heart failure subtype-specific risk [Speaker] Seyong Chung / Yonsei Univ., Korea
-

Pediatric Cardiology 1

Symposium

Pediatric Cardiology 1

Coronary Artery Issues in Pediatric and Congenital Heart Diseas

Oct. 15 (Thu.) 08:30-09:45, Art

Chairpersons : I Seok Kang , Woong-Han Kim

Panel : Chang Sin Kim , Jae Yoon Na , Mi-Kyoung Song , Jae Hong Lim

Learning Objective: 1. 선천성 관상동맥 기형(AAOCA, ALCAPA, coronary fistula)의 진단·위험도 평가와 운동제한 및 수술 적응증에 대한 최신 consensus를 이해합니다.
2. ASO, Ross 등 선천성 심장수술 후 발생하는 coronary ostial stenosis 등 관상동맥 합병증의 surveillance protocol과 임상적 접근법을 학습합니다.
3. 가와사키병 환자에서 CABG 적응증·conduit 선택과 함께, nuclear perfusion imaging, FFR/iFR, IVUS/OCT 등 다양한 modality를 활용한 lifespan 관상동맥 평가법을 익힙니다.

08:30-08:45	Congenital Coronary Anomalies: Diagnosis, Risk Stratification, and Contemporary Management [Speaker] Ja Kyoung Yoon / Sungkyunkwan Univ., Korea
08:45-09:00	Coronary Complications in Repaired CHD: ASO, Ross, and Beyond [Speaker] Eung Re Kim / Bucheon Sejong Hospital, Korea
09:00-09:15	Nuclear Myocardial Perfusion Imaging in Pediatric and Congenital Heart Disease
09:15-09:30	Coronary Evaluation and Intervention in Kawasaki Disease Patients with Coronary Aneurysm/Stenosis: FFR, IVUS, and Beyond [Speaker] Jeehoon Kang / Seoul National Univ., Korea
09:30-09:45	CABG in Kawasaki Disease: Indications, Conduit Selection, and Long-term Outcome [Speaker] Young-Nam Youn / Yonsei Univ., Korea

09:55-11:10

Intervention 2

Symposium

Intervention 2

When and Whom to Revascularize

Oct. 15 (Thu.) 09:55-11:10, Vista 1

Chairpersons : Myeong Ki Hong , Chang-Wook Nam

Panel : Donghyun Kim , Yong Cheol Kim , Hyuck-Jun Yoon , Hyun Sung Joh , Young Joon Hong

Learning Objective: 1. 본 세션은 다양한 임상상황에서 관상동맥 재개통 치료의 핵심 질문인 “언제 시행할 것인가”와 “누구에게 시행할 것인가”를 최신 임상근거를 바탕으로 재조명하고자 구성하였습니다.
2. 최근 발표된 iMODERN, FAST III, ALL-RISE, ORBITA-CTO, PRO-TAVI 등은 기존의 혈관조영술 중심 의사결정에서 벗어나, 임상적 맥락, physiology, 증상 부담, 동반 시술 위험도, 환자 중심 결과를 통합한 재개통 전략의 필요성을 보여주고 있습니다.
3. 단순히 “stenosis가 있으면 치료한다”는 접근에서 벗어나 재개통 치료의 timing, indication, expected benefit을 근거 중심으로 습득합니다.

09:55-10:10	Complete Revascularization in Myocardial Infarction: Immediate or Staged? [Speaker] Min Chul Kim / Chonnam National Univ., Korea
10:10-10:25	Angio-Derived FFR-Guided Revascularization: The Era of Wire-Free Physiology [Speaker] Sung Woo Cho / Inje Univ., Korea
10:25-10:40	CTO PCI Reconsidered: Symptoms vs. Prognosis After ORBITA-CTO [Speaker] Sanghoon Shin / Ewha Womans Univ., Korea
10:40-10:55	Coronary Revascularization Before TAVR: Is It Worth the Risk? [Speaker] Hyungdon Kook / Hanyang Univ., Korea
10:55-11:10	Discussion

ENG Echocardiography 2

Symposium

ENG Echocardiography 2

Valvular Heart Disease: Phenotyping and Decision-making

Oct. 15 (Thu.) 09:55-11:10, Vista 2

Chairpersons : Yong-Jin Kim , Kye Hun Kim

Panel : Sungseek Kim , Jino Park , Sang-Eun Lee

Learning Objective: 1. Understand the diagnostic limitations of conventional Left Ventricular Ejection Fraction (LVEF) in low afterload environments, and acquire clinical evidence for utilizing myocardial strain indicators, such as Global Longitudinal Strain (GLS), to detect potential myocardial functional decline in asymptomatic patients early and determine the optimal timing for intervention.
2. Review the latest phenotyping diagnostic methods that go beyond simply evaluating mitral regurgitation based on severity to subdivide it according to anatomical etiologies and hemodynamic mechanisms?such as degenerative, ventricular, and atrial types?and understand personalized treatment strategies based on these findings.
3. Analyze the hemodynamic dilemmas of patients with complex valvular disease who are symptomatic despite having a moderate single-indicator rating, or who experience dual pressure and volume loads on the myocardium due to concomitant stenosis and regurgitation (AS+AR), and establish preemptive treatment criteria to overcome blind spots in current guidelines.
4. Application of Data-Driven Precise Risk Stratification and Prediction Models for Mitral Regurgitation (MR)

09:55-10:10	The Role of Myocardial Strain in Asymptomatic Severe VHD: When to Intervene [Speaker] Marielle Scherrer-Crosbie / Hospital of the University of Pennsylvania, USA
10:10-10:25	Clinical Dilemmas and Decision-making in Symptomatic Moderate and Mixed Aortic Valve Disease [Speaker] Sung Ji Park / Sungkyunkwan Univ., Korea
10:25-10:40	Mitral Regurgitation Phenotyping: Degenerative, Ventricular, and Atrial Functional MR and Implications for Intervention [Speaker] Makoto Amaki / National Cerebral and Cardiovascular Center, Japan
10:40-10:55	Advanced Risk Stratification and Data-Driven Phenotyping in Mitral Regurgitation [Speaker] Soongu Kwak / Seoul National Univ., Korea
10:55-11:10	Discussion

Cardiogenic Shock 2

Symposium

Cardiogenic Shock 2

Evolving Approaches to MCS Patients

Oct. 15 (Thu.) 09:55-11:10, Vista 3

Chairpersons : Hyun-Jai Cho , Jae-Seung Jung

Panel : Dae Hwan Bae , Yang Hyun Cho , Hyoung-Won Cho , Min Ju Han

Learning Objective: 1. 새로운 device 인 Impella 및 central ECMO 전환의 적절한 candidate에 대해서 논의합니다.
2. MCS 유지 중 발생할 수 있는 합병증과 다장기 부전을 극복하기 위해, 기계 환기 전략, CRRT의 병합, 그리고 출혈과 혈전의 균형을 잡는 정밀한 항혈전 요법(Antithrombotics)까지 다학제적 고도 중환자 케어의 실제적인 해법을 공유합니다.

09:55-10:10	Which Patients Benefit Most from Impella? [Speaker] Min Chul Kim / Chonnam National Univ., Korea
10:10-10:25	Selecting Candidates for Central ECMO [Speaker] Ji Hoon Kim / Hallym Univ., Korea
10:25-10:40	Mechanical Ventilation Strategies in MCS Patients [Speaker] Ryoung-Eun Ko / Sungkyunkwan Univ., Korea
10:40-10:55	Renal Replacement Therapy During ECMO [Speaker] Ji Hyun CHA / Sungkyunkwan Univ., Korea
10:55-11:10	Antithrombotic Management in ECMO Patients [Speaker] Jeehoon Kang / Seoul National Univ., Korea

ENG Arrhythmia 1

Symposium

ENG Arrhythmia 1

Comprehensive AF Care

Oct. 15 (Thu.) 09:55-11:10, Walker 1

Chairpersons : Seil Oh , Dae Hyeok Kim

Panel : Hwajung Kim , Seong Jin Park , Jinsun Park , Chang Ok Seo , Gain Yu

Learning Objective: 1. Understand the pathophysiological characteristics of atrial fibrillation occurring in patients with HFpEF (Heart Failure with Preserved Ejection Fraction) and acquire knowledge of the clinical utility of catheter ablation in improving the patient's hemodynamic status and heart failure prognosis.
2. Identify modifiable risk factors (obesity, sleep apnea, alcohol consumption, etc.) contributing to the onset and recurrence of atrial fibrillation, and understand the importance of systematic lifestyle modification strategies and patient education to maximize procedural outcomes.
3. Identify the electrophysiological mechanisms by which autonomic nervous system imbalances influence the induction and maintenance of atrial fibrillation, and learn the theory and practice of the latest autonomic nervous system-targeted therapies, such as ganglion ablation (GP) and neuromodulation.
4. Go beyond the simple diagnosis of atrial fibrillation to accurately grasp the concept and measurement methods of 'Atrial Fibrillation Burden (AF Burden),' and analyze the correlation between the degree of Burden and long-term complications such as stroke, heart failure, and cognitive decline.

09:55-10:10	Catheter Ablation of AF in HFpEF: From "Why Not?" to "Why Wait?" [Speaker] Kina Jeon / Catholic Univ., Korea
10:10-10:25	Targeting the Autonomic Nervous System in Atrial Fibrillation: From Pathophysiology to Clinical Intervention [Speaker] Jum Seok Ko / Wonkwang Univ., Korea
10:25-10:40	Targeting the Autonomic Nervous System in Atrial Fibrillation: From Pathophysiology to Clinical Intervention [Speaker] Andre Ng / University of Leicester, UK
10:40-10:55	Beyond the Diagnosis: Why AF Burden Is the New Gold Standard for Risk Stratification [Speaker] Ki Hong Lee / Chonnam National Univ., Korea
10:55-11:10	Discussion

ENG Epidemiology 1

Symposium

ENG Epidemiology 1

Artificial Intelligence for Cardiovascular Disease Prevention: From Risk Prediction to Clinical Implementation

Oct. 15 (Thu.) 09:55-11:10, Walker 2

Learning Objective: 1. Understand AI capabilities and limitations in CVD prevention.
2. Identify how AI improves risk prediction.
3. Describe AI applications in primary prevention.
4. Explain AI use in heart failure management.

09:55-10:10	Artificial Intelligence in Cardiovascular Disease Prevention: Is It Ready for Prime Time?
10:10-10:25	AI for Precision Cardiovascular Risk Prediction: Beyond Traditional Risk Scores
10:25-10:40	AI-Driven Strategies for Primary Prevention of Cardiovascular Disease
10:40-10:55	AI-Enabled Secondary Prevention: Predicting Heart Failure Outcomes and Rehospitalization
10:55-11:10	Discussion

ENG a CAD 1

Oral

ENG a CAD 1

Oct. 15 (Thu.) 09:55-11:10, Grand 4

09:55-10:05 No.21 [K2026F-0141]	High-Intensity Versus Non-High-Intensity Statin Therapy in AMI Patients Achieving LDL-C [Speaker] JAEYONG LEE / Daegu Catholic Univ., Korea
10:05-10:15 No.22 [K2026F-0189]	One-month high sensitivity C-reactive protein versus lipid-related markers for residual risk after percutaneous coronary intervention: a retrospective cohort study [Speaker] Donghyeon Joo / Wonkwang Univ., Korea
10:15-10:25 No.23 [K2026F-0123]	Long term prognostic impact of high intensity statin in elderly diabetic patients with AMI from KAMIR-NIH-LIPID Registry [Speaker] Kyeong Seok Oh / Chungbuk National Univ., Korea
10:25-10:35 No.24 [E2026F-0011]	Sex Differences in Perivascular Adipose Tissue Inflammation in Patients with Suspected Coronary Artery Disease: A Deep Learning-Based Analysis Using Coronary Computed Tomographic Angiography [Speaker] Wenxi Han / Anhui University of Chinese Medicine, Sichuan University, China
10:35-10:45 No.25 [K2026F-0167]	Prognostic Value of Thigh Circumference as new Anthropometric Parameter in Patients With Acute Myocardial Infarction [Speaker] Youngjoon Kwon / Kyungpook National Univ., Korea
10:45-10:55 No.26 [K2026F-0122]	Late Residual Risk in Event-Free Survivors of Acute Myocardial Infarction [Speaker] Doo Sun SIM / Chonnam National Univ., Korea
10:55-11:05 No.27 [K2026F-0061]	Impact of Coronary Artery Spasm on 10-Year Clinical Outcomes in Mild-to-Moderate Atherosclerosis [Speaker] Seung-Woon RHA / Korea Univ., Korea

ENG a Vascular Research

Oral

ENG a Vascular Research

Oct. 15 (Thu.) 09:55-11:10, Grand 5

09:55-10:05 No.28 [E2026F-0073]	Comparative Performance of Inflammatory and Nutritional Biomarkers in Discriminating Chronic Limb-Threatening Ischemia Among Patients with Peripheral Artery Disease [Speaker] Abiseka Panji Baskoro / Universitas Sebelas Maret Hospital, Indonesia
10:05-10:15 No.29 [K2026F-0026]	Novel Device of screening CAD by Non-invasive Estimation of Coronary Resistance and Compliance: Prospective Diagnostic and Retrospective Validation Study. [Speaker] Byoung Kwon Lee / Yonsei Univ., Korea
10:15-10:25 No.30 [E2026F-0120]	Soluble P-Selectin’s Strength as an Adjunctive Biomarker for Deep Vein Thrombosis in Cancer Patients: An Analytic Cross-Sectional Study [Speaker] Eka Fithra Elfi / Dr. M. Djamil General Hospital Padang, Faculty of Medicine Universitas Andalas, Indonesia
10:25-10:35 No.31 [K2026F-0254]	Cumulative LDL-Cholesterol Exposure and Cardiovascular Outcomes in Lower Extremity Arterial Disease: A Single-Center Retrospective Study [Speaker] Joongmin Kim / National Health Insurance Service Ilsan Hospital, Korea
10:35-10:45 No.32 [E2026F-0078]	Clinical profile and outcomes of venous thromboembolism in critically ill patients in Bicol Medical Center [Speaker] Karla Louise Velasco / Bicol Medical Center, Philippines, Philippines
-
-

ENG a Heart Failure 2

Oral

ENG a Heart Failure 2

Oct. 15 (Thu.) 09:55-11:10, Grand 6

09:55-10:05 No.33 [K2026F-0124]	Cardiorenal anemia syndrome and clinical outcomes in patients hospitalized for acute heart failure: A post-hoc analysis from the TRANS-HF trial [Speaker] Moojun Kim / National Health Insurance Service Ilsan Hospital, Korea
10:05-10:15 No.34 [K2026F-0059]	Post-Discharge Blood Pressure Trajectories and Prognosis in Patients Hospitalized for Acute Heart Failure: Insights from the KorHF III Registry [Speaker] Seon-Ah JIN / Chungnam National Univ., Korea
10:15-10:25 No.35 [K2026F-0115]	Kidney Dysfunction Drives the Prognostic Burden of Cardiovascular-Kidney-Metabolic Syndrome in Acute Heart Failure with Reduced Ejection Fraction [Speaker] Jooyeon Lee / Yonsei Univ., Korea
10:25-10:35 No.36 [E2026F-0025]	Exercise Training / Heart Failure Medical Treatment [Speaker] Dr. Anand Patil / Medicover Hospitals, Navi Mumbai, India
10:35-10:45 No.37 [E2026F-0097]	Prognostic value of the CONUT nutritional score in HFpEF: a large-scale cohort study evaluating inflammation-driven effect modification [Speaker] Jiaying Yang / National Center for Cardiovascular Diseases, Fuwai Hospital, CAMS&PUMC , China
10:45-10:55 No.38 [E2026F-0049]	Prognostic value of NT-proBNP in the new era of heart failure with reduced EF treatment [Speaker] NGUYEN VU DAT / Nguyen Tri Phuong Hospital, Ho Chi Minh City, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam
10:55-11:05 No.39 [K2026F-0121]	Beta Blockers Drive the Adherence-Outcome Association After Acute Heart Failure: A Component-Level Analysis from the TRANS-HF trial [Speaker] Moojun Kim / National Health Insurance Service Ilsan Hospital, Korea

Pediatric Cardiology 2

Symposium

Pediatric Cardiology 2

The Road to Fontan: Decision-Making and Modern Surgical Strategy

Oct. 15 (Thu.) 09:55-11:10, Art

Chairpersons : Eun-Jung Bae , Tae-Jin Yun

Panel : Dong-Hee Kim , Seung Min Baek , Woo Seong Chang , Seyong Chung , Gwang-jun Choi

Learning Objective: 1. 단심실 환자의 borderline anatomy에서 1V vs 1.5V vs 2V repair를 결정하는 의사결정 framework과 각 전략의 long-term outcome을 이해합니다.
2. advanced pre-operative imaging을 활용한 surgical planning과, pre-Fontan hemodynamic 평가 및 risk stratification 원칙을 학습합니다.
3. Modern Fontan completion 술기 ? extracardiac vs lateral tunnel 선택, conduit size 및 fenestration strategy를 포함한 최신 surgical refinement를 알아봅니다.

09:55-10:10	Borderline Anatomy: One- or Two-Ventricle Repair? Decision-making and Long Term Outcome [Speaker] Seulgi Cha / Ulsan Univ., Korea
10:10-10:25	One-and-a-Half-Ventricle Repair: Indications, Techniques, and Long-term Outcomes [Speaker] Ji-Hyuk Yang / Sungkyunkwan Univ., Korea
10:25-10:40	Advanced Pre-operative Imaging and Surgical Planning in Single Ventricle
10:40-10:55	Pre-Fontan Evaluation: When Is the Patient Ready? Hemodynamic Assessment, and Risk Stratification [Speaker] So Ick Jang / Bucheon Sejong Hospital, Korea
10:55-11:10	Modern Fontan Completion: Conduit Selection, Fenestration Strategy, and Surgical Refinements [Speaker] Jae Gun Kwak / Seoul National Univ., Korea

11:20-12:35

Main 3

Symposium

Main 3

Junior Cardiologist Voices: Real Stories from Research, Practice, Teaching, and Burnout

Oct. 15 (Thu.) 11:20-12:35, Vista 1

Chairpersons : In-Ho Chae , Eue-Keun Choi

Panel : Jin Joo Park , Jeong Hoon Yang , Il-Young Oh , Seung-Pyo Lee , Young-Hyo Lim

Learning Objective: 전임의 또는 junior staff들이 자신의 경험담을 풀어내는 세션으로 연구, 진료, 교육, 학회 활동, 인간 관계, 번아웃 등을 다룹니다.

11:20-11:35	논문쓰는 사람의 현실: 논문작성이 이렇게 힘든 작업인가? [Speaker] Soongu Kwak / Seoul National Univ., Korea
11:35-11:50	배우는 사람에서 가르치는 사람으로(교육): 후배를 가르치면서 내가 배운 것들
11:50-12:05	버티는 법, 회복하는 법(번아웃): 지치지 않고 오래 일하기 [Speaker] Ji Hyun CHA / Sungkyunkwan Univ., Korea
12:05-12:20	병원 안의 인간관계: 좋은 동료가 좋은 의사를 만든다
12:20-12:35	Discussion

KSPH-KSC Joint Session

Joint Session

KSPH-KSC Joint Session

New Treatment Options for Pulmonary Hypertension in Korea: A Case-Based Learning

Oct. 15 (Thu.) 11:20-12:35, Vista 2

Chairpersons : Wook-Jin Chung , Kye Hun Kim

Learning Objective: 1. 최근 한국 의료 현장에 새로 소개된 폐동맥고혈압약제 및 시술에 대해 알아봅니다.
2. 증례 기반 강의를 통하여 실제 임상의 적용 및 효과를 간접 경험하도록 합니다.

11:20-11:35	Winrevair (Sotartercept), Activin Signaling Inhibitor for Group 1 & Group 2 [Speaker] Dae-Hee Kim / Ulsan Univ., Korea
11:35-11:50	Opsynvi (Macitentan+Tadarafil) for Group 1 [Speaker] Jung Hyun Choi / Pusan National Univ., Korea
11:50-12:05	Riociguat, sGC Stimulator, for Group 1 & Group 4 [Speaker] Sung-A Chang / Sungkyunkwan Univ., Korea
12:05-12:20	Balloon Pulmonary Angioplasty for Group 4 [Speaker] Chul-Min Ahn / Yonsei Univ., Korea
12:20-12:35	Discussion

Myocardial Infarction 1

Symposium

Myocardial Infarction 1

심근경색증 진료지침 2026: 무엇이 어떻게 바뀌었나?

Oct. 15 (Thu.) 11:20-12:35, Vista 3

Chairpersons : Jin Yong Hwang , Myung Ho Jeong

Panel : Taek Geun Kwon , Song-Yi Kim , Jung-Sun Kim , Jong Pil Park , Jin Bae Lee

Learning Objective: 1. 심근경색증의 최신 진료지침을 이해하고 한국의 의료현장에서 적용을 모색합니다.
2. 최신 인공지능기술의 발전정도를 이해하고 실제 임상에서의 적용 가능성을 탐색합니다.
3. 진료지침에 따른 심근경색증의 원인을 감별하여 치료에 적용할 수 있습니다.

11:20-11:35	5th Universal Definition of MI: 무엇이 바뀌고, 왜 중요한가? [Speaker] Min Gyu KANG / Gyeongsang National Univ., Korea
11:35-11:50	응급실 실전 활용: 최신 ACC/AHA & ESC ACS 가이드라인 핵심을 알려주마 [Speaker] Jong Shin Woo / Kyung Hee Univ., Korea
11:50-12:05	2026 심근경색연구회 재관류 진료지침 무엇이 어떻게 바뀌었나? [Speaker] Doyeon Hwang / Seoul National Univ., Korea
12:05-12:20	AI-ECG 기반 심근경색증 진단 및 이송 전략의 현재와 미래 [Speaker] Hyun Wook Ryoo / Kyungpook National Univ., Korea
12:20-12:35	Discussion

Main 4

Symposium

Main 4

Guideline Updates that Will Change Your Practice Tomorrow

Oct. 15 (Thu.) 11:20-12:35, Walker 1

Chairpersons : Bon-Kwon Koo , Geu-Ru Hong

Panel : Hack-Lyoung Kim , Bo Eun Park , Gyu Chul Oh , Soo Yong Lee

Learning Objective: 1. Understand the latest guideline updates in coronary artery disease, including antiplatelet and lipid-lowering strategies, and advances in interventional practice.
2. Understand the universal definition and classification of heart failure (HF), appreciate the emergence of cardiovascular-kidney-metabolic (CKM) syndrome, and update HF with preserved ejection fraction (HFpEF) management incorporating SGLT2 inhibitors, finerenone, and GLP-1 receptor agonists.
3 Recognize the shift from CHA₂DS₂-VASc to CHA₂DS₂-VA and the updated atrial fibrillation (AF) rhythm-control strategy in the 2024 ESC guideline, and understand conduction system pacing (CSP) as a physiological alternative to right ventricular (RV) pacing per the 2025 ESC/EHRA consensus.
4. Understand the personalized, multidisciplinary approach of the 2025 ESC guideline, including antihypertensive drug selection in pregnancy and the timing of surgical and interventional treatment for cardiovascular disease during pregnancy.
5. Update the indications for intervention and the choice between surgical and transcatheter approaches (TAVR, TEER) across the spectrum of valvular heart disease (VHD) per the 2025 ESC/EACTS guideline.

11:20-11:35	Interventional Cardiology: Rewriting Antiplatelet Therapy and Beyond [Speaker] Jeehoon Kang / Seoul National Univ., Korea
11:35-11:50	Heart Failure: A New Definition of HF Types, CKM Syndrome, and the HFpEF Revolution [Speaker] Sunki Lee / Korea Univ., Korea
11:50-12:05	Electrophysiology: From VASc to VA, and RV to Conduction System
12:05-12:20	Cardiovascular Disease in Pregnancy: A Paradigm Shift [Speaker] Seong-Mi Park / Korea Univ., Korea
12:20-12:35	Valvular Heart Disease: Redrawing the Lines Between Surgery and Intervention [Speaker] Hong-Mi Choi / Seoul National Univ., Korea

ENG Epidemiology 2

Symposium

ENG Epidemiology 2

CKM Syndrome: A Multidisciplinary Approach to Cardiovascular Disease Prevention

Oct. 15 (Thu.) 11:20-12:35, Walker 2

Chairpersons : Hyeon Chang Kim , Sang-Ho Jo

Panel : Eunji Kim , Jieun Lee , Inha Jung , Jong Hyun Jhee , Fatima Rodriguez

Learning Objective: 1. Understand the CKM syndrome framework and its relevance to cardiovascular disease prevention.
2. Identify key cardiometabolic risk factors across endocrine, kidney, and liver domains.
3. Describe multidisciplinary perspectives on CKM syndrome from different specialties.
4. Discuss strategies for integrated prevention across the CKM continuum.

11:20-11:35	The Cardiovascular-Kidney-Metabolic (CKM) Syndrome Framework: Implications for CVD Prevention [Speaker] Hokyou Lee / Yonsei Univ., Korea
11:35-11:50	Endocrine Perspective on CKM Syndrome: Implications for CVD Prevention [Speaker] Soo Lim / Seoul National Univ., Korea
11:50-12:05	Kidney Perspective on CKM Syndrome: Implications for CVD Prevention
12:05-12:20	Liver Perspective on CKM Syndrome: Implications for CVD Prevention [Speaker] Hye-Won Lee / Yonsei Univ., Korea
12:20-12:35	Discussion

a Arrhythmia 2

Oral

a Arrhythmia 2

Oct. 15 (Thu.) 11:20-12:35, Grand 4

11:20-11:30 No.40 [K2026F-0242]	Randomized Comparison of Safety and Efficacy of Pulsed Field Ablation in Atrial Fibrillation Patients Treated with a Penta-spline versus a Fixed-Loop Circular Catheter [Speaker] Woong Nam / Chung-Ang Univ., Korea
11:30-11:40 No.41 [K2026F-0255]	Right Heart Reverse Remodeling After Catheter Ablation of Atrial Fibrillation: Association With Tricuspid Regurgitation Response in Severe Functional TR [Speaker] Donghyun Kim / Ulsan Univ., Korea
11:40-11:50 No.42 [K2026F-0157]	Left atrial reverse remodeling is prognostic but does not capture statin-related clinical benefit in atrial fibrillation: a multicenter observational study with external validation [Speaker] In-Soo KIM / Yonsei Univ., Korea
11:50-12:00 No.43 [K2026F-0265]	Cardiopulmonary Exercise Capacity as an Effect Modifier of Catheter Ablation Benefit in Persistent Atrial Fibrillation [Speaker] Min Jeong KIM / Ewha Womans Univ., Korea
12:00-12:10 No.44 [K2026F-0040]	The Association between Life’s Essential 8, Alcohol Consumption, and the Incidence of Atrial Fibrillation: An Analysis using UK Biobank Data [Speaker] Do Young Kim / Catholic Univ., Korea
12:10-12:20 No.45 [K2026F-0085]	Discontinuation of Anticoagulation in Patients at Relatively High Risk of Stroke After Successful Catheter Ablation for Atrial Fibrillation: A Nationwide Cohort Study [Speaker] Young Shin LEE / Kyunghee Univ., Korea
12:20-12:30 No.46 [K2026F-0284]	Prognotic Impact of Body Composition Phenotypes in Atrial Fibrillation: Insights from the UK Biobank [Speaker] Hongju KIM / Dong Kang Hospital, Yonsei Univ., Korea

ENG a Intervention 1

Oral

ENG a Intervention 1

Oct. 15 (Thu.) 11:20-12:35, Grand 5

11:20-11:30 No.47 [K2026F-0071]	Clinical Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors Use After Acute Myocardial Infarction in Patients with Type 2 Diabetes: A Nationwide Population-Based Cohort Study [Speaker] Sang Young KIM / Yonsei Univ., Korea
11:30-11:40 No.48 [K2026F-0194]	On-Beta-Blocker Heart Rate and the Safety of Beta-Blocker Discontinuation in Stabilized Patients After Myocardial Infarction: A Secondary Analysis of the SMART-DECISION Trial [Speaker] Ho Sung Jeon / Yonsei Wonju Univ., Korea
11:40-11:50 No.49 [K2026F-0065]	Differential Prognostic Impact of Nebivolol in STEMI Survivors After Primary PCI: A Risk-Calibrated Analysis [Speaker] Seung-Woon RHA / Korea Univ., Korea
11:50-12:00 No.50 [K2026F-0234]	Bisoprolol versus Nebivolol after Percutaneous Coronary Intervention in Acute Myocardial Infarction with Reduced Left Ventricular Ejection Fraction [Speaker] JunChang Jeong / Yeungnam Univ., Korea
12:00-12:10 No.51 [E2026F-0092]	Ultra-short (≤ 1 Month) versus Standard-Duration Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing PCI [Speaker] Hendrianus Hendrianus / Natuna General Hospital, Indonesia
12:10-12:20 No.52 [E2026F-0088]	Guidance Over Guesswork: Navigating the Future of Femoral Artery Access with Ultrasound Guidance (A Systematic Review and Meta-Analysis) [Speaker] Elen Putri Cintya / Universitas Brawijaya, Indonesia
12:20-12:30 No.53 [E2026F-0114]	PREDICTORS OFOUTCOMES OF PATENT DUCTUS ARTERIOSUS (PDA)DEVICE CLOSURE WITH MODERATE TO SEVERE PULMONARY ARTERIAL HYPERTENSION (PAH)AMONG PEDIATRIC PATIENTS AT A TERTIARY CARDIAC CENTER [Speaker] francis ed gahuman / Philippine Heart Center , Philippines

ENG a Cardiovascular Imaging

Oral

ENG a Cardiovascular Imaging

Oct. 15 (Thu.) 11:20-12:35, Grand 6

11:20-11:30 No.54 [E2026F-0007]	Association of glycemic control with coronary plaque phenotype and burden: a CCTA study in patients with T2DM [Speaker] Xinyu Liu / West China School of Public health and West China Fourth Hospital, SiChuan University, China
11:30-11:40 No.55 [E2026F-0084]	A Deep Learning-Based CT Quantitative Risk Model for Delayed Endothelialization After Left Atrial Appendage Occlusion [Speaker] Qingsong Wang / PLA General Hospital, China
11:40-11:50 No.56 [E2026F-0086]	Quantitative Non-Contrast Cardiac Magnetic Resonance for Assessment of Residual Leaks After Left Atrial Appendage Occlusion A Diagnostic Accuracy Study Compared with Cardiac CTA [Speaker] Qingsong Wang / PLA General Hospital, China
11:50-12:00 No.57 [E2026F-0008]	CCTA Assessment of a Distinct Coronary Phenotype in Pneumoconiosis: Predominance of Noncalcified Plaque and Vascular Inflammation [Speaker] Dan Lin / West China School of Public health and West China Fourth Hospital, SiChuan University, China
12:00-12:10 No.58 [E2026F-0123]	Myocardial Fibrosis as a Stronger Risk Factor for Arrhythmic Mitral Valve Prolapse: A Risk Stratification with Cardiac Magnetic Resonance [Speaker] Elen Elen / National Cardiovascular Center Harapan Kita, Faculty of Medicine, Universitas, Indonesia
12:10-12:20 No.59 [E2026F-0020]	A Small Segment, A Big Impact: The Hidden Risk of Left Main Coronary Calcification [Speaker] Ruth Tri Mentari Lase / University of North Sumatera, Indonesia
12:20-12:30 No.60 [E2026F-0019]	Synergizing Anatomy and Function : Coronary Artery Calcium Score Meets AR-A Duration as Powerful Predictor of Major Adverse Cardiovascular Events [Speaker] Shanda Yudistiawan / University of North Sumatera, Indonesia

Pediatric Cardiology 3

Symposium

Pediatric Cardiology 3

Beyond Fontan Completion: Failing Fontan and Advanced Therapies

Oct. 15 (Thu.) 11:20-12:35, Art

Chairpersons : Jeong Jin Yu , Cheul Lee

Learning Objective: 1. Fontan completion 이후 요구되는 surgical reintervention(conduit change, valve repair, subaortic stenosis repair)의 적응증과 술기적 고려사항을 이해합니다.
2. Failing Fontan의 정의, 진단, risk stratification과, ISHLT 2025 pediatric heart failure guideline에 기반한 pulmonary vasodilator, SGLT2 inhibitor, MRA, ARNI 등 medical therapy의 evidence를 학습합니다.
3. Pre-Fontan 및 failing Fontan 환자에서의 mechanical circulatory support(systemic VAD vs cavopulmonary support, Berlin Heart, HeartMate 3) 전략과, heart 및 combined heart-liver transplantation의 listing criteria·allocation·outcome을 익힙니다.

11:20-11:35	Surgical Requirement after Fontan (Conduit Change, Valve Repair, Subaortic Stenosis Repair...) [Speaker] Eun Seok Choi / Ulsan Univ., Korea
11:35-11:50	Failing Fontan: Definition, Early Recognition and Risk Stratification [Speaker] Sang Yoon LEE / Sungkyunkwan Univ., Korea
11:50-12:05	Medical Therapy for the Failing Fontan: Pulmonary Vasodilators, SGLT2 Inhibitors, and the ISHLT 2025 Update [Speaker] Soo Jin Kim / Bucheon Sejong Hospital, Korea
12:05-12:20	Mechanical Circulatory Support in Single Ventricle: VAD Strategy in Pre-Fontan and Failing Fontan [Speaker] Yu Rim Shin / Yonsei Univ., Korea
12:20-12:35	Heart and Combined Heart-Liver Transplantation in Fontan: Indications, Allocation and Outcomes [Speaker] JinYoung Song / Sungkyunkwan Univ., Korea

13:45-15:00

Main 5

Symposium

Main 5

Cardiac Anatomy Live (Live Main Session ? Learning Heart Disease Through Real Hearts)

Oct. 15 (Thu.) 13:45-15:00, Vista 1

Chairpersons : Jeong Wook Seo , Sang-Chol Lee

Panel : Kim Kyung-Hee , Ju Young Na , Jun-Bean Park , Jae-Sun Uhm , David Hong

Learning Objective: 1. 심장내과 진료에서 자주 마주치는 질문을 중심으로, 주요 심질환의 병리를 이해할 필요성을 설명할 수 있습니다.
2. 허혈성 심질환의 다양한 실제 심장에서 경색의 시기별 육안 소견과 조직학적 진행(응고괴사 → 육아조직 → 섬유성 반흔)을 구분하여 설명할 수 있습니다.
3. 판막 질환의 여러 실제 판막에서 협착·역류를 일으키는 육안 및 조직 변화(석회화, 점액종성 변성, 섬유화)를 해석할 수 있습니다.
4. 비대성·확장성·침윤성 심근병증의 실제 심장에서 대표적 육안 및 현미경 소견을 대응시켜 감별에 활용할 수 있습니다.

13:45-14:00	심장내과 의사가 진료 중 궁금했던 심장병리를 병리의사에게 묻는다 [Speaker] Eun Kyoung Kim / Sungkyunkwan Univ., Korea
14:00-14:15	허혈성 심질환(Ischemic Heart Disease) [Speaker] Jung Sun Kim / Sungkyunkwan Univ., Korea
14:15-14:30	판막 질환(Valvular Heart Disease) [Speaker] Jiwon Koh / Seoul National Univ., Korea
14:30-14:45	심근병증(Cardiomyopathy) [Speaker] Eun Na Kim / Seoul National Univ., Korea
14:45-15:00	Discussion

Women Heart Disease 1

Symposium

Women Heart Disease 1

Atypical Is the New Typical: Recognizing Acute Coronary Syndrome (ACS) and Heart Failure in Women

Oct. 15 (Thu.) 13:45-15:00, Vista 2

Chairpersons : Byoung Kwon Lee , Mi-Seung Shin

Panel : Sung Eun Kim , Ji Hyun Kim , Hack-Lyoung Kim , Jieun Lee , In-Jeong Cho

Learning Objective: 1. 여성 ACS의 비전형적 증상 패턴과 고감도 트로포닌 성별 기준치의 중요성을 이해하고, 진단 공백이 발생하는 원인을 설명할 수 있습니다.
2. HFpEF가 여성에서 불균형적으로 높은 이유를 병태생리적 관점에서 설명하고, 임상에서 놓치지 않기 위한 핵심 단서를 인식할 수 있습니다.
3. 영상 검사에서 여성에 최적화된 접근법의 필요성을 이해하고, 진단 정확도를 높이기 위한 실질적 전략을 적용할 수 있습니다.

13:45-14:00	Atypical ACS Symptoms and Sex-related Diagnostic Delays [Speaker] Song-Yi Kim / Jeju National Univ., Korea
14:00-14:15	Troponin Sex-specific Cutoffs and Implications [Speaker] Ae-Young Her / Kangwon National Univ., Korea
14:15-14:30	HFpEF: Why Women Are Disproportionately Affected [Speaker] Kyeong-Hyeon Chun / Yonsei Univ., Korea
14:30-14:45	CMR and CCTA: Optimization of Imaging for Women [Speaker] Sang-Eun Lee / Ewha Womans Univ., Korea
14:45-15:00	Discussion

Myocardial Infarction 2

Symposium

Myocardial Infarction 2

심근경색 중재시술 2026: 어떻게 치료 할 것인가?

Oct. 15 (Thu.) 13:45-15:00, Vista 3

Chairpersons : Won Kim , Young Joon Hong

Panel : JON SUH , Young Jin Youn , Sang Yeub Lee , Janghoon Lee , Joo-Yong Hahn

Learning Objective: 1. 심근경색증의 중재시술 분야의 혈관내영상 검사와 인공지능기반 관상동맥생리학적 검사의 유용성을 최신 연구를 통해 알아봅니다.
2. 최근 대두되고 있는 약물코팅풍선의 효과와 안정성이 심근경색증 환자에서도 재현될 수 있을지 알아봅니다.
3. 한국의 심인성 쇼크 환자에서 임펠라와 에크모의 활용 가능성을 알아봅니다.

13:45-14:00	조영술만으로는 부족하다? IVUS/OCT는 심근경색중재시술에 필수적인가? [Speaker] Jung-Joon Cha / Korea Univ., Korea
14:00-14:15	Cath Lab으로 들어온 인공지능: 심근경색 다혈관질환에서 AI기반 FFR은 필요한가? [Speaker] Joo Myung Lee / Sungkyunkwan Univ., Korea
14:15-14:30	약물코팅풍선 전성시대: 심근경색 중재시술에도 유용한가? [Speaker] Dong Oh Kang / Korea Univ., Korea
14:30-14:45	심인성 쇼크 치료의 대전환: 임펠라와 에크모 어떻게 적용할까? [Speaker] Yongwhan Lim / Chonnam National Univ., Korea
14:45-15:00	Discussion

Arrhythmia 2

Symposium

Arrhythmia 2

Optimizing Persistent AF Ablation with PFA

Oct. 15 (Thu.) 13:45-15:00, Walker 1

Learning Objective: 1. 지속성 심방세동 환자에서 조기 개입이 임상적 예후에 미치는 이점을 이해하고, PFA를 활용한 최신 치료 전략을 습득합니다.
2. 지속성 심방세동 치료에 있어 폐정맥 격리술(PVI)의 한계를 인식하고, 환자별 심방 기질(Substrate)의 특성에 따른 맞춤형 절제 전략(후벽 격리, 전압 기반 절제 등)의 선택 기준을 정립합니다.
3. PFA(Pulsed Field Ablation) 기술이 지속성 심방세동 시술의 안전성과 효율성에 미치는 변화를 이해하고, 복잡한 기질 치료 시 3D 매핑 시스템 통합이 시술 정밀도와 장기 성공률에 미치는 실익을 비판적으로 고찰합니다.

13:45-14:00	Early Intervention in Persistent AF: Incorporating Lessons from AVANT GUARD into Substrate-Based Strategies
14:00-14:15	Transforming the Strategy for Persistent AF: High-Efficiency Substrate Modification in the Era of PFA
14:15-14:30	The Great PFA Debate: To Map or Not to Map in Persistent AF? Pros: "3D Mapping Is Essential for Persistent AF"
14:30-14:45	The Great PFA Debate: To Map or Not to Map in Persistent AF? Cons: "Fluoro-only PFA Is the Future of Efficiency"
14:45-15:00	Discussion

ENG Case 1

Case

ENG Case 1

Echo & Imaging 1

Oct. 15 (Thu.) 13:45-15:00, Grand 4

13:45-13:53 No.1 [EC2026F-0012]	Ventricular septal defect with Eisenmenger... or not? [Speaker] Yan Limin / Cardiology, National Heart Centre Singapore, Singapore
13:53-14:01 No.2 [KC2026F-0012]	Exercise stress echocardiography to predict recovery of left ventricular function after primary percutaneous coronary intervention in acute coronary syndromes [Speaker] Seweon KIM / Yonsei Univ., Korea
14:01-14:09 No.3 [KC2026F-0018]	Multimodal Imaging of Cardiac Complications in Granulomatosis With Polyangiitis: Aortitis, Complete Atrioventricular Block, and Eccentric Aortic Regurgitation [Speaker] Jo Ha Hye / Hanyang Univ., Korea
14:09-14:17 No.4 [EC2026F-0048]	Unmasking a Large Middle Mediastinal Paraganglioma: The Role of Multimodality Cardiovascular Imaging in Diagnosis and Surgical Planning [Speaker] Shelley Lauren S. Cham / Cardiology, Makati Medical Center, Philippines, Philippines
14:17-14:25 No.5 [EC2026F-0052]	Reversible Constrictive Physiology as the Presenting Feature of Tuberculous Pericarditis in a Young Healthcare Worker: A Diagnostic Odyssey [Speaker] Pramudya Astrid / Anatomy and Histology, Faculty of Medicine, Universitas Brawijaya, Indonesia
14:25-14:33 No.6 [EC2026F-0067]	Echocardiographic Features in the Diagnosis and Prognosis of a Rare Malignant Left Atrial Leiomyosarcoma Invading the Mitral Annulus Mimicking Benign Myxoma: A Case Report [Speaker] Tuoi Nguyen Thi Hong / Cardiology Department, Tam Anh General Hospital of Ho Chi Minh City, Vietnam
14:33-14:41 No.7 [EC2026F-0078]	Platypnea-Orthodeoxia Syndrome as a Cause of Recurrent Positional Transient Loss of Consciousness : A Diagnostic Role of Tilt Table Testing in Patient with Patent Foramen Ovale [Speaker] Diajeng Putri Dewanti / Division of Arrhythmia, National Cardiovascular Center Harapan Kita, Indonesia
14:41-14:49 No.8 [EC2026F-0096]	ALCAPA in elderly patient presented as sudden death. [Speaker] Sergei Iakovlev / Department of Cardiology, Botkin Hospital, Moscow, Russian Federation, Russian Federation
14:49-14:57 No.9 [KC2026F-0047]	Role of Multimodality Imaging in the Diagnosis of Post-TAVR Infective Endocarditis [Speaker] Jung Jiyoon / Yonsei Univ., Korea

ENG Case 2

Case

ENG Case 2

Intervention 1

Oct. 15 (Thu.) 13:45-15:00, Grand 5

13:45-13:53 No.10 [KC2026F-0013]	Stent Implantation for Right Inferior Pulmonary Vein Stenosis which is caused by Angiosarcoma from Left Atrium. [Speaker] Hoyoung Son / Chonnam National Univ., Korea
13:53-14:01 No.11 [KC2026F-0011]	Systemic Thrombolytic Resistance in Antithrombin III Deficiency Rescued by Catheter-Directed Thrombolysis [Speaker] Byengju SON / Dong Kang Hospital, Korea
14:01-14:09 No.12 [EC2026F-0030]	Utility of Hybrid Ablation Techniques in Resistant Calcium and a Stuck Burr [Speaker] Thomas George / Cardiology, Caritas Heart Institute, India
14:09-14:17 No.13 [EC2026F-0035]	Systemic Thrombolysis for High-Risk Pulmonary Embolism in Advanced Hepatocellular Carcinoma: A Therapeutic Dilemma in a Resource-Limited Setting [Speaker] Lutfi Hafiz Zunardi / Sunan Kalijaga General Hospital, Indonesia
14:17-14:25 No.14 [EC2026F-0039]	Iatrogenic Right Coronary Artery Dissection and perforation During Staged PCI with a back ground of early ISR: A Potentially Catastrophic Complication Managed Successfully [Speaker] ABDUL MANAN BARI / cardiology, PGHI Hospital Islamabad, Pakistan
14:25-14:33 No.15 [EC2026F-0043]	Intravenous Alteplase After Protamine Reversal of Procedural Heparin for Hyperacute M1 Occlusion Following Transcatheter Atrial Septal Defect Closure: A Case Report [Speaker] Rajesh Nepal / Department of Cardiology, Nobel Medical College Teaching Hospital, Biratnagar, Nepal, Nepal
14:33-14:41 No.16 [EC2026F-0059]	Post-PCI Recurrent Coronary Vasospasm Suggesting Overlap of Type I and Type II Kounis syndrome [Speaker] Yesui Gankhuyag / Cardiovascular Department, Cardiac Care Unit, Second State Central Hospital of Mongolia, Mongolia
14:41-14:49 No.17 [EC2026F-0064]	The Calcium Score Paradox in Acute Coronary Syndrome: Intravascular Ultrasound-guided Percutaneous Coronary Intervention for Non-calcified Vulnerable Ostial Left Anterior Descending Artery Plaque Detected by Coronary Computed Tomography Angiography [Speaker] Sonya Aprelladiva / Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, National Cardiovascular Center Harapan Kita / Universitas Indonesia Hospital, Indonesia
14:49-14:57 No.18 [EC2026F-0071]	Fulminant Cardiac Tamponade During Rituximab Therapy for Refractory Anti-N-Methyl-D-Aspartate Receptor Encephalitis Resulting in Obstructive Cardiac Arrest: A Case Report [Speaker] Rachelle Anne Cruz / cardiology, Asian Hospital And Medical Center, Philippines

ENG Case 3

Case

ENG Case 3

Pediatric Cardiology 1

Oct. 15 (Thu.) 13:45-15:00, Grand 6

13:45-13:53 No.19 [KC2026F-0021]	A Rare Reversible Etiology of Pediatric Dilated Cardiomyopathy [Speaker] Donghee Jang / Ulsan Univ., Korea
13:53-14:01 No.20 [KC2026F-0027]	Anatomical repair in a patient with congenitally corrected transposition of the great arteries, ventricular septal defect and tricuspid valve straddling [Speaker] Youngkwan SONG / Ulsan Univ., Korea
14:01-14:09 No.21 [KC2026F-0029]	A Challenging Journey to the Systemic Ventricle with Dextrocardia: Catheter Ablation of Ventricular Tachycardia in a Patient with Functional Single Ventricle after Lateral Tunnel Fontan operation [Speaker] BAN Ji Eun / Sejong Hospital, Korea
14:09-14:17 No.22 [EC2026F-0062]	Peripheral Arterial Pseudoaneurysm in an Adolescent With Severe Rheumatic Heart Disease: A Rare Case Report [Speaker] Maria Jeanlin Lagamayo / Pediatric Cardiology, Philippine Heart Center, Philippines
14:17-14:25 No.23 [EC2026F-0063]	Provisional Bifurcation Stenting Technique for Complex Stenosed Ductus Arteriosus and Pulmonary Artery Bifurcation: A Life-Saving Novel Strategy for Ductal Stenting in PA-IVS [Speaker] Dela Ulfiarakhma / Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita Jakarta, Indonesia
14:25-14:33 No.24 [KC2026F-0034]	Successful Aortic Valve Repair in an Infant with Complex Congenital Bicuspid Aortic Stenosis Initially Considered for Valve Replacement [Speaker] Han Cho / Seoul Univ., Korea
14:33-14:41 No.25 [EC2026F-0069]	Total physiological pacing in a patient with TGA post-atrial switch operation (Mustard) [Speaker] Wasim Rashid / Cardiology, Severance cardiovascular hospital, Yonsei University Health system, Korea
14:41-14:49 No.26 [EC2026F-0070]	First-in-human combined pulsed-fieldand radiofrequency ablation for ventricular tachycardia substrate modification in repaired tetralogy of Fallot with Melody valve [Speaker] Wasim Rashid / Cardiology, Severance cardiovascular hospital, Yonsei University Health system, Korea
14:49-14:57 No.27 [EC2026F-0108]	Trans catheter closure of Abernathy malformation in a young boy. [Speaker] Avinash Anantharaj / Cardiology, JIPMER Puducherry India, India

15:10-16:25

ENG ESC-KSC Joint Session

Joint Session

ENG ESC-KSC Joint Session

From Evidence to Implementation: The New ESC Heart Failure Guidelines 2026

Oct. 15 (Thu.) 15:10-16:25, Vista 1

Learning Objective: 1. Review the ESC HF guideline updated for 2026.
2. Identify the latest trends in heart failure treatment, which are undergoing the most rapid changes, and learn tips for applying them to actual patient treatment.
3. Understand the characteristics of heart failure patients with various comorbidities and establish a foundation for collaborative care with various medical specialties.

15:10-15:25	Key Updates in the ESC 2026 Heart Failure Guidelines: What Changed and Why?
15:25-15:40	From Guidelines to Bedside: Practical Implementation of Contemporary HF Care
15:40-15:55	The Expanding Role of Comorbidity Management in Modern HF Guidelines
15:55-16:10	Multidisciplinary and Patient-Centered Approaches in HF Care
16:10-16:25	Discussion

Women Heart Disease 2

Symposium

Women Heart Disease 2

Closing the Gap: Sex-specific Therapeutics and Intervention in Coronary Artery Disease

Oct. 15 (Thu.) 15:10-16:25, Vista 2

Chairpersons : Young Sup Byun , Seong-Mi Park

Panel : Soo Jin Kim , Jin Oh Na , Sang Min Park , Yong Hyun Park , Hyun Ju Yoon

Learning Objective: 1.?여성?ACS?환자에서 나타나는 과소치료(undertreatment)?현황 및 생물학적,?시스템적 요인을 이해합니다.
2.?여성 맞춤형 시술 및 약물 치료 전략을 이해합니다.
3.?심장재활 치료에서 성차를 이해하고,?맞춤형 재활 프로그램 설계의 필요성을 논의할 수 있습니다.

15:10-15:25	Undertreatment of Women with ACS: Evidence, Causes, and Solutions
15:25-15:40	PCI Outcomes in Women: Radial Access, Smaller Vessel Anatomy, Stent Sizing [Speaker] Ho Youn Won / Chung-Ang Univ., Korea
15:40-15:55	Antiplatelet & Anticoagulant Therapy: Sex Differences in Bleeding vs. Ischemic Risk [Speaker] Jung-Won Suh / Seoul National Univ., Korea
15:55-16:10	Cardiac Rehabilitation: Low Participation Rates in Women and Tailored Strategies [Speaker] SungA Bae / Yonsei Univ., Korea
16:10-16:25	Discussion

Cardiometabolic Syndrome 1

Symposium

Cardiometabolic Syndrome 1

Connecting the Dots: Inflammation and Cardiovascular Risk in CKM Syndrome

Oct. 15 (Thu.) 15:10-16:25, Vista 3

Chairpersons : Won Kim , Seung Hwan Han

Panel : Jong Shin Woo , Sung Kee Ryu , Mi-Hyang Jung , Sang-Ho Jo

Learning Objective: 1. 대사적 이상이 만성 전신 염증을 유발하고 죽상경화성 심혈관 위험을 가속화하는 분자생물학적 기전을 이해합니다.
2. 염증성 바이오마커를 활용하여 CKM 증후군 환자의 잔여 염증 위험을 정밀하게 층화하고 평가하는 임상적 능력을 배양합니다.
3. 심혈관 위험의 핵심 타겟인 Lp(a)의 병태생리적 역할을 파악하고, 이를 겨냥한 차세대 혁신 치료 전략을 습득합니다.

15:10-15:25	Metabolic Origins of Inflammation [Speaker] Hun-Jun Park / Catholic Univ., Korea
15:25-15:40	Vascular and Systemic Inflammation [Speaker] Hyung Joon Joo / Korea Univ., Korea
15:40-15:55	Lp(a) as a Novel Therapeutic Target in Cardiovascular Therapy [Speaker] Jin Wi / Gachon Univ., Korea
15:55-16:10	Inflammatory Biomarkers and Cardiovascular Risk Stratification [Speaker] Sang Eun Lee / Ulsan Univ., Korea
16:10-16:25	Discussion

Arrhythmia 3

Symposium

Arrhythmia 3

Next-Generation Stroke Prevention in Atrial Fibrillation

Oct. 15 (Thu.) 15:10-16:25, Walker 1

Chairpersons : Nam Ho Kim , Hui Nam Pak

Panel : Moon-Hyun KIM , Ung Jeong Do , Hee Tae Yu , Sung Ho Lee , Seyong Chung

Learning Objective: 1. 심방세동 환자의 뇌졸중 예방 전략 변화와 최신 근거를 이해합니다.
2. AF-CAD 환자의 항혈전 치료, LAAO, Factor XIa inhibitor, AI 기반 위험도 평가 등 차세대 stroke prevention 전략의 임상 적용 방안을 습득합니다.

15:10-15:25	Less Is More? Contemporary Antithrombotic Strategies for AF and CAD [Speaker] Seung-Jun Lee / Yonsei Univ., Korea
15:25-15:40	Left Atrial Appendage Occlusion in 2026: Who Truly Benefits? [Speaker] Seung Yong Shin / Korea Univ., Korea
15:40-15:55	Factor XIa Inhibitors and the Future of Precision Antithrombotic Therapy [Speaker] Yae Min Park / Gachon Univ., Korea
15:55-16:10	Artificial Intelligence-Based Biological Risk Profiling in AF [Speaker] Yongsoo Baek / Inha Univ., Korea
16:10-16:25	Discussion

Cardiovascular Imaging

Symposium

Cardiovascular Imaging

Advances in Multimodality Diagnosis of Ischemic Heart Disease

Oct. 15 (Thu.) 15:10-16:25, Walker 2

Chairpersons : Won Jun Kang , Eui-Young Choi

Panel : Cherry Kim , Sang-Eun Lee , Seok Hyun Lee , Sung-A Chang

Learning Objective: 1. 허혈성 심질환 진단 및 평가를 위한 최신 다중영상기법(multimodality imaging)의 역할을 이해합니다.
2. 기존 관상동맥 내 영상기법에서 AI 융합 영상기법까지의 발전 과정과 임상적 적용을 설명할 수 있습니다.
3. 허혈성 심질환의 조기 진단에서 최신 심초음파 기법 및 AI 기반 심초음파의 역할을 이해합니다.
4. 관상동맥질환에서 인공지능 기반 ECG 분석의 원리와 임상적 활용 가능성을 설명할 수 있습니다.
5. Photon-counting CT의 특징과 허혈성 심질환 영상에서의 최신 적용 분야를 이해합니다.
6. 허혈성 심질환에서 핵의학 심장영상(nuclear cardiology)의 최신 업데이트와 향후 발전 방향을 정리할 수 있습니다.

15:10-15:25	Evolution of Intracoronary Imaging: From Conventional Imaging to AI-Integrated Imaging [Speaker] Yong Cheol Kim / Yonsei Univ., Korea
15:25-15:40	Inovations in Echocardiography for Early Detection of Ischemic Heart Disease: Including AI Echocardiography [Speaker] Jiesuck Park / Seoul National Univ., Korea
15:40-15:55	Artificial Intelligence?Based ECG Analysis in Coronary Artery Disease [Speaker] Youngjin Cho / Seoul National Univ., Korea
15:55-16:10	Nuclear Cardioogy in Ischemic Heart Disease: Recent Update [Speaker] Ki-Seong Park / Chonnam National Univ., Korea
16:10-16:25	Photon-Counting CT in Ischemic Heart Disease: Redefining Coronary Imaging? [Speaker] Eun-Ah Park / Seoul National Univ., Korea

ENG Young Investigator award Competition 1
1-6

YIC

ENG Young Investigator award Competition 1
1-6

Oct. 15 (Thu.) 15:10-16:25, Grand 4

15:10-15:20 No.1 [K2026F-0281]	Clonal Hematopoiesis Predicts Postoperative Complications and Distinct Perioperative Immune Remodeling After Surgical Aortic Valve Replacement [Speaker] Yoonjin Kang / Seoul Univ., Korea
15:20-15:30 No.2 [K2026F-0075]	Intravital Multispectral Imaging Reveals that Psychological Stress Accelerates Myeloid Cell Recruitment and Pro-Inflammatory Macrophage Polarization in Atherosclerotic Plaques [Speaker] Seung Ho Shin / Korea Univ.,Korea Univ., Korea
15:30-15:40 No.3 [K2026F-0136]	Development of a Scalable and Reproducible Human Cardiac Organoid Model Enabled by Optimized Sequential Differentiation [Speaker] Sooji Yoo / Chonnam National Univ., Korea
15:40-15:50 No.4 [K2026F-0271]	Long-Term Multiorgan Outcomes After Neonatal Congenital Heart Surgery: Biventricular Repair versus Staged Intervention in a Nationwide IPTW-Adjusted Competing-Risk Cohort [Speaker] Jihye You / Jeonbuk National Univ., Korea
15:50-16:00 No.5 [K2026F-0050]	Identification of Atrial Arrhythmia Using Artificial Intelligence Analysis of Sinus Rhythm Holter ECG in Adults With Repaired Tetralogy of Fallot [Speaker] Seung Min Baek / Seoul Univ., Korea
16:00-16:10 No.6 [E2026F-0132]	A primate genetic model organism for cardiovascular disease [Speaker] Stephen Chang / Stanford University School of Medicine, Stanford University School of Medicine, United States
-

ENG Young Investigator award Competition 2
7-12

YIC

ENG Young Investigator award Competition 2
7-12

Oct. 15 (Thu.) 15:10-16:25, Grand 5

15:10-15:20 No.7 [E2026F-0035]	Explainable AI-ECG for Occlusive Myocardial Infarction Detection and Revascularization Stratification: An International Multicenter Validation Study [Speaker] Chiao Hsiang Chang / Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, R.O.C., Taiwan
15:20-15:30 No.8 [K2026F-0235]	Prevalence and Prognostic Impact of Coronary Microvascular Dysfunction According to Heart Failure: Insights from the Multicenter FLOW-CMD Registry [Speaker] Sang Yoon LEE / Sungkyunkwan Univ., Korea
15:30-15:40 No.9 [K2026F-0140]	AI-Driven Precision Medicine for DAPT Duration After PCI: A Patient-Level Pooled Analysis of Two Randomized Trials [Speaker] Junpil Yun / Seoul Univ., Korea
15:40-15:50 No.10 [K2026F-0146]	Artificial intelligence enabled Electrocardiographic prediction and Global risk Index Stratification (AEGIS) score for Predicting Ejection Fraction Decline After Myocardial Infarction with preserved ejection fraction - A Single Center Retrospective Cohort Study [Speaker] ohchul kwon / Seoul Univ., Korea
15:50-16:00 No.11 [K2026F-0105]	De-escalation Antiplatelet Strategies in High-Ischemic Risk Patients After Acute Coronary Syndrome: An Individual Patient Data Meta-analysis [Speaker] Sang Hyun Kim / Catholic Univ., 국군수도병원, Korea
16:00-16:10 No.12 [K2026F-0162]	Prognostic Implication of CYP2C19 Genotype During Chronic Clopidogrel Monotherapy After Percutaneous Coronary Intervention [Speaker] Jinhwan Jo / Chung-Ang Univ., Korea
-

ENG a Epidemiology 1

Oral

ENG a Epidemiology 1

Oct. 15 (Thu.) 15:10-16:25, Grand 6

15:10-15:20 No.61 [K2026F-0279]	Deviation from AI-learned electrocardiographic age and sex representations reveals physiological vulnerability to major adverse cardiovascular events [Speaker] Hanjin Park / Yonsei Univ., Korea
15:20-15:30 No.62 [E2026F-0100]	Artificial Intelligence (AI)?Enhanced Electrocardiography (ECG) as a Screening Tool for Clinically Significant Mitral Stenosis (MS) and Mitral Regurgitation (MR) in a Rheumatic-Endemic Population [Speaker] Muhamad Fajri Addai / Faculty of Medicine, Universitas Indonesia - National Cardiovascular Center Harapan Kita, Jakarta, Indonesia
15:30-15:40 No.63 [E2026F-0083]	Enhancing Cardiovascular Disease Prevention and Triage through an AI-Assisted Regional ECG Collaborative Network [Speaker] Qingsong Wang / PLA General Hospital, China
15:40-15:50 No.64 [K2026F-0056]	Clinical efficacy of a digital therapeutic for cardiac rehabilitation : a multicenter randomized controlled trial [Speaker] Jun Hyeong SONG / Inje Univ., Korea
15:50-16:00 No.65 [E2026F-0139]	Cardiac Yoga Protocol Improves Exercise Capacity and Attenuates Vascular Inflammation in Patients with Coronary Artery Disease Following Percutaneous Coronary Intervention: A Randomized Controlled Trial [Speaker] Swati Kumari / Post Graduate Institute Of Medical Education and Research, India
16:00-16:10 No.66 [K2026F-0288]	Low LDL-Cholesterol and the Risk of Hemorrhagic Stroke in Patients with Atrial Fibrillation Patients Initiating Anticoagulation: A Nationwide Cohort Study [Speaker] Seokmoon HAN / Seoul Univ., Korea
16:10-16:20 No.67 [E2026F-0043]	The Relationship Between Triglycerides Glucose Index with Coronary Artery Disease in Patients with Positive Treadmill Test [Speaker] Oeij Henri Wijaya / Faculty of Medicine, Public Health and Nursing Gadjah Mada University Yogyakarta., National Cardiovascular Center Harapan Kita, Jakarta, Indonesia

Adult Congenital Heart Disease 1

Symposium

Adult Congenital Heart Disease 1

How Shold We Follow up and Treat Adults with Repaired Tetralogy of Fallot?

Oct. 15 (Thu.) 15:10-16:25, Art

Chairpersons : Hyoung Doo Lee , Eun-Jung Bae

Panel : Chang Sin Kim , Cheul Lee , Seulgi Cha , Kwang Ho Choi

Commenter : Jae Young Choi

Learning Objective: 1. 성인기 팔로사징후 환자에서 영상검사를 활용한 체계적인 추적 평가 방법을 이해합니다.
2. 성인기 팔로사징후 환자에서 발생하는 부정맥의 평가와 치료 전략을 이해합니다.
3. 성인기 팔로사징후 환자의 비수술적 치료와 수술적 치료의 적응증 및 최신 치료 전략을 이해합니다.

15:10-15:25	Echocardiographic Assessment in Adults with Repaired Tetralogy of Fallot [Speaker] Jae Young Lee / Catholic Univ., Korea
15:25-15:40	The Role of Cardiac MRI and CT in Adults with Repaired Tetralogy of Fallot [Speaker] Hyun Woo Goo / Ulsan Univ., Korea
15:40-15:55	Transcatheter Management in Adults with Repaired Tetralogy of Fallot [Speaker] Gi Beom Kim / Seoul National Univ., Korea
15:55-16:10	Arrhythmia Risk and Management in Adults with Repaired Tetralogy of Fallot [Speaker] Jae-Sun Uhm / Yonsei Univ., Korea
16:10-16:25	Surgical Management in Adults with Repaired Tetralogy of Fallot? [Speaker] Chang-Ha Lee / Bucheon Sejong Hospital, Korea

16:35-17:50

ENG Intervention 3

Symposium

ENG Intervention 3

Hot topic of TAVR in 2026

Oct. 15 (Thu.) 16:35-17:50, Vista 1

Chairpersons : Seung-Hyuk Choi , Ung Kim

Panel : Kwon Oh Sung , Jae Sung Yu , Cheal Hyun Lee , Jo Ha Hye , Jung-Kyu Han

Learning Objective: 1. To understand the current evidence and guideline recommendations for TAVI in asymptomatic severe aortic stenosis
2. To understand the prevalence and high-risk features associated with reintervention following TAVR.
3. To compare the advantages and limitations of TAVR versus SAVR in patients with bicuspid aortic stenosis.

16:35-16:50	TAVI in Asymptomatic Severe Aortic Stenosis [Speaker] David J. Cohen / St. Francis Hospital & Heart Center, USA
16:50-17:05	Incidence and Predictors of Reintervention After TAVR [Speaker] Jung-Min Ahn / Ulsan Univ., Korea
-	Debate: Optimal Treatment for Severe Bicuspid Aortic Stenosis
17:05-17:20	Surgery Remains the Only Class I Indication [Speaker] Hyung Gon Je / Seoul National Univ., Korea
17:20-17:35	Why Not TAVR? [Speaker] Byung-Hee Hwang / Catholic Univ., Korea
17:35-17:50	Discussion

ENG ACC-KSC Joint Session

Joint Session

ENG ACC-KSC Joint Session

ACC Meets KSC in 2026

Oct. 15 (Thu.) 16:35-17:50, Vista 2

Chairpersons : Wayne Batchelor , Bon-Kwon Koo

Panel : Jung-Sun Kim , Hyung-Bok Park , Sang-Ho Jo , So-Yeon Choi , Cheol Ung Choi

Learning Objective: 1. To deliver key clinical insights from recent ACC-presented RCTs, including Ez-PAVE and SMART-DECISION, and to use them as a basis for discussing the broader topic beyond each individual trial.
2. To bridge ACC and KSC perspectives within current guidelines and ongoing controversies.

16:35-16:50	LDL Cholestetrol Targeting in Atherosclerotic Cardiovascular Disease: The Ez-PAVE Trial & More [Speaker] Byeong-Keuk Kim / Yonsei Univ., Korea
16:50-17:05	Transcatheter Tricuspid Valve Therapy: Initial US Commercial Experience [Speaker] Wayne Batchelor / Inova Health System, USA
17:05-17:20	Beta Blocker Therapy After Myocardial Infarction: The SMART-DECISION Trial & More [Speaker] Joo-Yong Hahn / Sungkyunkwan Univ., Korea
17:20-17:35	Contemporary Landscape of Treatment of Aortic Regurgitation [Speaker] Aakriti Gupta / Cedars-Sinai Medical Center, USA
17:35-17:50	Discussion

Cardiometabolic Syndrome 2

Symposium

Cardiometabolic Syndrome 2

Paradigm Shifts in Obesity: Expanding Horizons

Oct. 15 (Thu.) 16:35-17:50, Vista 3

Chairpersons : Byung Jin Kim , Sang Hyun Ihm

Panel : Jang-Young Kim , Mi-Seung Shin , Hyemoon Chung , Jeong Cheon Choe

Learning Objective: 1. 비만의 역사적 변천 과정을 고찰하고, 현대 의학이 정의하는 최신 기준과 임상적 개념을 파악합니다.
2. 비만이 심혈관계에 미치는 병태생리적 메커니즘을 규명하고, 주요 심혈관 합병증과의 연관성을 명확히 파악할 수 있습니다.
3. 비만 관리에 영향을 미치는 사회·환경적 요인들을 분석하고, 이를 극복하기 위한 다차원적이고 최신 치료 전략을 습득합니다.

16:35-16:50	Clinical Obesity: Evolution and Definition
16:50-17:05	Fat and the Heart: The Cardiovascular Impact of Obesity [Speaker] Kim Kyung-Hee / Sejong Hospital, Korea
17:05-17:20	Social Determinants of Health in Obesity Management [Speaker] Seungjoon Park / Kyung Hee Univ., Korea
17:20-17:35	Multidimensional Approaches in Contemporary Obesity Therapy [Speaker] Mi Hye Seo / Soonchunhyang Univ., Korea
17:35-17:50	Discussion

Main 6

Symposium

Main 6

The Emergence of Cardio-Kidney-Liver-Metabolic Syndrome

Oct. 15 (Thu.) 16:35-17:50, Walker 1

Learning Objective: 1. CKM에서 CKLM syndrome으로의 개념 확장 배경과 간(liver)을 포함한 multiorgan 상호작용의 병태생리 기전(meta-inflammation, insulin resistance, lipotoxicity, fibrotic remodeling)을 이해합니다.
2. MASLD/MASH가 심혈관 · 신장 outcome에 미치는 영향과 그 양방향 상호작용에 대한 최신 epidemiologic · pathophysiologic 근거를 습득합니다.
3. SGLT2 inhibitor, GLP-1/dual GIP-GLP-1 receptor agonist, finerenone 등 CKLM 전 영역에 작용하는 약제의 임상 적용 전략과, cardiologist가 활용할 수 있는 non-invasive liver fibrosis 선별 · 위험 층화 방법을 익힙니다.

16:35-16:50	The Necessity for the Birth of CKLM Syndrome: From the Cradle to the Grave [Speaker] Soo Lim / Seoul National Univ., Korea
16:50-17:05	MASLD, the New Kid on the Block: Why the Liver Joins the Equation [Speaker] Dae Won Jun / Hanyang Univ., Korea
17:05-17:20	One Drug, Multiple Organs: GLP-1 RA and the Cardiometabolic Continuum [Speaker] Jorge Plutzky / Brigham and Women's Hospital, USA
17:20-17:35	I am a Doctor Taking Weight-Loss Injections (나는 비만 주사를 맞는 의사다) [Speaker] Hyoung Woo Chang / Seoul National Univ., Korea
17:35-17:50	Discussion

ENG Cardio-Oncology

Symposium

ENG Cardio-Oncology

Post-Cancer Cardiovascular Risk: From Inflammation to Metabolic Interventions

Oct. 15 (Thu.) 16:35-17:50, Walker 2

Learning Objective: 1. Describe the emerging mechanisms of post-cancer CV risk, including accelerated cardiovascular aging, chronic inflamation, and changes in body composition.
2. Recognize the clinical implications of cardiometabolic and CKM risk in cancer survivors.
3. Discuss potential intervention strategies to improve cardiovascular health in cancer survivors.

16:35-16:50	Post-Cancer Accelerated CV aging - Inflammation as a Shared Pathway [Speaker] June-Wha Rhee / City of Hope Comprehensive Medical Center, USA
16:50-17:05	Body Composition Changes and CKM Risk after Cancer Treatment [Speaker] Mi-Hyang Jung / Catholic Univ., Korea
17:05-17:20	Role of Exercise and Rehabilitation in Post-Cancer CV Risks [Speaker] Kyuwan Lee / Ewha Womans University, Korea
17:20-17:35	Potential Role of GLP-1 Agonists and Metabolic Interventions for Cancer Survivors [Speaker] Jee Hee Yoon / Chonnam National Univ., Korea
17:35-17:50	Discussion

ENG Young Investigator award Competition 3
13-18

YIC

ENG Young Investigator award Competition 3
13-18

Oct. 15 (Thu.) 16:35-17:50, Grand 4

16:35-16:45 No.13 [K2026F-0053]	Statin therapy and total mortality in individuals with different lipoprotein(a) levels [Speaker] Yujin SHIN / Yonsei Univ., Korea
16:45-16:55 No.14 [K2026F-0149]	Exercise Hemodynamic Characterization of Obese Heart Failure With Preserved Ejection Fraction [Speaker] David Hong / Sungkyunkwan Univ., Korea
16:55-17:05 No.15 [K2026F-0037]	Artificial intelligence-enabled electrocardiography to predict left ventricular ejection fraction decline in patients with symptomatic obstructive hypertrophic cardiomyopathy receiving mavacamten [Speaker] Jee-Woong CHOI / Seoul Univ., Korea
17:05-17:15 No.16 [K2026F-0155]	Clinical Characteristics and Outcomes of Patients with Right Ventricular-Dominant Cardiogenic Shock on Venoarterial Extracorporeal Membrane Oxygenation [Speaker] Ye Chan Kim / Sungkyunkwan Univ., Korea
17:15-17:25 No.17 [K2026F-0182]	Clinical Risk and Long-Term Outcomes After Fractional Flow Reserve- versus Intravascular Ultrasound-Guided Percutaneous Coronary Intervention [Speaker] Jihun Song / Keimyung Univ., Korea
17:25-17:35 No.18 [K2026F-0251]	Clonal hematopoiesis of indeterminate potential and progression from paroxysmal to persistent atrial fibrillation [Speaker] Jae-Hyun Kim / Seoul Univ., Korea
-

ENG Young Investigator award Competition 4
19-24

YIC

ENG Young Investigator award Competition 4
19-24

Oct. 15 (Thu.) 16:35-17:50, Grand 5

16:35-16:45 No.19 [K2026F-0038]	Fully Automated Multi-Chamber Strain Profiling in Consecutive All-Comer Echocardiography: Feasibility, Phenotyping, and Prognostic Implications [Speaker] Su A Noh / Seoul Univ.,Seoul Univ., Korea
16:45-16:55 No.20 [K2026F-0110]	Physiological Left Atrial Staging in Hypertrophic Cardiomyopathy and the Risk of New-onset Atrial Fibrillation [Speaker] JAEHYUN LIM / Seoul Univ., Korea
16:55-17:05 No.21 [K2026F-0151]	Beyond Symptoms: Development and Internal Validation of a Prognostic Risk Score in Isolated Severe Tricuspid Regurgitation [Speaker] Da-Eun Sung / Sungkyunkwan Univ., Korea
17:05-17:15 No.22 [K2026F-0041]	Lipoprotein(a) and Progression of Aortic Valve Stenosis :A Propensity Analysis [Speaker] Ga Yun Kim / Ulsan Univ., Korea
17:15-17:25 No.23 [E2026F-0039]	Progressive Inflammatory Plaque Remodeling in Cardiac Allograft Vasculopathy: A Five-Year Serial Optical Coherence Tomography Study [Speaker] Marina Arai / Tohoku University Graduate School of Medicine, Japan
17:25-17:35 No.24 [K2026F-0118]	Refined Annotations and Specialized Augmentation for Minor Epicardial Arteries in Coronary Angiography [Speaker] Do-Hyun Kim / Seoul Univ., Korea
-

a Epidemiology 2

Oral

a Epidemiology 2

Oct. 15 (Thu.) 16:35-17:50, Grand 6

16:35-16:45 No.68 [K2026F-0280]	Gene-Specific Clonal Hematopoiesis and Cardiovascular Disease as Independent Risk Factors for Incident Dementia: A UK Biobank Study [Speaker] Moon-Hyun KIM / Ewha Womans Univ., Korea
16:45-16:55 No.69 [K2026F-0086]	Clinical Predictors of Stroke in the Hemodialysis Population: Evidence from a National Health Insurance Cohort [Speaker] Gaon Sim / Jeonbuk National Univ., Korea
16:55-17:05 No.70 [K2026F-0218]	Muscle-strengthening Activity and Clinical Outcomes after Incident Atrial Fibrillation: A Korean Nationwide Cohort Study [Speaker] Jaewook Chung / Seoul Univ., Korea
17:05-17:15 No.71 [K2026F-0229]	Degree of Urbanization and the Prevalence of Hypertension and Diabetes Mellitus in South Korea (Insight from Gyeonggi Province): A Cross-Sectional Analysis with Temporal Trends, 2008?2023 [Speaker] Sang-Suk Choi / Catholic Univ., Korea
17:15-17:25 No.72 [K2026F-0249]	Cardiovascular-kidney-metabolic syndrome among Korean young adults: KNHANES 2008-2024 [Speaker] Hyojin Kim / Seoul Univ., Korea
17:25-17:35 No.73 [K2026F-0156]	Esomeprazole Cotherapy and Bleeding Outcomes in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants [Speaker] Hyeong-Jun Noh / VHS Medical Center, Korea
17:35-17:45 No.74 [K2026F-0102]	Performance Evaluation of a PCG-PPG-Based Multimodal AI Architecture for the Diagnosis of Valvular Heart Disease. [Speaker] Qun Wei / Keimyung Univ., Korea

Adult Congenital Heart Disease 2

Symposium

Adult Congenital Heart Disease 2

How Should We Evaluate and Manage Coarctation of the Aorta in Adults?

Oct. 15 (Thu.) 16:35-17:50, Art

Chairpersons : JinYoung Song , Lucy Youngmin Eun

Panel : Woong Chol Kang , I Seok Kang , Hoon Ko , Jun-Bean Park , Jue Seong Lee

Commenter : I Seok Kang

Learning Objective: 1. 성인기 대동맥 축착 환자를 진단과 평가 방법을 이해합니다.
2. 성인기 대동맥 축착 환자의 비수술적 치료와 수술적 치료 전략을 이해합니다.
3. 성인기 대동맥 축착 환자의 고혈압 관리및 수술 후 합병증을 이해합니다.

16:35-16:50	Diagnosis and Evaluation of Native, Residual, and Recurrent Coarctation in Adults? [Speaker] Joung-Hee Byun / Pusan National Univ., Korea
16:50-17:05	Catheter-Based Treatment for Coarctation of the Aorta in Adults [Speaker] So Ick Jang / Bucheon Sejong Hospital, Korea
17:05-17:20	Surgical Treatment for Coarctation of the Aorta in Adults [Speaker] Hyungtae Kim / Pusan National Univ., Korea
17:20-17:35	Hypertension in Adults with Coarctation of the Aorta: Before and After Repair [Speaker] Jae-Hyeong Park / Chungnam National Univ., Korea
17:35-17:50	Late Aortic Complications after Coarctation Repair [Speaker] Woong-Han Kim / Seoul National Univ., Korea

10.16 Fri.

08:30-09:45

Intervention 4

Symposium

Intervention 4

Optimizing PCI in Patients with High-Risk Features: Case-Based Hot Debates

Oct. 16 (Fri.) 08:30-09:45, Vista 1

Chairpersons : Hyeon-Cheol Gwon , Youngkeun Ahn

Panel : Sinhyeok Kang , Dong Kie Kim , Jae-Hyeong Park , Chul-Min Ahn

Learning Objective: 1. 급성심근경색 및 다혈관질환을 동반한 심인성 쇼크 환자에서 재관류 전략과 기계적 순환보조장치 적용 시점에 대한 최신 근거와 임상적 쟁점을 이해합니다.
2. 허혈 및 출혈 위험이 모두 높은(bi-risk) PCI 환자에서 최적의 항혈전제 치료 전략에 대한 근거와 실제 적용 방안을 논의합니다.
3. 증례 기반 전문가 토론을 통해 고위험 PCI 환자에서의 실제 임상 의사결정 과정을 학습합니다.

-	Debate 1 - Revascularization Extent and MCS Strategy in Cardiogenic Shock
08:30- 08:35	Case 1 - AMI with Multi-Vessel Disease Complicated by Cardiogenic Shock [Speaker] Woo Jin Jang / Chung-Ang Univ., Korea
08:35-08:45	Culprit-Only PCI, with Escalation When Needed: Keep It Simple and Fast [Speaker] Janghoon Lee / Kyungpook National Univ., Korea
08:45- 08:55	MCS First, Then Complete Revascularization: Don’t Leave Ischemia Behind [Speaker] Jeong Hoon Yang / Sungkyunkwan Univ., Korea
08:55- 09:07	Discussion
-	Debate 2 - Post-PCI Antithrombotic Strategy in Bi-Risk Patients
09:07- 09:12	Case 2 - High Ischemic and Bleeding Risk (Bi-Risk) Patients After PCI [Speaker] Hanbit Park / Ulsan Univ., Korea
09:12-09:22	Ischemic Risk Comes First: Maintain Potent P2Y12-Based DAPT [Speaker] Kyung Woo Park / Seoul National Univ., Korea
09:22-09:32	Bleeding Kills Too: Individualized De-escalation is the Answer [Speaker] Young Bin Song / Sungkyunkwan Univ., Korea
09:32-09:44	Discussion
09:44-09:45	Wrap-up and Voting

ENG Echocardiography 3

Symposium

ENG Echocardiography 3

Strain Imaging in Subclinical and Multisystem Disease

Oct. 16 (Fri.) 08:30-09:45, Vista 2

Chairpersons : Hae Ok Jung , Jae-Hyeong Park

Panel : Saerom Kim , Byung Joo Sun , Chi Young Shim , Nuri Lee

Learning Objective: 1. Understand the clinical value of left atrial (LA) strain as a novel biomarker for asymptomatic heart disease, and explain how an integrated assessment combining LA and left ventricular (LV) strain (Integrated LA and LV strain) presents a new prognostic prediction paradigm that goes beyond existing indicators (LVEF/LVESD).
2. Apply the principles of strain imaging techniques and monitoring to clinical practice to detect cardiotoxicity and asymptomatic cardiac dysfunction early in patients undergoing anticancer therapy.
3. Learn methods to utilize strain for the early diagnosis of subclinical cardiac dysfunction and the assessment of multisystem disease risk in patient populations with systemic diseases such as hypertension, diabetes, and chronic kidney disease (CKD).

08:30-08:45	LA Strain as a Novel Biomarker in Subclinical Heart Disease [Speaker] Hyue Mee Kim / Chung-Ang Univ., Korea
08:45-09:00	Integrated LA and LV Strain Assessment: A New Prognostic Paradigm [Speaker] Jin Kyung Oh / Chungnam National Univ., Korea
09:00-09:15	Strain Monitoring in Cardio-oncology [Speaker] Marielle Scherrer-Crosbie / Hospital of the University of Pennsylvania, USA
09:15-09:30	Detecting Subclinical Cardiac Dysfunction in Hypertension, Diabetes, and CKD [Speaker] Jiwon Seo / Yonsei Univ., Korea
09:30-09:45	Discussion

Hypertension 1

Symposium

Hypertension 1

The Measurement Paradigm Shift: Out-of-Office BP and Cuffless Devices

Oct. 16 (Fri.) 08:30-09:45, Vista 3

Chairpersons : Jinho Shin , Kwang-il Kim

Panel : Min Gyu Kong , Woohyeun Kim , Jin Oh Na , Hyung Joon Joo

Learning Objective: 1. 진료실혈압 측정의 한계를 이해하고, 고혈압의 진단과 치료에서 활동혈압측정과 가정혈압측정을 포함한 진료실 밖 혈압 측정의 임상적 중요성을 설명할 수 있습니다.
2. 야간고혈압, 아침고혈압, dipping pattern, 혈압변동성이 심혈관위험도 평가와 치료 전략 수립에 갖는 의미를 이해합니다.
3. 커프리스 혈압 측정기기의 근거, 한계, 임상 적용 가능성을 비판적으로 평가하고, 실제 진료 workflow에 통합하기 위한 고려사항을 논의합니다.

08:30-08:45	Office BP Is Not Enough: Why Out-of-Office BP Became Central in Hypertension Care [Speaker] Eun Mi Lee / Dongguk Univ., Korea
08:45-09:00	Nocturnal and Morning Hypertension: The Missing Target in Routine Practice [Speaker] Byung Sik KIM / Hanyang Univ., Korea
09:00-09:15	The World's First Cuffless Recommendation: What Was the Evidence? [Speaker] Hae-Young Lee / Seoul National Univ., Korea
09:15-09:30	How Should Cuffless BP Monitoring Be Integrated Into Clinical Workflows? [Speaker] Jeong-Hun Shin / Hanyang Univ., Korea
09:30-09:45	Discussion

Arrhythmia 4

Symposium

Arrhythmia 4

Contemporary Approaches to Complex SVTs

Oct. 16 (Fri.) 08:30-09:45, Walker 1

Chairpersons : Yong Seog Oh , Sung-Won Jang

Panel : Yeji Kim , Hye Ree Kim , Kwang Jin Chun , Chai Min Jung

Learning Objective: 1. 다양한 형태의 SVT에 대한 최신 진단 접근법과 EP maneuver를 이해합니다.
2. 복잡한 SVT의 mapping 및 catheter ablation 전략과 실제 임상 적용 팁을 습득합니다.

08:30-08:45	Septal Tachycardias: Diagnostic Challenges in the EP Lab [Speaker] Hyo-Jeong Ahn / Seoul National Univ., Korea
08:45-09:00	Atypical AVNRT: Mechanisms, Diagnosis, and Ablation Strategy [Speaker] Tae-Wan CHUNG / Keimyung Univ., Korea
09:00-09:15	Challenging Accessory Pathways: Practical Tips and Pitfalls [Speaker] Min Kim / Sungkyunkwan Univ., Korea
09:15-09:30	Mapping and Ablation Strategies for Complex Atrial Tachycardias [Speaker] Dae In Lee / Korea Univ., Korea
09:30-09:45	Discussion

Lipid & Atherosclerosis 1

Symposium

Lipid & Atherosclerosis 1

The Patient We Keep Missing: Cardiovascular Risk Beyond Conventional Lipids

Oct. 16 (Fri.) 08:30-09:45, Walker 2

Learning Objective: 1. LDL-C 목표 달성만으로는 심혈관 잔여 위험이 해소되지 않음을 인식합니다.
2. 심외막 지방, 혈당-지질 상호작용, 심부전, 성별 차이 등 비전통적 위험 인자를 임상에 적용합니다.
3. 표준 지질 검사로 포착되지 않는 고위험 환자군에 대한 맞춤형 치료 전략을 수립합니다.

08:30-08:42	LDL-C Is on Target, But Why Is My Patient Still Having Events?
08:42-08:54	When Glucose Meets Cholesterol: A Hidden Accelerator of Atherosclerosis
08:54-09:06	Lipid management in CKD, Why Standard Guideline Don't Always Apply
09:06-09:18	Same LDL-C, Different Risk: Why Women Need a Different Approach
09:18-09:30	Lipid Lowering After Stroke, Who, When, and How Aggressively?
09:30-09:45	Discussion

a Cardiogenic Shock

Oral

a Cardiogenic Shock

Oct. 16 (Fri.) 08:30-09:45, Grand 4

08:30-08:40 No.75 [K2026F-0090]	Patterns of Multiorgan Failure and Clinical Outcomes in Patients With Cardiogenic Shock [Speaker] Kim Onyou / Korea Univ., Korea
08:40-08:50 No.76 [K2026F-0232]	Hemoglobin time-in-target range in patients treated with venoarterial extracorporeal membrane oxygenation [Speaker] Dong WOO SUH / Yonsei Univ., Korea
08:50-09:00 No.77 [K2026F-0174]	Post-Discharge Socioeconomic Decline and Long-Term Clinical Outcomes in Cardiogenic Shock Survivors: A Nationwide Cohort Study [Speaker] Ji Hyun CHA / Sungkyunkwan Univ., Korea
09:00-09:10 No.78 [K2026F-0169]	Impact of the Obesity for Patients undergoing Mechanical Circulatory Support due to Cardiogenic Shock [Speaker] Sang Yoon LEE / Sungkyunkwan Univ., Korea
09:10-09:20 No.79 [K2026F-0187]	Dynamic Changes in Right Ventricular Free Wall Strain During Hemodialysis Identify Patients at Risk for Intradialytic Hypotension [Speaker] Hyounjeong Shin / Kosin Univ., Korea
09:20-09:30 No.80 [K2026F-0060]	Pre-Decannulation Duplex Ultrasound-Guided Strategy Reduces Arterial Complications After Femoral VA-ECMO [Speaker] Jae U Lee / Sungkyunkwan Univ., Korea
09:30-09:40 No.81 [K2026F-0103]	Acute Kidney Injury, Continuous Renal Replacement Therapy requirements, and Clinical Outcomes in a VA-ECMO Registry [Speaker] Kil Yoon Pack / Sungkyunkwan Univ., Korea

ENG a Basic Research 1

Oral

ENG a Basic Research 1

Oct. 16 (Fri.) 08:30-09:45, Grand 5

08:30-08:40 No.82 [K2026F-0289]	Macrophage-Targeted Oxygen-Generating Theranostic Photoactivation Facilitates Inflammation Resolution and Stabilization of Hypoxic Atherosclerotic Plaques [Speaker] JIN HYUK KIM / Korea Univ., Korea
08:40-08:50 No.83 [K2026F-0018]	POU3F1 promotes redox-dependent cardiomyocyte-fibroblast remodeling in dilated cardiomyopathy [Speaker] Hongyan Zhou / Chonnam National Univ., Korea
08:50-09:00 No.84 [E2026F-0091]	Beyond Urate Metabolism: Shared Polygenic Architecture and Cardiometabolic Pathways Linking Serum Uric Acid and Blood Pressure in the Taiwan Biobank [Speaker] Rizki Amalia Gumilang / "Academic Hospital Universitas Gadjah Mada, Indonesia Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Indonesia", Indonesia
09:00-09:10 No.85 [E2026F-0128]	Neurovascular and Cardiovascular Alterations Associated with Depression-Like Phenotypes in Socially Defeated Mice [Speaker] Hee-Dae Kim / University of Arizona College of Medicine-Phoenix, United States
09:10-09:20 No.86 [E2026F-0014]	Differential multi-cytokine profiles reveal inflammatory imbalance in STEMI versusNSTEACS: Implications for subtype-specific immunity [Speaker] Ankur Mittal / Postgraduate Institute of Medical Education And Research (PGIMER), Chandigarh, India
09:20-09:30 No.87 [E2026F-0071]	Epigallocatechin Gallate Based pH-Sensitive PEGylated Liposomes ameliorate isoproterenol induced chronic heart failure via Alteration of PI3K-AKT/Nrf2/ARE and Gal-3/TLR4/ MyD88/NF-κB pathways in rats [Speaker] Vikas Kumar / Sam Higginbottom University of Agriculture, Technology & Sciences, India
09:30-09:40 No.88 [K2026F-0180]	Development of a Human iPSC-Derived Macrophage Platform for Modeling Macrophage-Myofibroblast Transition After Myocardial Infarction [Speaker] Hyang Hee Cho / Chonnam National Univ., Korea

ENG a Pediatric Cardiology 1

Oral

ENG a Pediatric Cardiology 1

Oct. 16 (Fri.) 08:30-09:45, Grand 6

08:30-08:40 No.89 [K2026F-0278]	Single-Nucleus and Spatial Transcriptomic Atlas of Adult Repaired Tetralogy of Fallot Reveals Cardiomyocyte- and Matrifibrocyte-Associated Remodeling [Speaker] Dong Ryeol Shin / Seoul Univ., Korea
08:40-08:50 No.90 [K2026F-0250]	Does Morphology Matter? Right Ventricular Outflow Tract-Based Strategy Is Associated with Reoperation Outcomes After One-Stage Repair in Pulmonary Atresia with Ventricular Septal Defect [Speaker] Eun Chae Kim / Bucheon Sejong Hospital, Korea
08:50-09:00 No.91 [K2026F-0106]	Interstage Outcomes and Predictors of Pulmonary Artery Reintervention Following Bilateral Pulmonary Artery Banding in Neonates [Speaker] Donghee Jang / Ulsan Univ., Korea
09:00-09:10 No.92 [K2026F-0290]	Transcatheter Closure of Ventricular Septal Defects [Speaker] Na Hyun Lee / Yonsei Univ., Korea
09:10-09:20 No.93 [K2026F-0238]	Early Experience of Minimally Invasive Repair of Congenital Heart Disease in Pediatric Patients via Right Vertical Infra-Axillary Thoracotomy [Speaker] Eung Re Kim / Bucheon Sejong Hospital, Korea
09:20-09:30 No.94 [K2026F-0101]	Surgical Outcomes of Tetralogy of Fallot in Patients Weighing [Speaker] Donghee Jang / Ulsan Univ., Korea
09:30-09:40 No.95 [K2026F-0296]	Longitudinal Changes in Aortic Root Dilation During GnRH Agonist Therapy in Pediatric Marfan Syndrome [Speaker] Shinhyeung KWAK / Sungkyunkwan Univ., Korea

Insurance Issues 1

Symposium

Insurance Issues 1

국내 신의료·혁신의료기술 제도 개선

Oct. 16 (Fri.) 08:30-09:45, Art

Chairpersons : Bon-Kwon Koo , Jang-Whan Bae

Panel : Il-Young Oh , Seung-Yul Lee

Learning Objective: 1. 국산 신의료·혁신의료기술이 임상에 도입되는 과정에서 겪는 인허가 및 보험등재상의 장벽을 침습적·비침습적 의료기기 사례를 통해 이해합니다.
2. 국내 개발 기술과 해외 도입 기술이 신의료기술평가 및 급여 진입에서 거치는 제도·절차의 차이를 파악합니다.
3. 혁신의료기술의 원활한 임상 진입을 위한 제도 개선 방향을 함께 모색합니다.

08:30-08:45	국산 신의료/혁신의료 기술 도입 경험: 침습적 의료기기 [Speaker] Min Ku Chon / Pusan National Univ., Korea
08:45-09:00	국산 신의료/혁신의료 기술 도입 경험: 비침습적 의료기기 [Speaker] Jung-Joon Cha / Korea Univ., Korea
09:00-09:15	국내개발 및 해외 신의료기술 도입 제도와 절차
09:15-09:45	Discussion

09:55-11:10

ENG Intervention 5

Symposium

ENG Intervention 5

Optimizing PCI in Lesions with High-Risk Procedural Features

Oct. 16 (Fri.) 09:55-11:10, Vista 1

Chairpersons : David J. Cohen , Joo-Yong Hahn

Panel : Doo Sun SIM , Gwon Pung Lee , Yun Kyeong Cho , Jung Ho Heo

Learning Objective: 1. Integrate coronary physiology (FFR/iFR/QFR) and IVUS/OCT to optimize pre-procedural planning, post-PCI functional assessment, and stent optimization in complex high-risk PCI.
2. Understand how to select appropriate calcium modification devices, including IVL, rotational/orbital atherectomy, and scoring balloons, based on the morphology and severity of calcified lesions.
3. Apply individualized, evidence-based antithrombotic strategies by balancing ischemic and bleeding risks after complex PCI, including left main, long stent, multivessel PCI, and severe calcification.

09:55-10:10	Image-Guided PCI in Complex Lesions: Applying Recent Trial Evidence to Everyday Practice [Speaker] Junghoon Lee / Catholic Univ., Korea
10:10-10:25	Physiology-Guided PCI in Complex Lesions: From Pre-procedural Planning to Post-PCI Optimization [Speaker] Joo Myung Lee / Sungkyunkwan Univ., Korea
10:25-10:40	Drug-Coated Balloons in Complex PCI: Selecting the Right Lesion and Strategy [Speaker] Chor-Cheung Frankie Tam / University of Hong Kong, Hong Kong
10:40-10:55	Calcium Modification in Complex PCI: Matching the Right Tool to the Right Calcium Pattern [Speaker] Jung-Hee Lee / Yonsei Wonju Univ., Korea
10:55-11:10	Antithrombotic Strategy After Complex PCI: Navigating the Ischemic-Bleeding Trade-off [Speaker] Jung-Kyu Han / Seoul National Univ., Korea

Echocardiography 4

Symposium

Echocardiography 4

AI in Echocardiography

Oct. 16 (Fri.) 09:55-11:10, Vista 2

Chairpersons : Goo-Yeong Cho , Sung Kee Ryu

Panel : Sunghee Park , Hyo Suk Ahn , Yeonyee E. Yoon , Seonhwa Lee

Learning Objective: 1. AI 기반 영상 획득 보조 기술이 검사자의 업무와 영상 품질에 미치는 영향을 이해합니다.
2. 자동 심초음파 정량화 알고리즘의 정확도, 재현성, 임상 신뢰도와 적용 한계를 비판적으로 평가합니다.
3. 영상과 임상 정보를 함께 학습하는 차세대 인공지능 모델이 심초음파 진단과 예후 예측에서 가질 수 있는 가능성을 설명합니다.

09:55-10:10	AI-guided Image Acquisition and Workflow Transformation [Speaker] Jiesuck Park / Seoul National Univ., Korea
10:10-10:25	Automated Echo Quantification: Accuracy, Reproducibility, Clinical Reliability [Speaker] Inki Moon / Soonchunhyang Univ., Korea
10:25-10:40	AI-based Screening for Cardiac Amyloidosis [Speaker] Darae Kim / Sungkyunkwan Univ., Korea
10:40-10:55	From AI-ECG Screening to Multimodal Foundation Models in Echocardiography [Speaker] Seung-Pyo Lee / Seoul National Univ., Korea
10:55-11:10	Discussion

Hypertension 2

Symposium

Hypertension 2

Contemporary Antihypertensive Therapy for Uncontrolled Hypertension

Oct. 16 (Fri.) 09:55-11:10, Vista 3

Chairpersons : Wook Bum Pyun , Sang Hyun Ihm

Panel : Jae-Hyeong Park , Il Suk Sohn , Jin Kyung Oh , Seonghoon Choi

Learning Objective: 1. 조절되지 않는 고혈압 또는 난치성 고혈압의 개념을 이해하고, 가성저항성, 복약순응도, 백의효과, 이차성 고혈압을 감별하는 실제 진료 접근법을 설명할 수 있습니다.
2. 2026 대한고혈압학회 진료지침의 병용요법 및 단일제형복합요법 권고를 바탕으로, 저용량 및 초저용량 병합요법의 근거와 임상적 활용 가능성을 이해합니다.
3. ARNI, mineralocorticoid receptor antagonist, amiloride, aldosterone synthase inhibitor 등 새로운 약물치료 전략의 근거와 조절되지 않는 고혈압에서의 위치를 논의할 수 있습니다.

09:55-10:10	Uncontrolled Hypertension: Redefinition and Treatment Algorithm [Speaker] Soo Jin Kim / Bucheon Sejong Hospital, Korea
10:10-10:25	Optimizing Combination Therapy: The Role of Single-Pill Combinations [Speaker] Jieun Lee / Catholic Univ., Korea
10:25-10:40	ARNI as a New Option for Uncontrolled Hypertension [Speaker] Dae-Hee Kim / Ulsan Univ., Korea
10:40-10:55	Targeting Aldosterone in Uncontrolled Hypertension: From MRAs to Aldosterone Synthase Inhibitors [Speaker] Chan Joo Lee / Yonsei Univ., Korea
10:55-11:10	Discussion

Arrhythmia 5

Symposium

Arrhythmia 5

CIED Infection in the Complex Patient: Decisions from Extraction to Reimplantation

Oct. 16 (Fri.) 09:55-11:10, Walker 1

Chairpersons : Tae Joon Cha , Sang Weon Park

Panel : Donghyun Kim , Sung Soo KIM , In-Soo KIM , Kyung Yeon Lee , Eun-Sun Jin

Learning Objective: 1. CIED infection을 동반한 pacing-dependent 환자에서 high-risk lead extraction의 전략과 다학제 평가의 흐름을 이해합니다.
2. 고령, 다중 원인 cardiomyopathy, improved ejection fraction을 동반한 환자에서 secondary prevention SCD 전략의 최신 evidence와 임상 적용을 익힙니다.
3. TV-ICD, EV-ICD, S-ICD, 그리고 TV-CSP, leadless pacemaker 등 다양한 device option의 evidence와 한계를 환자별 맥락에서 통합적으로 평가합니다.

09:55-10:10	[CASE] A ICD Infection Case: HFimpEF, Prior VT/VF, and Substantial V-Pacing Burden [Speaker] Young Jun Park / Korea Univ., Korea
10:10-10:25	High-Risk Lead Extraction: The Infected, Pacing-Dependent Heart [Speaker] Seung Jung Park / Sungkyunkwan Univ., Korea
10:25-10:40	Rethinking SCD Prevention in the Elderly HFimpEF Patient with Mixed Etiology [Speaker] Junho Hyun / Ulsan Univ., Korea
10:40-10:55	Which ICD is Best for This Patients (TV-ICD, EV-ICD, S-ICD)? [Speaker] Lae Young Jung / Jeonbuk National Univ., Korea
10:55-11:10	Which Pacing Modality Is Best for This Patient? (TV-CSP or Leadless) [Speaker] Jong Min Hwang / Keimyung Univ., Korea

Lipid & Atherosclerosis 2

Symposium

Lipid & Atherosclerosis 2

2026 Korean Lipid Guidelines: Key Updates and Clinical Implications

Oct. 16 (Fri.) 09:55-11:10, Walker 2

Learning Objective: 1. 2026년 지질 진료지침의 LDL-C 목표치 정밀화와 risk-enhancing factor 추가의 임상적 의미를 이해합니다.
2. 비스타틴 지질강하제(bempedoic acid 등)의 가이드라인 내 새로운 위치를 파악하고 처방에 적용합니다.
3. 개정된 식사요법 권고안과 HIV·염증성 질환 등 특수 집단에서의 지질 관리 전략을 임상에 적용합니다.

09:55-10:10	Same Targets, Smarter Decisions (LDL-C Goal Refinement and Risk-Enhancing Factors in the 2026 Guidelines)
10:10-10:25	How the 2026 Guidelines Reposition Bempedoic Acid and Other Non-Statin Therapies
10:25-10:40	You Are What You Eat (Updated Dietary Recommendations in the 2026 Lipid Guidelines)
10:40-10:55	Lipid Management in Special Populations
10:55-11:10	Discussion

ENG a CAD 2

Oral

ENG a CAD 2

Oct. 16 (Fri.) 09:55-11:10, Grand 4

09:55-10:05 No.96 [K2026F-0253]	T-Wave Inversion Trajectory and Left Ventricular Functional Recovery After STEMI [Speaker] Jeongmun Kim / Hallym Univ., Korea
10:05-10:15 No.97 [E2026F-0094]	Prognostic implications of responsiveness to aspirin and a P2Y12 inhibitor after drug-eluting stent implantation in patients with acute coronary syndrome [Speaker] Hendrianus Hendrianus / Natuna General Hospital, Indonesia
10:15-10:25 No.98 [K2026F-0165]	Initial Antiplatelet Strategy and 1-Year Outcomes in East Asian Patients With Acute Myocardial Infarction and Renal Dysfunction [Speaker] Seok Oh / Chonnam National Univ., Korea
10:25-10:35 No.99 [E2026F-0082]	Apolipoprotein B-to-A1 Ratio and Coronary Vasospastic Response in Patients Undergoing Intracoronary Acetylcholine Testing [Speaker] Abiseka Panji Baskoro / Universitas Sebelas Maret Hospital, Indonesia
10:35-10:45 No.100 [K2026F-0109]	Three-Year Outcome After Percutaneous Coronary Intervention for Acute Myocardial Infarction in Octogenarians [Speaker] Doo Sun SIM / Chonnam National Univ., Korea
10:45-10:55 No.101 [E2026F-0143]	Sex Differences in Coronary Artery Disease Phenotypes: Insights From a 10-Year Indonesian Catheterisation Laboratory Registry (2016 - 2025) [Speaker] Dasdo Antonius Sinaga / Awal Bros Hospital Pekanbaru, Indonesia, Indonesia
10:55-11:05 No.102 [K2026F-0072]	Impact of Routine Angiographic Follow-up on Long-term Clinical Outcomes in Patients with Multivessel Disease underwent Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea

a Basic Research 2

Oral

a Basic Research 2

Oct. 16 (Fri.) 09:55-11:10, Grand 5

09:55-10:05 No.103 [K2026F-0073]	Hepatic CXCL1 mediates liver-heart inflammatory crosstalk in heart failure [Speaker] Ji-Young KANG / Yonsei Univ., Korea
10:05-10:15 No.104 [K2026F-0227]	Aquaporin-4 Modulation Mediates the Protective Effects of Empagliflozin Against Atrial Fibrillation Through Regulation of Calcium Handling and Fibrotic Remodeling [Speaker] Jieun Hong / Inha Univ., Korea
10:15-10:25 No.105 [K2026F-0154]	IL-35 mRNA-Loaded Functionalized Enucleated Mesenchymal stem cell Nanoplatform for Immunomodulation in Atrial Fibrillation [Speaker] Gyeongseo Yoo / Yonsei University, Korea
10:25-10:35 No.106 [K2026F-0178]	Cardiac-Targeted RUNX1 Silencing via M2 Macrophage-Camouflaged Lipid Nanoparticles Bypasses Hepatic Clearance [Speaker] Jaewoong Lee / Yonsei University, Korea
10:35-10:45 No.107 [K2026F-0225]	GLP-1/GIP Receptor Agonist Can Attenuate Atrial Fibrillation in a Pulmonary Arterial Hypertension Rat Model [Speaker] Byeongil Yu / Korea Univ., Korea
10:45-10:55 No.108 [K2026F-0070]	Liver-Targeted CXCR1/IL-22 mRNA Therapy Confers Cardioprotection via a Liver-Heart Axis in Myocardial Infarction [Speaker] Dasom MUN / Yonsei Univ., Korea
10:55-11:05 No.109 [K2026F-0228]	Six-Month Preclinical Evaluation of a Magnesium Hydroxide-Sirolimus-Eluting Bioresorbable Vascular Scaffold versus Everolimus-Eluting DES in Porcine Coronary Arteries [Speaker] Dae Sung Park / Chonnam National Univ., Korea

ENG a Pediatric Cardiology 2

Oral

ENG a Pediatric Cardiology 2

Oct. 16 (Fri.) 09:55-11:10, Grand 6

09:55-10:05 No.110 [K2026F-0191]	Outcomes After Tetralogy of Fallot Repair with Preservation of Intact Pulmonary Valve Structure
10:05-10:15 No.111 [K2026F-0094]	Respiratory Morbidity and Outcomes After Surgical Repair of Tetralogy of Fallot With Absent Pulmonary Valve Syndrome.
10:15-10:25 No.112 [K2026F-0054]	Restoration of Ventricular Function after Percutaneous Pulmonary Valve Implantation with a Self-Expandable Pulsta Valve in Native Right Ventricular Outflow Tract
10:25-10:35 No.113 [K2026F-0257]	Clinical Efficacy and Outcomes of Percutaneous Transcatheter Stent Implantation for Extracardiac conduit Fontan Stenosis
10:35-10:45 No.114 [E2026F-0090]	Initial Mid-Term Experience with Tetralogy of Fallot Repair Using the Right Atrial Appendage as a Neo-Pulmonary Valve
10:45-10:55 No.115 [E2026F-0135]	Early Blood Pressure Abnormalities Following Pediatric Coarctation Repair: Association With Left Ventricular Myocardial Work
10:55-11:05 No.116 [E2026F-0113]	The Truth Untold: Levoatriocardinal Vein as the Missing Piece in Persistent Cyanosis in Complex Congenital Heart Disease

Insurance Issues 2

Symposium

Insurance Issues 2

심장계 중환자실(CICU) 진료체계 개선

Oct. 16 (Fri.) 09:55-11:10, Art

Panel : Jung-Woo SON , Sangho Ahn , Jae-Seung Jung

Learning Objective: 1.심혈관계 중증 환자 진료를 위한 CICU 신설의 필요성과 적정 운영 기준을 심장내과·심장혈관흉부외과 관점에서 이해합니다.
2.심부전환자, 심장 중환자에게 시행되는 고난이도 검사·시술 의료행위의 특성과 현행 보상체계의 한계를 파악합니다.
3.다학제 협진 기반의 CICU 체계 확립과 적정 수가 보상을 위한 개선 방향을 논의합니다.

09:55-10:10	심혈관계 중증 환자 진료를 위한 CICU 신설 및 기준의 필요성-심장내과 [Speaker] Soo Yong Lee / Pusan National Univ., Korea
10:10-10:25	심혈관계 중증 환자 진료를 위한 CICU 신설 및 기준의 필요성-심장혈관흉부외과 [Speaker] Jae Beom Kim / Keimyung Univ., Korea
10:25-10:40	심장 중환자의 고난이도 검사,시술 의료행위 보상 [Speaker] Jeong Hoon Yang / Sungkyunkwan Univ., Korea
10:40-10:55	Discussion

12:10-12:50

Scientific Session
[Daiichisankyo/Daewoong]

Scientific Session

Scientific Session
[Daiichisankyo/Daewoong]

Innovations in Cardiovascular Care: Digital Monitoring and Personalized Treatment

Oct. 16 (Fri.) 12:10-12:50, Vista 2

Chairpersons : YoungKeun On , Sung-Won Jang

12:10-12:30	Pioneering Inpatient Telemonitoring: The Differentiated Value of thynC [Speaker] Ki Hong Lee / Chonnam National Univ., Korea
12:30-12:50	Individualized Anticoagulation in AF: The Role of Dose Optimization with Edoxaban [Speaker] Pil-Sung Yang / Yonsei Univ., Korea

13:10-14:25

ENG Main 7

Symposium

ENG Main 7

AI in Cardiovascular Medicine: Patient Care, Clinical Trials, and Training

Oct. 16 (Fri.) 13:10-14:25, Vista 1

Chairpersons : Hyun-Young Park , Hyeon Chang Kim

Panel : Jung-Won Suh , Ju Hee Lee , Ji-Hun Jang , Juhee Cho

Learning Objective: 1. Understand current applications of AI in cardiovascular patient care
2. Identify how AI can enhance clinical trial design and execution
3. Recognize the role of AI in training future cardiologists

13:10-13:25	AI in Cardiovascular Care: From Risk Prediction to Clinical Decision-Making [Speaker] Fatima Rodriguez / Stanford University School of Medicine, USA
13:25-13:40	AI in Clinical Trials: Enhancing Design, Recruitment, and Analysis [Speaker] Byung-Ho Nam / HERINGS, Korea
13:40-13:55	AI in Medical Training: Prep aring the Next Generation of Cardiologists [Speaker] Chae-Ryoung Park / Yonsei Univ., Korea
13:55-14:10	AI in medical writing: Prompt, Context, and Harness [Speaker] Ki-Hyun Jeon / Seoul National Univ., Korea
14:10-14:25	Discussion

Echocardiography 5

Symposium

Echocardiography 5

Echocardiographic Signatures of CKM Syndrome Across Organ Axes

Oct. 16 (Fri.) 13:10-14:25, Vista 2

Chairpersons : Seung Woo Park , Jang-Young Kim

Panel : SungA Bae , Ha Young Yu , Seonhwa Lee , Ji-Hun Jang

Learning Objective: 1. AHA 2023 CKM staging을 심초음의 관점에서 재해석하여, subclinical LV remodeling, atrial myopathy, RV-PA coupling 등 각 stage에서 심초음파가 포착해야 할 신호를 framework로 제시합니다. 이어지는 세 강의를 관통하는 conceptual map을 제공합니다.
2. Cardiorenal axis에서 acute decompensation 시점의 congestion phenotyping(VExUS, renal venous Doppler, IVC dynamics)과 만성기의 LA strain, RV-PA coupling, diastolic remodeling을 하나의 연속선상에서 통합합니다.
3. Adiposity-driven cardiac remodeling을 EAT, concentric remodeling, GLS reduction, LA myopathy를 중심으로 정리하고, obesity-HFpEF phenotype에서 echo의 진단적·예후적 가치를 다룹니다. SUMMIT trial 등 incretin 시대의 echo 변화도 포괄합니다.
4. MASLD 환자에서 관찰되는 LV concentric remodeling, atrial myopathy, hepatic vein/portal flow 패턴을 정리하고, MASLD-HFpEF 연결과 임상적 의의를 echo phenotype 중심으로 다룬다.

13:10-13:25	An Echocardiographic Framework for Cardiovascular-Kidney-Metabolic Syndrome [Speaker] Sung-Hee Shin / Inha Univ., Korea
13:25-13:40	Cardiorenal Phenotyping by Echocardiography from Acute Congestion to Chronic Remodeling [Speaker] In-Jeong Cho / Ewha Womans Univ., Korea
13:40-13:55	Cardiac Signatures of Obesity and Cardiometabolic Burden [Speaker] Seong-Mi Park / Korea Univ., Korea
13:55-14:10	Echocardiographic Phenotypes of the Hepatocardiac Axis in MASLD [Speaker] Chan Soon Park / Ulsan Univ., Korea
14:10-14:25	Discussion

ENG APSC-KSC Joint Session

Joint Session

ENG APSC-KSC Joint Session

Cardiomyopathy in the Era of Disease-modifying Therapy

Oct. 16 (Fri.) 13:10-14:25, Vista 3

Learning Objective: 1. Understand the diagnostic clues for differentiating HCM and phenocopy diseases using echocardiography and multimodality diagnostic algorithms.
2. Explain echocardiography-based patient selection and dose adjustment principles in the use of Mavacamten and aficamten.
3. Clinically apply the diagnostic pathways of cardiac amyloidosis and echo monitoring strategies in the era of disease-modifying therapy.

13:10-13:25	HCM and Phenocopies in the Targeted-therapy Era
13:25-13:40	Mavacamten and Aicamten: Echo-guided Patient Selection and Monitoring
13:40-13:55	Cardiac Amyloidosis: Red Flags and Multimodality Diagnostic Pathway
13:55-14:10	ATTR-CM in the Era of Disease-modifying Therapy: Treatment Monitoring with Echocardiography
14:10-14:25	Discussion

Main 8

Symposium

Main 8

ECG Combat; Conquer the Waves and Win the Battle!

Oct. 16 (Fri.) 13:10-14:25, Walker 1

Chairpersons : Minsu Kim , Young CHOI

Learning Objective: 1. 임상적으로 중요한 ECG finding을 신속히 파악합니다.
2. 비정상 ECG 소견에 대한 추가 검사 방법을 이해합니다.
3. 비정상 ECG 소견에 따른 치료 방법을 이해합니다.

13:10-13:23	Bradyarrhythmia [Speaker] Juntae Kim / Dankuk Univ., Yonsei Univ., Korea
13:23-13:36	Narrow QRS Tachycardia [Speaker] Young Shin LEE / Kyunghee Univ., Korea
13:36-13:49	Wide QRS Tachycardia [Speaker] Woo-Hyun Lim / Seoul National Univ., Korea
13:49-14:02	Ischemic Heart Disease [Speaker] Sung Soo Cho / Yonsei Univ., Korea
14:02-14:15	Pediatric ECG [Speaker] In Su Choi / Chonnam National Univ., Korea
14:15-14:25	Winner Awards Ceremony

Main 9

Symposium

Main 9

If This Patient was My Family Member, What would I Do?

Oct. 16 (Fri.) 13:10-14:25, Walker 2

Chairpersons : Donghoon Choi , Goo-Yeong Cho

Learning Objective: 1. Textbook 또는 guideline으로만 결정을 내리기 힘든 complex 상황에 대해 어떻게 해결했는지를 같이 고민합니다.
2. Medical ethics와 clinical benefit이 충돌하는 경우에 대한 상황에서 어떤 결정을 내리는 것이 맞는지에 대해 토의합니다.

13:10-13:25	산모에서의 심장판막질환: 지금 중재해야 할까, 아니면 좀 더 기다려도 될까 [Speaker] Seung-Pyo Lee / Seoul National Univ., Korea
13:25-13:40	TBD [Speaker] Jin Wi / Gachon Univ., Korea
13:40-13:55	젊은 성인의 병원밖 심정지 (OHCA in a Young Adult) [Speaker] In Sook Kang / Ewha Womans Univ., Korea
13:55-14:10	TBD [Speaker] Joon Hwa Hong / Chung-Ang Univ., Korea
14:10-14:25	Discussion

ENG Case 4

Case

ENG Case 4

Intervention 2

Oct. 16 (Fri.) 13:10-14:25, Grand 4

13:10-13:18 No.28 [KC2026F-0024]	A Stepwise Bailout Strategy for RotaWire Fracture During Rotational Atherectomy Using the Knuckle-Twister Technique and Rotational Atherectomy-Assisted Fragment Ablation [Speaker] Her Sung-Ho / Catholic Univ., Korea
13:18-13:26 No.29 [EC2026F-0076]	From Failed Bypass to Full Pedal Flow: Hybrid Antegrade-Retrograde Revascularization for Complex Multilevel Chronic Total Occlusion in Chronic Limb Threatening Ischemia [Speaker] Abiseka Panji Baskoro / Universitas Sebelas Maret Hospital, Indonesia
13:26-13:34 No.30 [EC2026F-0085]	Case Study: A 64-Year-Old Man with Abdominal Aortic Aneurysm: How to Diagnose and Is it Necessary to Intervene? [Speaker] NANDA SETYA PUTRI / cardiology, pakisaji cardiovascular center, Indonesia
13:34-13:42 No.31 [EC2026F-0090]	Endovascular Reconstruction of Surgically Altered Common Femoral Anatomy using Trans-graft interwoven Nitinol Stenting and Bailout Stent-strut Fenestration [Speaker] Aditya Reza Pratama / Ulin General Hospital, Indonesia
13:42-13:50 No.32 [EC2026F-0092]	Percutaneous Closure of a Postoperative Aortic Pseudoaneurysm: A Salvage Strategy in Patients with Prohibitive Surgical Risk [Speaker] PHUC NANG VU / Tam Anh general hospital, Vietnam
13:50-13:58 No.33 [EC2026F-0098]	TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) IN AN ELDERLY PATIENT WITH SEVERE AORTIC STENOSIS, PORCELAIN AORTA, AND COMPLEX VASCULAR ANATOMY [Speaker] Jowana Lyn Pagulayan-Rivas / Cardiology, Asian Cardiovascular Institute, Philippines
13:58-14:06 No.34 [EC2026F-0103]	transcatheter closure of anomalous origin of left coronary artery from pulmonary artery in an adult [Speaker] Avinash Anantharaj / Cardiology, JIPMER Puducherry India, India
14:06-14:14 No.35 [KC2026F-0053]	Endovascular Bypass Catheter Technique for Limb Salvage in Acute Limb Ischemia [Speaker] KIM Ji Bak / Hanil Hospital, Korea
14:14-14:22 No.36 [EC2026F-0113]	When the Pocket is Too Big to Handle: A Serial Case of Non-surgical Treatment Strategy for a Large Femoral Artery Access-Related Pseudoaneurysm [Speaker] Eka Fithra Elfi / Dr. M. Djamil General Hospital Padang, Faculty of Medicine Universitas Andalas, Indonesia

ENG Case 5

Case

ENG Case 5

Arrhythmia

Oct. 16 (Fri.) 13:10-14:25, Grand 5

13:10-13:18 No.37 [KC2026F-0030]	Beyond the Wide QRS Three Unusual Tachycardia Cases Unmasked by Electrophysiologic Clues [Speaker] Heeyoung Park / Sungkyunkwan Univ., Korea
13:18-13:26 No.38 [EC2026F-0055]	Refractory Ventricular Arrhythmia In Acute Myocardial Infarction Complicated By Cardiogenic Shock : A Challenging Case In Non-PCI Center [Speaker] Dimas Muhammad Rifqi / Cardiology, Pakisaji Cardiovascular Center, Indonesia
13:26-13:34 No.39 [EC2026F-0056]	Three-dimensional (3D) re-entry VT circuit in a patient with burned-out hypertrophic cardiomyopathy [Speaker] Kofi Tekyi Asamoah / Division of Cardiology, Yonsei University College of Medicine, Korea
13:34-13:42 No.40 [EC2026F-0068]	Unravelling the substrate in malignant Early repolarization syndrome [Speaker] Wasim Rashid / Cardiology, Severance cardiovascular hospital, Yonsei University Health system, Korea
13:42-13:50 No.41 [EC2026F-0087]	Incessant Ventricular Tachycardia in an Asymptomatic Neonate [Speaker] Mary Michie Gambe / Pediatric Cardiology, Philippine Heart Center, Philippines
13:50-13:58 No.42 [EC2026F-0089]	SUCCESSFUL SURGICAL RECONSTRUCTION FOR CATASTROPHIC PULMONARY VEIN STENOSIS POST-CATHETER ABLATION USING THE SUTURELESS TECHNIQUE: THE FIRST CASE REPORT AT OUR CENTER [Speaker] An Nguyen Thai / Cardiac Surgery and Intensive Care, Cho Ray Hospital, Vietnam
13:58-14:06 No.43 [EC2026F-0091]	From Hyperconduction to Conduction Failure: An Unusual Evolution from Incessant SVT to Transient AV Block in an Adolescent [Speaker] NANDA SETYA PUTRI / cardiology, pakisaji cardiovascular center, Indonesia
14:06-14:14 No.44 [EC2026F-0095]	Four-Pathway Wolff-Parkinson-White Syndrome: Sequential Radiofrequency Ablation and Lessons in Procedural Endpoints [Speaker] Muzaffar Annaev / Tashkent Kimyo international university, Uzbekistan
14:14-14:22 No.45 [EC2026F-0106]	When SVT Was Not the Diagnosis: Fatal Electrical Storm Unmasking Extensive Myocardial Injury [Speaker] Ghyna Fakhriah / cardiology , datu sanggul regional hospital, south kalimantan, Indonesia

ENG Case 6

Case

ENG Case 6

Pediatric Cardiology 2

Oct. 16 (Fri.) 13:10-14:25, Grand 6

13:10-13:18 No.46 [EC2026F-0014]	INSIDE OUT: A Rare Case of Thoracic Ectopia Cordis [Speaker] Kristian Lawrence Rubiano / Department of Pediatric Cardiology, Philippine Heart Center, Philippines
13:18-13:26 No.47 [KC2026F-0016]	Successful Single-Stage Intracardiac Repair and Cardiac Repositioning in Thoracoabdominal Ectopia Cordis [Speaker] Lee June Yeop / Seoul Univ., Korea
13:26-13:34 No.48 [KC2026F-0019]	Staged Bloodless Palliation of Hypoplastic Left Heart Syndrome: A Multidisciplinary Challenge [Speaker] Eung Re Kim / Bucheon Sejong Hospital, Korea
13:34-13:42 No.49 [EC2026F-0054]	Looking Beyond the Child: Cascade Family Screening Revealed Previously Unrecognized Severe Coarctation of the Aorta in the Father [Speaker] Thuy Thuc Minh Pham / Tam Anh General Hospital of Ho Chi Minh City, University of Medicine & Pharmacy Ho Chi Minh City, Vietnam
13:42-13:50 No.50 [KC2026F-0031]	Levoatrial Cardinal Vein Across the Age Spectrum: A Single-Center Case Series of Seven Patients Managed by Surgical Repair or Transcatheter Occlusion [Speaker] TCHAH NURI / Pediatric Cardiology, Severance Hospital, Korea
13:50-13:58 No.51 [KC2026F-0035]	Valve-Sparing Aortic Root Replacement in Young Patients with Connective Tissue Disorders: Two Cases of Marfan and Loeys-Dietz Syndrome [Speaker] Ji Yun Han / Seoul Univ., Korea
13:58-14:06 No.52 [KC2026F-0044]	Long-term management in a specific CHD-PAH patient who ultimately needed lung transplantation [Speaker] Lee Duck Woo / Seoul Univ., Korea
14:06-14:14 No.53 [KC2026F-0046]	Modified Double Root Translocation in Complex Transposition of the Great Arteries - Pivot Rotation Technique Hinged on the Retained Left Coronary Artery: A Case Report [Speaker] Eun Chae Kim / Bucheon Sejong Hospital, Korea
14:14-14:22 No.54 [EC2026F-0112]	Survival to Adulthood with Anomalous Left Coronary Artery from the Pulmonary Artery (ALCAPA): A Rare Case with Extensive Coronary Collateralization [Speaker] Shindi Eugene Tiurma Tampubolon / Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Indonesia

14:35-15:50

ENG Intervention 6

Symposium

ENG Intervention 6

Mastering Complex CTO PCI: Techniques, Strategies, and Boundaries

Oct. 16 (Fri.) 14:35-15:50, Vista 1

Chairpersons : Hun Sik Park , Cheol Woong Yu

Panel : Jong Il Park , JON SUH , Junpil Yun , Sangyong Jo , Jung Rae Cho

Learning Objective: 1. To understand the step-by-step principles of subintimal wiring techniques and select the appropriate approach based on lesion characteristics.
2. To apply two-stage strategies (investment procedure, staged stenting) to high-risk CTO lesions, incorporating the latest evidence from INVEST-CTO and STAR to guide procedural planning and timing.
3. To recognize the unique anatomical challenges of CTO PCI in post-CABG patients informed by the PROCTOR trial, and identify evidence-based criteria for choosing surgical revascularization over percutaneous intervention.

14:35-14:50	Two-Stage Strategy for Complex CTO PCI: Insights from INVEST-CTO and STAR [Speaker] Kyusup Lee / Catholic Univ., Korea
14:50-15:05	Investment Procedures: When and How [Speaker] Kook-Jin Chun / Pusan National Univ., Korea
15:05-15:20	Subintimal Wiring in CTO PCI: Key Techniques and Practical Tips [Speaker] Kenichiro Shimoji / Saiseikai Utsunomiya Hospital, Japan
15:20-15:35	CTO PCI in Post-CABG Patients: Strategy, Challenges, and Lessons from PROCTOR [Speaker] Ji Yong Jang / National Health Insurance Service Ilsanhospital, Korea
15:35-15:50	When to Choose CABG Over PCI in CTO Patients [Speaker] Jun Sung Kim / Seoul National Univ., Korea

ENG Basic Research 1

Symposium

ENG Basic Research 1

Basic and Translational Research in Cardiometabolic Disease: Linking Metabolic Dysfunction, Inflammation, and Cardiovascular Disease

Oct. 16 (Fri.) 14:35-15:50, Vista 2

Chairpersons : Jin Han , Soon Jun Hong

Panel : Eui-Soon Kim , Hae Young Yang , Seok Oh , Chang Myung Oh , Sung Woo Cho

Learning Objective: Understand the pathophysiology of the interconnectedness of metabolic abnormalities, inflammatory responses, and cardiovascular diseases in cardiometabolic diseases, and identify the latest trends in basic and translational research and their potential for clinical expansion based on this understanding.

14:35-14:50	TBD [Speaker] Hun-Jun Park / Catholic Univ., Korea
14:50-15:05	Immunology in Atherosclerosis - From Disease Mechanisms to Risk Prediction [Speaker] Andreas Zirlik / Medical University of Graz, Austria
15:05-15:20	Insulin/IGF-1 Signaling in the Heart [Speaker] Kae Won Cho / Soonchunhyang Institute of Medi-Bio Science, Korea
15:20-15:35	Resistin and Mitochondria [Speaker] Han-Mo Yang / Seoul National Univ., Korea
15:35-15:50	Discussion

Main 10

Symposium

Main 10

Beyond the University Hospital: A Practical Guide to Private Practice and Employment in Cardiology

Oct. 16 (Fri.) 14:35-15:50, Vista 3

Learning Objective: 1. 대학병원 밖에서 심장내과 전문의가 선택할 수 있는 다양한 진로를 이해합니다.
2. 심장내과 개원 및 봉직 현장에서 요구되는 실제 운영 요소를 이해합니다.
3. 심장질환 중심 외래와 검사실 운영 전략을 설명할 수 있습니다.
4. 대학병원과 지역 의료기관 간 협진 및 의뢰·회송 체계를 이해하고 적용할 수 있습니다.

14:35-14:55	대학병원 밖 심장내과 의사의 진로: 개원과 봉직의 현실
14:55-15:15	심장내과 개원의의 현실적인 수익 구조와 운영 모델
15:15-15:35	TBA
15:35-15:50	Discussion

Main 11

Symposium

Main 11

Learning from the Worst: My Most Difficult Case and What It Taught Me

Oct. 16 (Fri.) 14:35-15:50, Walker 1

Chairperson : Seung-Woon RHA

Panel : Jin-Kyu Park , Young Jin Youn , Jae U Lee

Learning Objective: 1. 환자 치료 중 예상치 못한 합병증 경험을 공유하고, 실수로 부터 교훈을 얻습니다.
2. 시술/수술 전 검사 결과를 바탕으로 최선의 선택을 결정합니다.

14:35-14:45	My nightmare case(my worst case) - Education case session (구조심질환 관련, TAVI or M-TEER관련 이미지 연관하여) [Speaker] Eun Kyoung Kim / Sungkyunkwan Univ., Korea
14:45-14:55	My nightmare case(my worst case) - Education case session (Shock or 심부전 시술 관련, CRT-D, L-VAD, or ECMO, ) [Speaker] Dae Hwan Bae / Bucheon Sejong Hospital, Korea
14:55-15:05	My nightmare case(my worst case) - Education case session (Arrythmia 시술) [Speaker] Jaemin Shim / Korea Univ., Korea
15:05-15:15	My nightmare case(my worst case) - Education case session (Coronary Intervention) [Speaker] Cheal Hyun Lee / Keimyung Univ., Korea
15:15-15:25	Discussion

ENG Heart Failure 2

Symposium

ENG Heart Failure 2

From Good Research to High-Impact Publication

Oct. 16 (Fri.) 14:35-15:50, Walker 2

Learning Objective: 1. Discuss strategic approaches for submission to high-impact heart failure journals that consider publication from the research design stage.
2. Understand the principles of data visualization and scientific storytelling, and be able to apply them to writing actual papers.
3. Establish revision strategies to analyze reviewer comments and respond logically and systematically, and listen to the perspective of JCF editors.

14:35-14:50	Designing, Presenting, and Publishing High-Impact HF Research [Speaker] Jong-Chan Youn / Catholic Univ., Korea
14:50-15:05	Beyond the Data: Graphs, Central Illustrations, and Scientific Storytelling [Speaker] Chan Joo Lee / Yonsei Univ., Korea
15:05-15:20	Mastering Revisions: Turning Reviewers’ Comments Into Acceptance [Speaker] Jin Joo Park / Seoul National Univ., Korea
15:20-15:35	Inside the Journal of Cardiac Failure: What Editors Are Looking For [Speaker] Anuradha Lala-Trindade / Mount Sinai Hospital, USA
15:35-15:50	Discussion

ENG a Arrhythmia 3

Oral

ENG a Arrhythmia 3

Oct. 16 (Fri.) 14:35-15:50, Grand 4

14:35-14:45 No.117 [K2026F-0129]	Extra-pulmonary vein drivers as a potential mechanism of the antiarrhythmic drug-resistant atrial fibrillation after catheter ablation: Digital twin-guided virtual drug test [Speaker] Taehyun HWANG / Yonsei Univ., Korea
14:45-14:55 No.118 [K2026F-0043]	An AI-ECG Atrial Fibrillation Score Predicts Long-Term Incidence of Atrial Fibrillation and Adverse Cardiovascular Outcomes in Newly Diagnosed Diabetes: A Retrospective Cohort Study [Speaker] Yoonji Kim / Inha Univ., Korea
14:55-15:05 No.119 [K2026F-0282]	Phenome- and disease-wide association study of proteomic signatures for atrial fibrillation [Speaker] Hanjin Park / Yonsei Univ., Korea
15:05-15:15 No.120 [K2026F-0153]	Polygenic Predisposition to Resting Heart Rate and Sick Sinus Syndrome in Atrial Fibrillation: A UK Biobank Cohort Study result [Speaker] Sangho Nam / Yonsei Univ., Korea
15:15-15:25 No.121 [K2026F-0221]	Bachmann’s Bundle Area Pacing in Korea: A Two-Center Cohort Study Demonstrating High Procedural Success and Stable Mid-Term Lead Performance [Speaker] Soonil Kwon / CHA Univ., Korea
15:25-15:35 No.122 [K2026F-0274]	Left Atrial Volume and NT-proBNP Trends after Bachmann’s Bundle Pacing versus Right Atrial Appendage Pacing in ICD Recipients: A Single-Centre Pilot [Speaker] Tae-Wan CHUNG / Keimyung Univ., Korea
15:35-15:45 No.123 [E2026F-0047]	Association of electrocardiographic parameters with left ventricular ejection fraction in patients with left bundle branch block and permanent cardiac pacemakers [Speaker] Muzaffar Annaev / Tashkent Kimyo international university, Uzbekistan

a Lipid & Atherosclerosis / Women Heart Disease

Oral

a Lipid & Atherosclerosis / Women Heart Disease

Oct. 16 (Fri.) 14:35-15:50, Grand 5

14:35-14:45 No.124 [K2026F-0264]	Different Prognostic Utility of ARC-HBR Criteria Among Gender in Korean Acute Myocardial Infarction Patients: Insights from the KAMIR IV and V Registry [Speaker] Yungjung Ko / Chonnam National Univ., Korea
14:45-14:55 No.125 [E2026F-0093]	Does Sex Influence the Relative Benefits of TAVI Versus SAVR Over Time? [Speaker] Hendrianus Hendrianus / Natuna General Hospital, Indonesia
14:55-15:05 No.126 [E2026F-0134]	Dynapenia and Liver Fibrosis Risk in Older Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease [Speaker] Olesia Karshina / MOO VO Kyrgyz-Russian Slavic University, Kyrgyzstan
15:05-15:15 No.127 [E2026F-0042]	Indulging in leisure activities pursuits on Andrids/LEDs play a role in the rise of Obesity, T2DM & Cardio-metabolic issues in the Younger Demographic [Speaker] QULSOOM Naz / King George's Medical University, India
15:15-15:25 No.128 [E2026F-0102]	Comparative Assessment of Platelet Aggregation, Oxidative Stress Markers, and Lipid Profile in Patients with Coronary Artery Disease on Mono- and Dual Antiplatelet Therapy [Speaker] Rizida Sharasutdinova / Ulyanovsk State University, Russian Federation
15:25-15:35 No.129 [K2026F-0017]	Long-term average atherogenic index of plasma and cardiovascular mortality in 8.9 million Korean adults: A nationwide cohort study [Speaker] Ki-Bum WON / Chung-Ang Univ., Korea

ENG a Pediatric Cardiology 3

Oral

ENG a Pediatric Cardiology 3

Oct. 16 (Fri.) 14:35-15:50, Grand 6

14:35-14:45 No.130 [K2026F-0295]	Long-Term Outcomes of Extracardiac Fontan Conduit Replacement: A Single-Center Experience [Speaker] Ji Hyun Bang / Seoul Univ., Korea
14:45-14:55 No.131 [E2026F-0108]	Severe Infectious Complications Before and After Definitive Repair of Complex Congenital Heart Disease [Speaker] Ly Vatthana / Hebron Medical Center, Phnom Penh, Cambodia
14:55-15:05 No.132 [K2026F-0266]	Long-term results of pulmonary valve and right ventricle preservation after total correction of tetralogy of Fallot [Speaker] Han Cho / Seoul Univ., Korea
15:05-15:15 No.133 [K2026F-0294]	Transcather Closure of Coronary Artery Fistulae in Children : A single center experience [Speaker] Na Hyun Lee / Yonsei Univ., Korea
15:15-15:25 No.134 [K2026F-0022]	Real-World Outcomes of Pulmonary Hypertension in the Era of Advanced Therapies in a Tertiary Children’s Hospital [Speaker] Kyung Suk Lee / Hanyang Univ., Korea
15:25-15:35 No.135 [E2026F-0075]	Hybrid Pulmonary Valve Implantation in Large Right Ventricular Outflow Tract Using a PULSTA Self-Expanding Valve [Speaker] Trong Phu Pham / University Medical Center Ho Chi Minh City, Vietnam
15:35-15:45 No.136 [K2026F-0272]	Two Decades of Single Ventricle Palliation in Korea: Survival Improvement and the Persistent Burden of Fontan Morbidity [Speaker] Jihye You / Jeonbuk National Univ., Korea

Healthcare Policy 1

Symposium

Healthcare Policy 1

정책위원회 통계소위원회 세션

Oct. 16 (Fri.) 14:35-15:50, Art

Panel : Gi Beom Kim , Darae Kim , Nak-Hoon Son , Sung-Hee Shin , Seung-Jun Lee

Learning Objective: 1. To understand the current status and temporal trends of major heart diseases in Korea.
2. To identify priorities for the sustainable production, standardization, and policy use of heart disease statistics.

14:35-14:50	Introduction of KSC Heart Disease Statistics [Speaker] Ju-Mi Lee / Chungnam National Univ., Korea
14:50-15:05	부정맥, 선천성심질환 현황 [Speaker] Eun-Sun Jin / Kyung Hee Univ., Korea
15:05-15:20	관상동맥질환, 말초혈관질환 현황 [Speaker] Seung-Jun Lee / Yonsei Univ., Korea
15:20-15:35	심부전, 심근병증, 판막질환, 폐고혈압 현황 [Speaker] Darae Kim / Sungkyunkwan Univ., Korea
15:35-15:50	Discussion

16:00-17:15

Basic Research 2

Symposium

Basic Research 2

임상의도 쉽게 읽는 심장 기초연구 논문: 실험 데이터 해석의 첫걸음

Oct. 16 (Fri.) 16:00-17:15, Vista 2

Chairpersons : Pil-Ki Min , Jong-Il Choi

Panel : Chan Soon Park , Ji Yong Jang , Seyong Chung , Hyung Joon Joo , David Hong

Learning Objective: 임상의가 심장 기초연구 논문에서 자주 접하는 RT-PCR, Western blot, ELISA, FACS, 미토콘드리아 기능검사, transcriptomics 데이터를 이해하고, 연구 결과의 의미와 한계를 스스로 해석할 수 있도록 합니다.

16:00-16:15	RT-PCR, Western Blot, ELISA: 발현 데이터는 어떻게 읽어야 하나? [Speaker] Jihoon Nah / Chungnam National University, Korea
16:15-16:30	FACS 데이터 해석하기: 세포군, 염증세포, 면역반응을 보는 법 [Speaker] Yong Sook Kim / Chonnam National Univ., Korea
16:30-16:45	Mitochondrial Function Assay 쉽게 이해하기 [Speaker] Hyoung Kyu Kim / Inje Univ., Korea
16:45-17:00	Transcriptomics와 Pathway Analysis: 대규모 오믹스 데이터에서 메시지 찾기 [Speaker] Jun Il Kim / Soongsil University, Korea
17:00-17:15	Discussion

Myocardial Infarction 3

Symposium

Myocardial Infarction 3

심근경색 약물치료 2026: 줄일 약, 계속할 약, 시작할 약

Oct. 16 (Fri.) 16:00-17:15, Vista 3

Chairpersons : Jang-Whan Bae , Chang-Wook Nam

Panel : Juhan Kim , Chang-Hwan Yoon , Young-Hoon Jeong , Woong Gil Choi

Learning Objective: 1. 급성 심근경색증의 최적의 약물치료 조합과 전략을 모색합니다.
2. 심근경색증의 발생기전을 알아보고 적합한 약물치료의 타깃에 대해 모색합니다.
3. 심근경색증의 잔여 위험에 대해 알아보고 예후 개선을 위한 전략을 제시합니다.

16:00-16:15	항혈소판치료: 강하게? 짦게? 맞춤형으로? [Speaker] Sodam Jung / Ewha Womans Univ., Korea
16:15-16:30	베타차단제: 누구에게 계속 필요한가? [Speaker] Ki Hong Choi / Sungkyunkwan Univ., Korea
16:30-16:45	강화된 LDL 콜레스테롤 목표: LDL 콜레스테롤만 낮추면 되는가? [Speaker] Jaehoon Chung / Gachon Univ., Korea
16:45-17:00	잔여염증위험의 타깃화: 임상데이터로 본 항염증요법의 허와 실 [Speaker] Seung-Yul Lee / CHA Univ., Korea
17:00-17:15	Discussion

Arrhythmia 6

Symposium

Arrhythmia 6

CRT in the Complex Patient: Decisions from Initial Strategy to Recurrent VT

Oct. 16 (Fri.) 16:00-17:15, Walker 1

Chairpersons : Kee-Joon Choi , Myung-Yong Lee

Panel : Hye Bin Gwag , Soonil Kwon , Jae-Hyun Kim , Je-Wook Park , Yun Young Choi

Learning Objective: 1. Mixed-etiology cardiomyopathy 환자에서 conduction system pacing (LBBAP), biventricular pacing, hybrid CRT (HOT-CRT, LOT-CRT)의 최신 무작위 임상시험 결과를 비판적으로 해석하고 환자별 CRT 전략을 수립합니다.
2. CRT response를 ejection fraction뿐 아니라 NT-proBNP, HF hospitalization, QRS narrowing, cardiac MRI scar burden을 통합한 다층적 지표로 평가합니다.
3. Mixed-etiology cardiomyopathy 환자에서 documented VT 발생 후 ICD upgrade, VT ablation, 그리고 차세대 LBBP-shock lead 등 통합 device therapy의 evidence와 향후 적용 가능성을 이해합니다.

16:00-16:15	[Case] A CRT Case: HCMP and ICMP Overlap, Initially No ICD, Then Sustained VT [Speaker] So-Ryoung Lee / Seoul National Univ., Korea
16:15-16:30	LBBAP-CRT vs BiV-CRT in 2026: What the New Trials Tell Us [Speaker] Daehoon Kim / Yonsei Univ., Korea
16:30-16:45	Do We Always Have to Choose? Hybrid CRT (HOT-CRT, LOT-CRT) in 2026 [Speaker] Juwon Kim / Sungkyunkwan Univ., Korea
16:45-17:00	Is CRT Working? Clinical Markers of Response Beyond EF [Speaker] Soongu Kwak / Seoul National Univ., Korea
17:00-17:15	Rethinking the Whole Journey: Optimal Device Strategy from Initial CRT to Recurrent VT, with the Future of LBBP-Shock Lead [Speaker] Min Soo Cho / Ulsan Univ., Korea

ENG Heart Failure 3

Symposium

ENG Heart Failure 3

Hot Therapeutic Approaches in Heart Failure: From Metabolic to Molecular Targets

Oct. 16 (Fri.) 16:00-17:15, Walker 2

Chairpersons : Dae Gyun Park , Kye Hun Kim

Panel : DeaYoung Kim , Se-Eun Kim , Eui-Soon Kim , Hae-Young Lee , Kyeong-Hyeon Chun

Learning Objective: 1. Understand that the role of GLP-1 receptor agonists in heart failure is expanding beyond simple weight loss to encompass multi-mechanical actions.
2. Understand the cardio-renal-metabolic protective effects based on the latest evidence regarding MRA, and discuss combination strategies with existing therapies.
3. Examine the various roles of cardiac myosin inhibition in HCM and understand how electrophysiological therapy in heart failure can contribute to improving outcomes.

16:00-16:15	GLP-1 Therapies in Heart Failure: Beyond Weight Reduction [Speaker] Amanda R. Vest / Cleveland Clinic, USA
16:15-16:30	From Heart Failure to Multi-Organ Protection: The Expanding Role of MRAs [Speaker] Dong-Hyuk Cho / Korea Univ., Korea
16:30-16:45	From Obstruction to Precision Therapy: Cardiac Myosin Inhibition in HCM [Speaker] Hyemoon Chung / Kyung Hee Univ., Korea
16:45-17:00	Novel EP Therapeutics on Better HF Outcomes [Speaker] Jaemin Shim / Korea Univ., Korea
17:00-17:15	Discussion

ENG a Echocardiography 1

Oral

ENG a Echocardiography 1

Oct. 16 (Fri.) 16:00-17:15, Grand 4

16:00-16:10 No.137 [K2026F-0120]	Predicting New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy: Validation of the HCM-AF Score and Incremental Value of Left Atrial Reservoir Strain [Speaker] Juhi Park / Seoul Univ., Korea
16:10-16:20 No.138 [K2026F-0028]	Impact of Persistent Outpatient Loop Diuretic Therapy on Clinical Outcomes in Heart Failure with Preserved Ejection Fraction and Small Left Ventricular Volume Phenotype [Speaker] Do-Hyun Kim / Seoul Univ., Korea
16:20-16:30 No.139 [K2026F-0183]	Clinical, Genetic, and Hemodynamic Associations of Morphological Subtypes in Hypertrophic Cardiomyopathy [Speaker] Kina Jeon / Catholic Univ., Korea
16:30-16:40 No.140 [K2026F-0283]	Comparison of Supine Supine Bicycle and Upright Treadmill Exercise echocardiography in Patients With Mitral Stenosis [Speaker] Jinyoung Lee / Sungkyunkwan Univ., Korea
16:40-16:50 No.141 [E2026F-0045]	Echocardiography-Based Radiomics for the Non-Invasive Assessment of Pressure- and Volume-Overload-Induced Myocardial Fibrosis [Speaker] Marton Tokodi / Semmelweis University, Hungary
16:50-17:00 No.142 [K2026F-0246]	Burnout Hypertrophic Cardiomyopathy: Phenotype-Specific Incidence, Remodeling Trajectories, and Long-Term Outcomes [Speaker] Dayoung Baek / Ulsan Univ., Korea
17:00-17:10 No.143 [K2026F-0161]	Hybrid versus End-to-End Deep Learning for Detection of Reduced Left Ventricular Ejection Fraction from Chest Radiography: A Multicenter Study with Prospective and External Validation [Speaker] Sangyoon Cho / Yonsei Univ., Korea

ENG a Intervention 2

Oral

ENG a Intervention 2

Oct. 16 (Fri.) 16:00-17:15, Grand 5

16:00-16:10 No.144 [K2026F-0067]	Impact of Transient Atrial Fibrillation in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention [Speaker] Ho Sung Jeon / Yonsei Wonju Univ., Korea
16:10-16:20 No.145 [E2026F-0136]	Potential Inhibition of Aortic Valve Calcification by Eicosapentaenoic Acid: Implications for Non-Invasive Treatment of Aortic Stenosis [Speaker] Jiaohua Chen / Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China
16:20-16:30 No.146 [E2026F-0126]	Intravascular Ultrasound Guided Intervention in Calcified Coronary Lesions: Three-Year Follow-Up Outcomes of CAPIRO Study [Speaker] Khanh-Hung Doan / Hue University of Medicine and Pharmacy, Vietnam
16:30-16:40 No.147 [E2026F-0129]	Admission NT-proBNP Level as a Marker of Biological Frailty and Cause-Specific Mortality After Percutaneous Coronary Intervention [Speaker] Aditya Reza Pratama / Ulin General Hospital, Indonesia
16:40-16:50 No.148 [E2026F-0050]	Efficacy of Balloon Mitral Valvuloplasty among Different Patient Subsets: Insights from a Retrospective Analysis [Speaker] Mahesh Ahire / SMBT Heart Institute, Nashik , Maharashtra, India
16:50-17:00 No.149 [E2026F-0054]	PREDICTORS OF OUTCOME OF INFANTS WTH PULMONIC VALVE ATRESIA WHO UNDERWENT PATENT DUCTUS ARTERIOSUS STENTING [Speaker] GABRIELLE VALDEZ / Philippine Heart Center, Philippines
17:00-17:10 No.150 [K2026F-0066]	Feasibility and Safety of Distal Radial Access for the Ergonovine Provocation Test [Speaker] Sang Young KIM / Yonsei Univ., Korea

a Pediatric Cardiology 4

Oral

a Pediatric Cardiology 4

Oct. 16 (Fri.) 16:00-17:15, Grand 6

16:00-16:10 No.151 [K2026F-0049]	연구비 Spatial Transcriptomic Analysis of Pathologic Lymph Node Tissues in Children Exploring the Pathophysiological Mechanisms of Kawasaki disease - A Pilot Study [Speaker] Jin-Hee OH / Catholic Univ., Korea
16:10-16:20 No.152 [K2026F-0057]	Hybrid Exercise Rehabilitation Increases Lean Body Mass without Increasing Adiposity in Children with Fontan Circulation: A Pilot Intervention Study [Speaker] Hyun Jeong KIM / University Of Seoul, Korea
16:20-16:30 No.153 [K2026F-0273]	Nationwide Long-Term Survival and Complexity-Graded Multiorgan Morbidity in Pulmonary Atresia with Intact Ventricular Septum, by Terminal Treatment Pathway [Speaker] Jihye You / Jeonbuk National Univ., Korea
16:30-16:40 No.154 [K2026F-0125]	Impact of Surgical Timing on Postoperative Outcomes after Arterial Switch Operation for d-Transposition of the Great Arteries: A Meta-Analysis [Speaker] Jung Min Park / National Health Insurance Service Ilsan Hospital, Korea
16:40-16:50 No.155 [K2026F-0096]	Balloon Atrial Septostomy and Clinical Outcomes in Neonates with Dextro-Transposition of the Great Arteries: A Systematic Review and Meta-Analysis [Speaker] Jae Hee SEOL / Yonsei Univ., Korea
16:50-17:00 No.156 [K2026F-0092]	Impact of Coronary Artery Anatomy on Outcomes After Arterial Switch Operation in d-Transposition of the Great Arteries: A Meta-analysis [Speaker] Gwang-jun Choi / Sungkyunkwan Univ., Korea
17:00-17:10 No.157 [K2026F-0020]	Computed tomography-based coronary artery Z-score for children with Kawasaki disease [Speaker] Hyun Woo Goo / Ulsan Univ., Korea

Healthcare Policy 2

Symposium

Healthcare Policy 2

심뇌법개정안 통과에 따른 후속 대책

Oct. 16 (Fri.) 16:00-17:15, Art

Learning Objective: 1. 개정 심뇌혈관질환관리법의 주요 변화와 후속 하위법령 정비 방향을 설명할 수 있습니다.
2. 심뇌혈관센터 지정체계 개편안을 이해하고, 지역완결형 진료체계 구축에 필요한 인력, 재정, 이송체계상의 전제조건을 제시할 수 있습니다.
3. 만성심장질환의 국가 관리체계 편입을 위한 역학적 근거와 성과지표, 재정 기전을 논의할 수 있습니다.

16:00-16:15	심뇌혈관센터 지정체계 개편 및 지역완결형 진료체계 구축
16:15-16:30	만성심장질환의 국가 관리 편입
16:30-16:45	심뇌혈관질환특별법 개정에 따른 정책 개편 방향
16:45-17:15	Discussion

10.17 Sat.

08:30-09:45

Main 12

Symposium

Main 12

AI Technologies, Building the Evidence & Experience to Transform Our Workflows

Oct. 17 (Sat.) 08:30-09:45, Vista 1

Chairpersons : Kyung Hwan Kim , Hyuk-Jae Chang

Panel : Jinsun Park , Dong Ho Shin , Won Jae Lee , Hui-Jeong Hwang

08:30-08:37	Sky Labs, CART BP [Speaker] Jack Byunghwan Lee / Sky Labs, Korea
08:37-08:45	CART BP 실사용 경험
08:45-08:52	ARPI, ECG Buddy [Speaker] Joong Hee Kim / ARPI, Korea
08:52-09:00	ECG Buddy 실사용 경험
09:00-09:07	Vuno, DeepCARS
09:07-09:15	DeepCARS 실사용 경험
09:15-09:22	Seers, thynC [Speaker] Heeseok Song / SEERS, Korea
09:22-09:30	thynC 실사용 경험
09:30-09:45	Discussion

Vascular Research 1

Symposium

Vascular Research 1

Factors Affecting Vascular Health

Oct. 17 (Sat.) 08:30-09:45, Vista 2

Learning Objective: 1. 당뇨병, 고혈압, 이상지질혈증, 대기오염 등 혈관 건강에 영향을 미치는 주요 위험인자들이 혈관 내피세포 손상 및 동맥 리모델링을 유발하는 병태생리학적 기전을 통합적으로 이해합니다.
2. 스타틴 치료 이후에도 잔존하는 지질 잔여 위험(Lp(a), remnant cholesterol 등)과 혈압 조절 이상의 혈관 리모델링 기전을 이해하고, 이에 대한 새로운 치료 전략(SGLT2i, GLP-1RA, Lp(a) 저하 치료 등)의 혈관 보호 근거를 설명할 수 있습니다.
3. 초미세먼지(PM2.5), 기후변화 등 환경적 위험인자의 혈관 독성 기전과 임상적 영향을 이해하고, 복합 노출(polyvascular risk) 관점에서 환자를 평가하는 통합적 사고를 적용할 수 있습니다.

08:30-08:45	Diabetic Vasculopathy: From Hyperglycemia to the Vessel Wall
08:45-09:00	Hypertension-Driven Vascular Remodeling: Beyond Blood Pressure Numbers
09:00-09:15	Lipids and the Vascular Wall: Residual Risk After Statin Era
09:15-09:30	The Invisible Assault: Air Pollution, Climate Change, and Vascular Injury
09:30-09:45	Discussion

Cardiac Surgery

Symposium

Cardiac Surgery

Transforming Heart Failure Care: The Present and Future of Mechanical Circulatory Support

Oct. 17 (Sat.) 08:30-09:45, Vista 3

Chairpersons : Sung Ho Jung , In Seok Jeong

Panel : Kitae Kim , Do Jung Kim , Yun Seok Kim , Jooyeon Lee , LEE HEEMOON

Learning Objective: 1. 심부전 환자에서 MCS 의 역할과 적응증을 이해합니다.
2. MCS 종류에 따른 환자선택, 시기결정, 합병증 관리 전략을 익힙니다.
3. 최신 가이드라인과 실제 임상적용 포인트를 숙지합니다.

08:30-08:45	Bridging Strategies in End-Stage Heart Failure: When to Escalate to MCS [Speaker] Jong-Chan Youn / Catholic Univ., Korea
08:45-09:00	Mechanical Cicrulatory Support in Cardiogenic Shock: Choosing Among IABP, Impella, and ECMO [Speaker] Hong-rae Kim / Ulsan Univ., Korea
09:00-09:15	Long-term Ventricular Assist Devices: Patient Selection, Management, and Complications [Speaker] Sungjoon Park / Yonsei Univ., Korea
09:15-09:30	INTERMACS-Guided Decision Making in MCS: Timing, Patient Profiles, and Device Strategy [Speaker] Min Ho Ju / Pusan National Univ., Korea
09:30-09:45	Right Ventricular Failure in the Era of MCS: Prediction, Prevention, and Management [Speaker] Yang Hyun Cho / Sungkyunkwan Univ., Korea

ENG TSOC-KSC Joint Session

Joint Session

ENG TSOC-KSC Joint Session

Pulsed Field Ablation in 2026: Safety and Efficacy

Oct. 17 (Sat.) 08:30-09:45, Walker 1

Learning Objective: 1. Understand the mechanisms of PFA procedure-specific complications (coronary artery spasm, cerebral embolism, hemolysis) and acquire clinical management strategies.
2. Evaluate the long-term durability of PFA and establish optimal management strategies based on the characteristics of the post-procedure blanking period.
3. Acquire the rationale and strategies for PFA redoablation in recurrent AF.

08:30-08:45	Real-World PFA Safety: Coronary Spasm, Cerebral Embolism, and Hemolysis [Speaker] Chan Hee Lee / Yeungnam Univ., Korea
08:45-09:00	How Durable Is PFA?: Evidence from Remapping Studies and Long-Term Trials [Speaker] Li-Wei Lo / Taipei Veterans General Hospital, Taiwan
09:00-09:15	Redefining the Blanking Period After PFA: Optimal Post-PFA Management [Speaker] Yun Gi Kim / Korea Univ., Korea
09:15-09:30	Pulsed Field Ablation for Redo AF Ablation: Evidence and Strategy [Speaker] Fa-Po Chung / Taipei Veterans General Hospital, Taiwan
09:30-09:45	Discussion

Main 13

Symposium

Main 13

Cath Lab Essentials - From Decision-Making to Real-World Practice

Oct. 17 (Sat.) 08:30-09:45, Walker 2

08:30-08:45	Cath lab에서의 위기 상황 대처(Cath Lab): no-reflow, perforation, shock 대응 프로토콜 or 복잡병변 PCI에서 Allied Professional의 역할: 준비부터 합병증 대응까지
08:45-09:00	초음파 판독의 함정(Echo Lab): 흔하지만 놓치기 쉬운 오류들 or 응급 상황에서의 point-of-care echo: 빠르고 정확하게
09:00-09:15	ECMO/Impella 환자 관리의 실제(CCU): 합병증 예방과 모니터링 포인트 or Cardiogenic shock management: 최신 치료 알고리즘과 팀 접근
09:15-09:30	퇴원 후 재입원 줄이기(병동): 심부전 환자 교육과 관리 전략 or 심장재활의 실제: 운동 처방부터 순응도 향상까지
09:30-09:45	Discussion

ENG a Cardio-Oncology

Oral

ENG a Cardio-Oncology

Oct. 17 (Sat.) 08:30-09:45, Grand 4

08:30-08:40 No.158 [K2026F-0275]	Natural History of Right Heart Thrombus in cancer patients : Clinical Impact of Thrombus Organization [Speaker] Seung Hyuk Bang / Sungkyunkwan Univ., Korea
08:40-08:50 No.159 [E2026F-0089]	Mitigating Chemotherapy-Related Cardiotoxicity with SGLT2 Inhibitors: A Meta-Analysis [Speaker] Elen Putri Cintya / Universitas Brawijaya, Indonesia
08:50-09:00 No.160 [K2026F-0145]	연구비 Circulating cardiomyocyte-specific cell-free DNA analysis to predict the cancer therapy related-cardiac dysfunction in ERBB2-postive breast cancer [Speaker] Min Gyu KANG / Gyeongsang National Univ., Korea
09:00-09:10 No.161 [E2026F-0127]	Silent Scarring: Fibrosis Profiling in Degenerative Mitral Valve Disease Through Histopathological and Digital Analysis [Speaker] Pamelia Mayorita / Dr. M. Djamil General Hospital, Faculty of Medicine Universitas Andalas, Indonesia
09:10-09:20 No.162 [K2026F-0285]	Clinical Outcomes and Impact of Anticoagulation in Incidental Versus Symptomatic Cancer-Associated Pulmonary Embolism [Speaker] Eunsom Jang / Sungkyunkwan Univ., Korea
09:20-09:30 No.163 [E2026F-0105]	Atrial Myxoma Masquerading as Mitral Stenosis in a Young Male [Speaker] Manuel John Dayao / University of the Philippines - Philippine General Hospital, Philippines
09:30-09:40 No.164 [K2026F-0260]	Characteristics, Outcomes, and Temporal Trends of Heart Transplant Recipients With and Without Pre-transplant History of Malignancy: A Nationwide Population Based Cohort Study [Speaker] Joon-Seok Kim / Catholic Univ., Korea

a CAD 3

Oral

a CAD 3

Oct. 17 (Sat.) 08:30-09:45, Grand 5

08:30-08:40 No.165 [K2026F-0082]	Prasugrel versus Ticagrelor After Complete Revascularization in ST-Segment Elevation Myocardial Infarction With Multivessel Disease: A Substudy of the OPTION-STEMI Trial [Speaker] Sung-Won Kim / Jeonbuk National Univ., Korea
08:40-08:50 No.166 [K2026F-0233]	Impact of IVUS-Guided PCI on Clinical Outcomes After 1-Month DAPT Followed by Reduced-Dose Prasugrel Monotherapy in Acute Myocardial Infarction: A Subgroup Analysis From the 4D-ACS Trial [Speaker] Min-Yi Park / Inha Univ., Korea
08:50-09:00 No.167 [K2026F-0076]	Addressing the Discrepancy Between Lipid and Glycemic Surveillance to Improve Long-Term Survival Following Acute Myocardial Infarction [Speaker] Jee-Woong CHOI / Seoul Univ., Korea
09:00-09:10 No.168 [K2026F-0084]	Geographic Disparities in Total Ischemic Time and Their Impact on In-Hospital Outcomes in Patients with ST-Elevation Myocardial Infarction in Korea: Data from the K-PCI 2018 Registry Cohort [Speaker] Sung Gyun Gyun / Yonsei Wonju Univ., Korea
09:10-09:20 No.169 [K2026F-0128]	Long-term clinical outcomes of vasodilating beta-blockers in acute myocardial infarction patients with preserved left ventricular ejection fraction [Speaker] SungGu Kim / Jeju National Univ., Korea
09:20-09:30 No.170 [K2026F-0019]	Comparative Effectiveness and Safety of Ticagrelor Versus Clopidogrel in Korean Patients With Multivessel Acute Myocardial Infarction and Diabetes: A Sex-Stratified Analysis From the KAMIR-V Registry [Speaker] Yeong Eun Cho / Chonnam National Univ., Korea
09:30-09:40 No.171 [K2026F-0148]	Timing of complete revascularization in ST-segment elevation myocardial infarction and multivessel disease in patients with high GRACE score: A secondary analysis of the OPTION-STEMI trial [Speaker] Min Gyu KANG / Gyeongsang National Univ., Korea

a Echocardiography 2

Oral

a Echocardiography 2

Oct. 17 (Sat.) 08:30-09:45, Grand 6

08:30-08:40 No.172 [K2026F-0042]	Impaired Right Ventricular Functional Reserve During Early Exercise in Heart Failure with Preserved Ejection Fraction [Speaker] So-Young Lee / Catholic Univ., Korea
08:40-08:50 No.173 [K2026F-0243]	Stage- and Sex-Dependent Left Ventricular Mass Normalization After Aortic Valve Replacement in Chronic Severe Aortic Regurgitation [Speaker] Jihun Song / Keimyung Univ., Korea
08:50-09:00 No.174 [K2026F-0015]	Clinical significance of Mitral annular disjunction: From presentation to genetic evaluation [Speaker] Ha Young Yu / Korea Univ., Korea
09:00-09:10 No.175 [K2026F-0224]	Mechanism-Dependent Distortion of Doppler-Derived Right Ventricular Systolic Pressure in Complete Atrioventricular Block: Paired Echocardiographic and Invasive Hemodynamic Findings. [Speaker] Byengju SON / Dong Kang Hospital, Korea
09:10-09:20 No.176 [K2026F-0159]	Impact of Baseline Left Ventricular Systolic Dysfunction on Echocardiographic Changes After Transcatheter Aortic Valve Implantation [Speaker] Hoyoung Son / Chonnam National Univ., Korea
09:20-09:30 No.177 [K2026F-0032]	Differences Between Mavacamten Dosing Protocol and Real-World Use in Obstructive Hypertrophic Cardiomyopathy [Speaker] Sang Gon Yoon / Busan Univ., Yonsei Univ., Korea
09:30-09:40 No.178 [K2026F-0176]	Effectiveness of a Short term Education Program: Basic level Critical Care Echocardiography for Residents (ESCAPE R study) [Speaker] Yongwhan Lim / Chonnam National Univ., Korea

전공의 교육세션

Symposium

전공의 교육세션

조랩 전공의에서 만랩 전공의가 되기 위한 팁들

Oct. 17 (Sat.) 08:30-09:45, Art

Chairpersons : Eui-Young Choi , Jae-Hyeong Park

Panel : Bong Joon Kim , Yoonji Kim , Soo Yong Lee

08:30-08:45	응급실에서 살아남기(1): 혈압이 낮아요 [Speaker] In-Cheol Kim / Keimyung Univ., Korea
08:45-09:00	응급실에서 살아남기(2): 숨이 차요 [Speaker] Sung-Hee Shin / Inha Univ., Korea
09:00-09:15	큰 눈을 뜨고 봐야하는 심전도들 [Speaker] Min Kim / Sungkyunkwan Univ., Korea
09:15-09:30	심초음파 결과지는 이렇게 해석하지! [Speaker] Seonhwa Lee / Yonsei Univ., Korea
09:30-09:45	슬기로운 전공의 AI 활용법 [Speaker] Ki-Hyun Jeon / Seoul National Univ., Korea

09:55-11:10

Main 14

Symposium

Main 14

Advice for Early Career Cardiologists, Looking Outside the Clinics

Oct. 17 (Sat.) 09:55-11:10, Vista 1

Chairperson : Young Hak Kim

Panel : Ye Chan Kim , Jae-Hyun Kim , Ha Young Yu , Jooyeon Lee , Min Soo Jeong

Learning Objective: 1. 심장학에 입문한 젊은 의사들이 환자들을 보는 임상 분야 뿐만 아니라, 각종 헬스케어 분야에서 다양한 진로가 있음을 탐색합니다.
2. 임상 진료 이외에 다양한 분야에 진출한 선배들의 시행착오, 경험담을 통해 자신에게 맞는 분야의 가능성이 있을지 고민해 봅니다.
3. 임상을 현재 하고 있더라도 다양한 분야에서 심장학 전문 의사들의 전문가적 식견이 필요함을 이해합니다.

09:55-10:10	정부 연구 기관에서의 Career [Speaker] Hyun-Young Park / Eulji Univ., Korea
10:10-10:25	Industry에서의 새로운 역할 [Speaker] Hak Seung Lee / Medical AI, Korea
10:25-10:40	해외에서 심혈관 연구자로서의 길 [Speaker] Young-sup Yoon / Yonsei Univ., Korea
10:40-11:10	Discussion

ENG Vascular Research 2

Symposium

ENG Vascular Research 2

The Forgotten Dimension: Frailty, Aging, and Rare Vascular Vulnerabilities

Oct. 17 (Sat.) 09:55-11:10, Vista 2

Learning Objective: 1. Understand the impact of frailty as an independent vascular risk factor on the incidence, treatment response, and prognosis of cardiovascular disease, and be able to explain the evidence and clinical implications regarding why current guidelines do not adequately reflect this.
2. Learn practical methods for measuring vascular age in elderly patients and the limitations of its interpretation, and evaluate the clinical evidence for adjusting anticoagulant therapy intensity based on the degree of frailty in patients with atrial fibrillation (AF) and venous thromboembolism (VTE).
3. Learn the clinical characteristics, differential diagnostic strategies, and latest treatment guidelines for rare vascular diseases, such as Takayasu's arteritis and fibromuscular dysplasia (FMD), which are prone to delayed diagnosis in the elderly.

09:55-10:10	Frailty as a Vascular Risk Factor: The Missing Variable in Cardiovascular Guidelines
10:10-10:25	How to Measure Vascular Age in Frail Older Adults
10:25-10:40	Anticoagulation in Frail Patients with AF and VTE: How Far Can We Push?
10:40-10:55	Rare Vascular Diseases in Aging: Takayasu Arteritis, Fibromuscular Dysplasia (FMD), and Beyond
10:55-11:10	Discussion

Cardiovascular Genome and Precision Medicine

Symposium

Cardiovascular Genome and Precision Medicine

Genetics and Precision Medicine in Cardiology: From Discovery to Clinical Practice

Oct. 17 (Sat.) 09:55-11:10, Vista 3

Panel : Jun-Bean Park , Taek Kyu Park , Jiwon Seo , Seon-Ah JIN

Learning Objective: 1. 유전자 검사의 목적, 실제 응용에 대한 최신 지견을 업데이트 합니다.
2. 유전성 부정맥질환과 정밀 의료 적용에 대해 리뷰 합니다.
3. 심장혈관질환 환자 임상에 적용할 수 있는 AI 기반 정밀 의료에 대해 리뷰합니다.

09:55-10:13	Genetic Testing in Modern Cardiology: Who, When, and How
10:13-10:31	Precision Medicine in Channelopathies
10:31-10:49	Future of Cardiovascular Care: AI, Multi-omics and Precision Therapeutics
10:49-11:07	Discussion

Smart Health

Symposium

Smart Health

Medical AI You Can Use Today: A Practical Guide for Research and Practice (지금 바로 쓰는 의료 AI)

Oct. 17 (Sat.) 09:55-11:10, Walker 1

Learning Objective: 1. 참석자는 AI 도구를 활용해 연구를 설계하고 데이터를 분석하는 실제 방법을 익힙니다.
2. 참석자는 논문 작성과 의료 AI 검증에 적용할 수 있는 구체적 워크플로우와 체크리스트를 습득합니다.
3. 참석자는 진료 현장에서 업무 효율을 높이는 AI 활용법을 자신의 임상에 바로 적용할 수 있습니다.

09:55-10:10	연구에 바로 쓰는 AI: 설계부터 데이터 분석까지
10:10-10:25	AI로 논문 쓰기: 초안부터 투고까지 실전 워크플로우
10:25-10:40	믿고 쓰기 전에: 의료 AI 검증·레드팀 실전 체크리스트
10:40-10:55	진료 현장에서 바로 쓰는 AI 효율화 노하우
10:55-11:10	Discussion

ENG JCS-KSC Joint Session

Joint Session

ENG JCS-KSC Joint Session

Advances and Controversies in Renal Denervation

Oct. 17 (Sat.) 09:55-11:10, Walker 2

Chairpersons : Jinho Shin , Seung-Hyuk Choi

Panel : Kwang-il Kim , Byeong-Keuk Kim

Learning Objective: 1. Understand the current status and future clinical role of renal denervation in the latest hypertension treatment guidelines.
2. Review the selection of appropriate patient candidates, pre-procedure evaluation, actual procedural techniques, and precautions for renal denervation.
3. Discuss new indications beyond resistant hypertension and innovative treatment approaches, including extravascular renal denervation.

09:55-10:10	Renal Denervation in Comtemporary Hypertension Guidelines: Current Postion and Perspectives [Speaker] Kazuomi Kario / Jichi Medical University Hospital, Japan
10:10-10:25	Appropriate Use of Renal Denervation and Practical Procedural Techniques [Speaker] Jiro Aoki / St. Luke's International Hospital, Japan
10:25-10:40	Expanding the indications: Beyond Resistatn Hyptertension [Speaker] Jun Won Lee / Yonsei Wonju Univ., Korea
10:40-10:55	Innovative Therapies: Extravascular Renal Denervation [Speaker] Chang Wook Jeong / Seoul National Univ., Korea
10:55-11:10	Discussion

ENG a Arrhythmia 4

Oral

ENG a Arrhythmia 4

Oct. 17 (Sat.) 09:55-11:10, Grand 4

09:55-10:05 No.179 [K2026F-0219]	Incidence and Characteristics of Tricuspid Regurgitation After Left Bundle Branch Area Pacing: A Korean Multicenter Registry Study [Speaker] Soonil Kwon / CHA Univ., Korea
10:05-10:15 No.180 [K2026F-0270]	Optimal Monitoring Duration for Premature Ventricular Complex Burden Assessment Using a Single-Lead Electrocardiogram [Speaker] Tae-Wan CHUNG / Keimyung Univ., Korea
10:15-10:25 No.181 [K2026F-0247]	Long-Term Clinical Outcomes of Apical Versus Asymmetric Hypertrophic Cardiomyopathy [Speaker] Jaehan Kim / Ulsan Univ., Korea
10:25-10:35 No.182 [K2026F-0034]	Real-World Off-Label Sacubitril/Valsartan Dosing and Clinical Outcomes in Patients with Heart Failure and End-Stage Kidney Disease [Speaker] Sung Il IM / Kosin Univ., Korea
10:35-10:45 No.183 [E2026F-0063]	Cardiac Autonomic Function and Quality of Life Following Group Supportive Psychotherapy in Maintenance Hemodialysis Patients: A Randomized Controlled Trial [Speaker] Dian Jeger / Faculty of Medicine, Udayana University, Indonesia
10:45-10:55 No.184 [E2026F-0024]	Pediatric Dysrhythmias: A Five-Year Review of Clinical Profile, Management, and Outcomes in a Philippine Tertiary Government Hospital (2021-2025) [Speaker] Catherine Joy Go / University of the Philippines - Philippine General Hospital, Philippines
10:55-11:05 No.185 [E2026F-0118]	Age-Specific Amplification of Arrhythmic Burden During Silent Myocardial Ischemia: Is Working-Age Population at Higher Risk? [Speaker] Ochgerel Tyeliman / Central military hospital, Mongolia

a Intervention 3

Oral

a Intervention 3

Oct. 17 (Sat.) 09:55-11:10, Grand 5

09:55-10:05 No.186 [K2026F-0107]	연구비 Contemporary Clinical Practices in Korean Patients With Coronary Chronic Total Occlusion: Results From the K-CTO Nationwide Retrospective Registry [Speaker] JON SUH / Soonchunhyang Univ., Korea
10:05-10:15 No.187 [K2026F-0267]	Automated Aortic Root Quantification Using Deep Learning-Based Segmentation of Pre-TAVR CT: External Validation [Speaker] Jihoon Kweon / Ulsan Univ., Korea
10:15-10:25 No.188 [K2026F-0077]	Coronary Microvascular Dysfunction Among Patients With Diabetes: A Subgroup Analysis of the Multicenter FLOW-CMD Registry [Speaker] Jae U Lee / Sungkyunkwan Univ., Korea
10:25-10:35 No.189 [K2026F-0144]	Clinical Outcomes After Complete Revascularization Through Successful CTO PCI in Multivessel Coronary Artery Disease [Speaker] Dong-Eon Kim / Soonchunhyang Univ., Korea
10:35-10:45 No.190 [K2026F-0175]	Clinical Outcomes of Fenestrated Aortic Arch Stent Graft for Aortic Arch Diseases : A Prospective Multicenter Study [Speaker] Ki Ung Kang / Busan Univ., Korea
10:45-10:55 No.191 [K2026F-0223]	Mid-Term Outcomes of Endovascular Aneurysm Repair With the INCRAFT Stent Graft System: Retrospective Combined Korean Multi-Center and Single-Center Registry Analysis [Speaker] Sung Hyun Kim / Yonsei Univ., Korea
10:55-11:05 No.192 [K2026F-0135]	Comparison of 1- versus 2-stent strategy for bifurcation lesions in complex and high-risk indicated patients [Speaker] Jiyun Park / Dong-A Univ., Korea

ENG a Heart Failure 3

Oral

ENG a Heart Failure 3

Oct. 17 (Sat.) 09:55-11:10, Grand 6

09:55-10:05 No.193 [E2026F-0018]	Colchicine as a part of complex therapy of inflammatory dilated cardiomyopathy: impact on systolic function and reverse left ventricular remodelling [Speaker] Madina Akhtamova / Republican Specialized Cardiology Scientific Practical Centre, Uzbekistan
10:05-10:15 No.194 [E2026F-0031]	LONG-TERM OUTCOMES OF VIABILITY-GUIDED CORONARY REVASCULARIZATION IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY AND REDUCED LEFT VENTRICULAR EJECTION FRACTION [Speaker] Bahram Kadyrov / International Cardiology Center, Directorate of International Medical Centers, Ashgabat, Turkmenistan
10:15-10:25 No.195 [E2026F-0117]	Implantable Cardioverter-Defibrillators After DANISH: Contemporary Evidence Supporting Survival Benefit in Non-Ischemic Cardiomyopathy: An Updated Meta-Analysis [Speaker] Jhon Fritz Kevin Caraig / St. Luke's Medical Center, Philippines
10:25-10:35 No.196 [E2026F-0095]	Elevated Red Cell Distribution Width Identifies a High-Risk Non-Anaemic Phenotype in Heart Failure With Preserved Ejection Fraction [Speaker] Jiaying Yang / National Center for Cardiovascular Diseases, Fuwai Hospital, CAMS&PUMC , China
10:35-10:45 No.197 [E2026F-0056]	A Mechanism-Based Investigation of Combined Xuebijing and rhBNP Therapy Attenuates Septic Cardiomyopathy-Induced Myocardial Injury. [Speaker] Shizhao Xiang / West China School of Public Health, and West China Fourth Hospital, Sichuan University, China
10:45-10:55 No.198 [E2026F-0096]	Development and optimization of Umbelliferone Loaded chitosan lipid nanoparticles ameliorate Streptozotocin induced Myocardial Infarction via alteration of Keap1/Nrf2/HO 1 and SIRT1/Notch1 signaling pathway [Speaker] R Kakkar / SGSS, India
10:55-11:05 No.199 [E2026F-0072]	Solid Lipid Nanoparticle Loaded Nimbolide Attenuates Cardio-Metabolic Dysfunction in Diabetic Cardiomyopathy via Modulation of AMPK/SIRT1/PPARα, PI3K/AkT and HO-1/Nrf2 Signaling Pathways [Speaker] D Chauhan / Rajkamal Science & Management College, Bahadrabad, India

전공의 Award

Case

전공의 Award

Oct. 17 (Sat.) 09:55-11:10, Art

09:55-10:10 No.1 [KAC2026F-00004]	Branch Preserving Arch Repair With Fenestrated Aortic Stent Graft [Speaker] Yu Young KIM / Pusan National Univ., Korea
10:10-10:25 No.2 [KAC2026F-00012]	Recurrent myocardial injury: Unmasking Pheochromocytoma [Speaker] Yo Jin Kim / Keimyung University Dongsan Medical Center, Korea
10:25-10:40 No.3 [KAC2026F-00016]	Congenital agenesis of right-sided pericardium mimicking a mediastinal tumor on chest X-ray [Speaker] Sunhaeng Lee / Chonnam National Univ., Korea
10:40-10:55 No.4 [KAC2026F-00017]	Constrictive pericarditis as a manifestation of IgG4-related disease [Speaker] Yoonji Kim / Inha Univ., Korea
10:55-11:10 No.5 [KAC2026F-00020]	Unexplained Pericardial Effusion with Extracardiac Findings : A Case of Erdheim-Chester Disease [Speaker] Minkyu Kang / Chungnam National Univ., Korea

11:20-12:00

Scientific Session
[Chong Kun Dang]

Scientific Session

Scientific Session
[Chong Kun Dang]

Oct. 17 (Sat.) 11:20-12:00, Vista 3

Chairpersons : Sang Hyun Kim , Sang-Hak Lee

11:20-11:40	Long-Term Antiplatelet Therapy in High-Risk PCI : A-CLOSE [Speaker] Seung-Jun Lee / Yonsei Univ., Korea
11:40-12:00

12:20-13:35

Intervention 7

Symposium

Intervention 7

Transcatheter Management of Valvular Regurgitation: Mitral and Tricuspid

Oct. 17 (Sat.) 12:20-13:35, Vista 1

Learning Objective: 1. Severe MR 및 TR의 병태생리와 영상 소견을 이해하고, transcatheter intervention의 적절한 환자 선택 기준을 습득합니다.
2. Severe MR 및 TR에서 최신 transcatheter valve repair 및 replacement 기기와 임상 근거를 이해하고, 각 치료법의 적응증과 한계를 파악합니다.
3. Pivot-balloon system 및 transcatheter caval valve implantation 등 국내외에서 시행되고 있는 TR 특화 치료법의 안전성과 효과를 학습하고, 실제 임상 경험을 공유합니다.

12:20-12:35	Pathophysiology, Imaging, and Patient Selection for Transcatheter Intervention in Severe MR and TR [Speaker] Jiwon Seo / Yonsei Univ., Korea
12:35-12:50	Transcatheter Valve Repair and Replacement for MR and TR: Current Devices and Evidence [Speaker] Sung Jin Hong / Yonsei Univ., Korea
12:50-13:05	Safety and Clinical Efficacy of the Pivot-Balloon System for Severe TR [Speaker] Min Ku Chon / Pusan National Univ., Korea
13:05-13:20	Clinical Experience and Emerging Evidence in Transcatheter Caval Valve Implantation [Speaker] Kwan Yong Lee / Catholic Univ., Korea
13:20-13:35	Discussion

Echocardiography 6

Symposium

Echocardiography 6

Point-of-Care and Critical Care Echocardiography

Oct. 17 (Sat.) 12:20-13:35, Vista 2

Chairpersons : Ji Yong Choi , Sang-Chol Lee

Panel : Min Jeong KIM , So Ree Kim , Ji Hoon Kim , Minha Jeong

Learning Objective: 1. 중환자실과 응급실에서 echo·POCUS를 통한 hemodynamic 평가와 shock·호흡곤란 감별 프로토콜을 이해합니다.
2. ECMO·Impella·IABP 환자에서 echo 기반 운영과 weaning 의사결정 원칙을 설명합니다.
3. 심낭천자 등 bedside cardiac procedure에서 echo의 procedural guidance를 임상에 적용합니다.

12:20-12:35	Hemodynamic Assessment in the ICU with POCUS [Speaker] In-Cheol Kim / Keimyung Univ., Korea
12:35-12:50	POCUS Protocols for Shock and Acute Dyspnea in the Emergency Department [Speaker] Jang Won Sohn / Yeungnam Univ., Korea
12:50-13:05	Echo Monitoring of Mechanical Circulatory Support: ECMO, Impella, IABP [Speaker] Sang Hyun Lee / Pusan National Univ., Korea
13:05-13:20	Procedural POCUS: Pericardiocentesis and Bedside Cardiac Interventions [Speaker] Jung-Woo SON / Yonsei Wonju Univ., Korea
13:20-13:35	Discussion

Nurse-Technician Session 1

Symposium

Nurse-Technician Session 1

The Evolution of Interventional Cardiology: From Data to Evidence-Based PCI

Oct. 17 (Sat.) 12:20-13:35, Vista 3

Learning Objective: 1. 실제 데이터 접근법이 최신 심도자실 연구와 임상 의사결정에 어떻게 변화를 가져오고 있는지 이해합니다.
2. 임상 연구 논문을 비판적으로 해석하고, 근거 기반 사고를 중재심장학 진료에 적용할 수 있는 실질적인 역량을 함양합니다.
3. PCI 전략을 둘러싼 최신 근거를 이해하고, PCI의 임상적 효과와 한계, 그리고 시술 최적화의 중요성을 평가합니다.

12:20-12:35	From Cath Lab Data to Clinical Evidence: Lessons from EMR-Based Research
12:35-12:50	Reading Beyond the Abstract: A Practical Guide to Clinical Evidence
12:50-13:05	When PCI Wasn't Always the Answer (Recent ORBITA analysis)
13:05-13:20	When Better PCI Wasn't Always Better(IVUS-CHIP Trial)
13:20-13:35	Discussion

Arrhythmia 7

Symposium

Arrhythmia 7

Sudden Cardiac Death

Oct. 17 (Sat.) 12:20-13:35, Walker 1

Chairpersons : Dae Kyeong Kim , Jong-Il Choi

Panel : So Young Yang , Hyung Ki Jeong , Seokmoon HAN , Taehyun HWANG

Learning Objective: 1. 급성 심장사를 예방할 수 있는 방법을 이해합니다.
2. 급성 심장사의 유전성 원인에 대해 이해합니다.
3. 최신의 약물적 치료 및 시술적 치료에 대해 이해합니다.

12:20-12:35	Transvenous Vs. Subqutaneous ICD for Prevention of SCD [Speaker] Youngjin Cho / Seoul National Univ., Korea
12:35-12:50	Recent Updates on Management of LQTS: Drugs and ICDs [Speaker] Joo Hee Jeong / Korea Univ., Korea
12:50-13:05	Lamin Cardiomyopathy: Genetic Evaluation to ICD Implantation [Speaker] Hanjin Park / Yonsei Univ., Korea
13:05-13:20	Revealing Concealed Cardiomyopathy in Idiopathic Ventricular Fibrillation [Speaker] Young CHOI / Catholic Univ., Korea
13:20-13:35	Can Mevacamten Reduce Sudden Cardiac Death in HCMP Patients? [Speaker] Sahmin Lee / Ulsan Univ., Korea

Heart Failure 4

Symposium

Heart Failure 4

Highlights from Latest Heart Failure Trials: Expert Perspectives

Oct. 17 (Sat.) 12:20-13:35, Walker 2

Chairpersons : Dong Ju Choi , Sukkeun Hong

Panel : Ha Young Yu , Seonhwa Lee , Kina Jeon , Seonghoon Choi , Junho Hyun

Learning Objective: 1. Heart Failure 2026과 ESC 2026에서 발표된 심부전 분야 주요 임상시험의 핵심 결과를 이해하고, 각 연구가 기존 치료 패러다임에 어떤 변화를 가져오는지 해석합니다.
2. 새로운 임상시험 결과가 현재 심부전 가이드라인의 권고 사항과 어떻게 연결되고 서로 상충되는지를 파악하고, 임상 현장에서의 적용 가능성을 판단합니다.
3. 국내 임상 환경을 고려하여 최신 임상시험 결과를 한국 심부전 환자 진료에 실질적으로 적용하기 위한 전략을 논의합니다.

12:20-12:35	TBD [Speaker] Jino Park / Inje Univ., Korea
12:35-12:50	TBD [Speaker] Sunki Lee / Korea Univ., Korea
12:50-13:05	TBD [Speaker] Gyu Chul Oh / Catholic Univ., Korea
13:05-13:20	TBD [Speaker] Jooyeon Lee / Yonsei Univ., Korea
13:20-13:35	TBD [Speaker] CHOI Kang-Un / Dongkuk Univ., Korea

ENG Case 7

Case

ENG Case 7

AMI & CAD

Oct. 17 (Sat.) 12:20-13:35, Grand 4

12:20-12:28 No.55 [EC2026F-0008]	Hypothyroidism Complicated with Hyperlipidemia, Elevated Creatine Kinase, and Coronary Heart Disease：A case report [Speaker] feng lyu / cardiology, shengzhou people's hospital, China
12:28-12:36 No.56 [EC2026F-0018]	Chronic Ischemic Brainstem Injury Following Coronary Artery Disease and PCI: A Neurocardiac Case Report [Speaker] Muheebur Rehman / Health Care Science, PhD Program in Healthcare Science, College of Healthcare Science, China Medical University, Taichung, Taiwan, Taiwan
12:36-12:44 No.57 [EC2026F-0032]	First-in-Human Application of Negative Pressure Haemostasis for Refractory Distal Coronary Perforation After Failed Balloon Tamponade [Speaker] Taufik Hidayat / Cardiology, Awal Bros Hospital, Indonesia
12:44-12:52 No.58 [EC2026F-0037]	Acute myocardial infarction in a young woman with systemic lupus erythematosus with secondary antiphospholipid syndrome [Speaker] Rose Kathlene Pilor / Internal Medicine, Saint Louis University Sacred Heart Medical Center, Philippines
12:52-13:00 No.59 [KC2026F-0020]	When Thrombus Was Not the Whole Story: IVUS-Defined RCA Ostial Dissection After Thrombus-Heavy STEMI PCI [Speaker] Jeongmun Kim / Hallym Univ., Korea
13:00-13:08 No.60 [EC2026F-0080]	The pan-cardiovascular manifestations of Lupus Erythematosus in a 23-year-old nulligravid female [Speaker] Jethro Villanueva / Internal Medicine, Saint Louis University Sacred Heart Medical Center, Philippines
13:08-13:16 No.61 [EC2026F-0081]	Peripartum acute coronary syndrome with left main-multivessel coronary artery disease: navigating diagnosis, revascularization, and risk [Speaker] Andrew Nobiantoro Gunawan / Cardiovascular Department, Awal Bros Hospital Pekanbaru, Indonesia
13:16-13:24 No.62 [KC2026F-0051]	Synergistic rota-lithotripsy for complex calcified in-stent restenosis [Speaker] Jee-Woong CHOI / Seoul Univ., Korea
13:24-13:32 No.63 [KC2026F-0052]	Total arterial, minimally invasive multivessel coronary artery bypass grafting with bilateral internal thoracic artery with off-pump, aortic no touch strategy. [Speaker] LEE HEEMOON / Sejong Hospital, Korea

ENG Case 8

Case

ENG Case 8

Echo & Imagnig 2

Oct. 17 (Sat.) 12:20-13:35, Grand 5

12:20-12:28 No.64 [EC2026F-0011]	Extreme levocardia with hypoplasia of left pulmonary arteries and lung : A rare case [Speaker] Perdana Rezha / Cardiology and vascular medicine , Universitas Indonesia, Indonesia
12:28-12:36 No.65 [EC2026F-0016]	Severe Aortic Stenosis, Moderate Aortic, Mitral, and Tricuspid Regurgitation: Which One(s) to Attack? [Speaker] Nicky Alexandra / Cardiology and Vascular Medicine, Universitas Indonesia, Indonesia
12:36-12:44 No.66 [EC2026F-0020]	Inferior ST-Elevation Myocardial Infarction in Adults with Anomalous Aortic Origin of Coronary Artery: A Multimodality Imaging Case Series [Speaker] Benedictus Hanjaya Suwandi / Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Division of Nuclear Cardiology and Cardiovascular Imaging, National Cardiovascular Center Harapan Kita, Indonesia
12:44-12:52 No.67 [KC2026F-0017]	Delayed anterior mitral leaflet perforation after transcatheter aortic valve implantation with prosthesis?leaflet interaction [Speaker] CHOI Kang-Un / Dongkuk Univ., Korea
12:52-13:00 No.68 [KC2026F-0022]	A Hidden Hole in a Decade-Old Bioprosthetic Mitral Valve: Three-Dimensional Echocardiographic Diagnosis of Leaflet Perforation Confirmed at Surgery [Speaker] Ha Sang Jin / VHS Medical Center, Korea
13:00-13:08 No.69 [EC2026F-0049]	Post-Myocarditis Scar as an Arrhythmic Substrate: The Diagnostic Value of CMR in a Patient with Coronary Artery Disease [Speaker] Gvozdeva Anna / Cardiology, Botkin Hospital, Russian Federation
13:08-13:16 No.70 [EC2026F-0061]	Survival Without Protection: Unmasking Severe Ischemia Behind Preserved Ventricular Function in Adult Anomalous Left Anterior Descending Artery from the Pulmonary Artery (ALADPA) Through Multimodality Imaging [Speaker] Dela Ulfiarakhma / Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita Jakarta, Indonesia
13:16-13:24 No.71 [KC2026F-0040]	Unexplained Massive Pericardial Effusion Revealing Intrapericardial Lymphangioma [Speaker] Jung Eunjoo / Kosin Univ., Korea
13:24-13:32 No.72 [EC2026F-0107]	Multimodality Imaging of Adult Superior Sinus Venosus Defect With Dual Right Superior Pulmonary Venous Drainage [Speaker] Tuoi T.H. Nguyen / Cardiovascular Center, Tam Anh General Hospital, Vietnam

ENG Case 9

Case

ENG Case 9

Heart Failure

Oct. 17 (Sat.) 12:20-13:35, Grand 6

12:20-12:28 No.73 [EC2026F-0007]	The unhappy triad of inflammatory cardiomyopathy, atrial flutter and systemic arterial thrombosis associated with anabolic steroid misuse. [Speaker] Madina Akhtamova / Republican Specialized Cardiology Scientific Practical Centre, Uzbekistan
12:28-12:36 No.74 [EC2026F-0019]	Unraveling Constrictive Pericarditis of Unknown Etiology in Limited Experience Center: The Crucial Role of Right Heart Catheterization and Multimodality Imaging [Speaker] Benedictus Hanjaya Suwandi / Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Division of Nuclear Cardiology and Cardiovascular Imaging, National Cardiovascular Center Harapan Kita, Indonesia
12:36-12:44 No.75 [KC2026F-0032]	A Giant Right Coronary Artery to Right Ventricular Fistula Causing Decompensated Right Heart Failure and Tricuspid Valve Destruction [Speaker] Jae-Hyun Kim / Seoul Univ., Korea
12:44-12:52 No.76 [KC2026F-0043]	Pulmonary Tumor Thrombotic Microangiopathy Masquerading as Pulmonary Arterial Hypertension: A Reversible Cause of Rapidly Progressive Right Heart Failure [Speaker] CHO SeokChul / Cardiology, Severance Hospital, Korea
12:52-13:00 No.77 [KC2026F-0045]	Catecholamine-Mediated Stress Cardiomyopathy Mimicking Primary Myocardial Disease: A Case Report [Speaker] Kim Dong Woo / Catholic Univ., Korea
13:00-13:08 No.78 [KC2026F-0048]	A Hidden Genetic Diagnosis Behind Mitral Valve Prolapse, Recurrent Arrhythmias, and Cardiomyopathy: Williams Beuren Syndrome [Speaker] Choi Jee Eun / Yonsei Univ., Korea
13:08-13:16 No.79 [KC2026F-0049]	AL Amyloidosis Masquerading as Hypertrophic Cardiomyopathy with Severe Mitral Regurgitation [Speaker] Kim Kyung-Hee / Sejong Hospital, Korea
13:16-13:24 No.80 [EC2026F-0111]	Beyond the Beat: A Case Series of Cardiac Malignancy Revealing the Spectrum of Cardio-Oncology [Speaker] Pamelia Mayorita / Dr. M. Djamil General Hospital, Faculty of Medicine Universitas Andalas, Indonesia
13:24-13:32 No.81 [KC2026F-0054]	Hemodynamic Optimization of Pacing Rate in Patients with Heart Failure with Preserved Ejection Fraction: A Case Series of Two Distinct Hemodynamic Phenotypes [Speaker] Ye Chan Kim / Sungkyunkwan Univ., Korea

Ethics Workshop
12:20-14:20
[필수교육]

Symposium

Ethics Workshop
12:20-14:20
[필수교육]

Oct. 17 (Sat.) 12:20-13:35, Art

12:20-12:55	강화된 면허 취소법과 의료 전문직 윤리
12:55-13:30	의료분쟁조정법 개정과 심장학 윤리
13:30-14:05	생성형 AI 시대의 의학 연구 윤리
14:05-14:20	대한심장학회 자율 윤리의 이정표

13:45-15:00

Intervention 8

Symposium

Intervention 8

Beyond the Lower Extremity: A Case-Based, Guideline-Oriented Approach to Non-Lower-Extremity PAD

Oct. 17 (Sat.) 13:45-15:00, Vista 1

Chairpersons : Jae-Hwan Lee , Seung Whan Lee

Panel : Sang-Hyeon Park , Ha Wook Park , Chang Bae Sohn , Ji Woong Yoo , Han Young Jin

Learning Objective: 1. 2024 ESC 진료지침을 바탕으로, 가이드라인 기반 치료 기준 정립
2. 적절한 중재시술 치료 적응증과 타이밍, 적절한 약물치료법 학습
3. 증례로 배워보는 중재시술 기법 및 Technical Tip 습득

13:45-14:00	Carotid and Vertebral Artery Disease [Speaker] Chang-Hwan Yoon / Seoul National Univ., Korea
14:00-14:15	Upper Extremity Artery Disease [Speaker] Oh Hyun Lee / Yonsei Univ., Korea
14:15-14:30	Renal Artery Disease [Speaker] Su Hong Kim / Busan Veterans Hospital, Korea
14:30-14:45	Aortic Disease [Speaker] Taek Kyu Park / Sungkyunkwan Univ., Korea
14:45-15:00	Mesenteric Artery Disease [Speaker] Young Jin Youn / Yonsei Wonju Univ., Korea

Echocardiography 7

Symposium

Echocardiography 7

Right Ventricle and Pulmonary Hemodynamics

Oct. 17 (Sat.) 13:45-15:00, Vista 2

Chairpersons : Jong-Min Song , Wook-Jin Chung

Panel : Hoyoung Son , Mi-Hyang Jung , Kyungeun Ha , Ran Heo

Learning Objective: 1. 2022년 ESC/ERS guideline에 따른 폐고혈압의 echo 평가 알고리즘을 이해합니다.
2. RV-PA coupling의 임상적 의미와 TAPSE/PASP, RV strain의 활용을 설명합니다.
3. 심부전 환자의 우심실 적응 양상을 평가하고 운동부하 심초음파를 통한 조기 폐혈관 질환 검출법을 임상에 적용합니다.

13:45-14:00	Contemporary Echocardiographic Assessment of Pulmonary Hypertension [Speaker] Hyemoon Chung / Kyung Hee Univ., Korea
14:00-14:15	RV-PA Coupling: From TAPSE/PASP to RV Strain [Speaker] Moon Seung Soh / Ajou Univ., Korea
14:15-14:30	RV Adaptation and Maladaptation Across the Heart Failure Spectrum [Speaker] Jung Hyun Choi / Pusan National Univ., Korea
14:30-14:45	Exercise Echocardiography for Early Pulmonary Vascular Disease [Speaker] Seo Yeon Gwak / Korea Univ., Korea
14:45-15:00	Discussion

Nurse-Technician Session 2

Symposium

Nurse-Technician Session 2

Small Changes, Big Impact: Rethinking Interventional Cardiology

Oct. 17 (Sat.) 13:45-15:00, Vista 3

Learning Objective: 1. 작은 변화가 큰 결과로 이어지는 현대 중재 심장학의 새로운 치료 전략을 이해합니다.
2. 최소 침습적 접근, 맞춤형 시술 계획, 정밀한 평가를 통한 환자 중심 중재술의 발전을 살펴봅니다.
3. 혈역학과 인공지능 기술의 발전이 이끄는 미래 중재 심장학의 방향을 이해합니다.

13:45-13:57	Small Contrast, Better Outcomes: The Era of Safer PCI
13:57-14:09	Small Access, Smarter Intervention: The New Era of Minimalist PCI
14:09-14:21	Small Numbers, Big Decisions: The Return of PAC-Guided Care
14:21-14:33	Small Annulus, Smart Solutions: Optimizing TAVI Outcomes
14:33-14:45	Small Signals, Smarter PCI: AI-Guided Intervention
14:45-15:00	Discussion

Arrhythmia 8

Symposium

Arrhythmia 8

Ventricular Tachcyardia and Fibrillation

Oct. 17 (Sat.) 13:45-15:00, Walker 1

Chairpersons : Gi Byoung Nam , Kyoung-Min Park

Panel : Soyoon Park , Euija Lee , Min Soo Jeong , Jin A Choi

Learning Objective: 1. 심실 빈맥의 시술적 치료를 효과적으로 수행할 수 있는 방법을 이해합니다.
2. 난치성 심실 빈맥의 치료를 이해합니다.
3. 심실 빈맥 및 세동을 줄일 수 있는 약물적 치료에 대해 이해합니다.

13:45-14:00	Finding a Sweet Spot for Energy Delivery for VT Ablation [Speaker] ji hyun Lee / Seoul National Univ., Korea
14:00-14:15	My Tips for Epicardial Mapping and Ablation [Speaker] Jae-Sun Uhm / Yonsei Univ., Korea
14:15-14:30	Patients with VT Storm: Medical Treatment to Ablation [Speaker] Minsu Kim / Chungnam National Univ., Korea
14:30-14:45	Recent Updates in Medical Treatment to Reduce VT and VF in Heart Failure Patients [Speaker] Hee Jeong Lee / Keimyung Univ., Korea
14:45-15:00	Discussion

Heart Failure 5

Symposium

Heart Failure 5

Back to Basics in Heart Failure

Oct. 17 (Sat.) 13:45-15:00, Walker 2

Chairpersons : Myeong-Chan Cho , Jin-Ok Jeong

Panel : Saerom Kim , Ah Ram Kim , Minjung Bak , Heejin Lee

Learning Objective: 1. BNP 및 NT-proBNP의 심부전 진단·경과 관찰에서의 임상적 의미와 함께, 비심부전 요인(신기능 저하, 비만, 심방세동 등)에 의한 pitfall을 이해하고 올바르게 적용할 수 있습니다.
2. EF 측정 방법 및 임상적 맥락에 따라 비판적으로 해석하고, 수치 이면에 있는 실제 의미를 파악하여 환자 진료에 적절히 활용할 수 있습니다.
3. E/e' 과 LVEDP 및 PCWP의 생리적 기반과 측정 한계를 이해하고, 이완 기능 평가 및 혈역학적 판단 시 흔히 발생하는 오류를 극복하여 임상에 적용할 수 있습니다.

13:45-14:00	The Truth About BNP: Interpretation and Clinical Pitfalls [Speaker] Jin Oh Choi / Sungkyunkwan Univ., Korea
14:00-14:15	The Truth About EF: Beyond the Numbers [Speaker] Jung Hyun Choi / Pusan National Univ., Korea
14:15-14:30	The Truth About E/e': Strengths, Limitations, and Pitfalls [Speaker] Chi Young Shim / Yonsei Univ., Korea
14:30-14:45	The Truth About LVEDP and PCWP: Hemodynamic Insights and Misconceptions
14:45-15:00	Discussion

a Arrhythmia 5

Oral

a Arrhythmia 5

Oct. 17 (Sat.) 13:45-15:00, Grand 4

13:45-13:55 No.200 [K2026F-0131]	연구비 Effectiveness of self management mobile application for patients with cardiac implantable electronic device [Speaker] Young CHOI / Catholic Univ., Korea
13:55-14:05 No.201 [K2026F-0286]	Bachmann Bundle Versus Right Atrial Appendage Pacing: Impact on Atrial Function and Structural Remodeling [Speaker] Ye Chan Kim / Sungkyunkwan Univ., Korea
14:05-14:15 No.202 [K2026F-0104]	Comparative Clinical Outcomes of Left Bundle Branch Area Pacing versus Right Ventricular Pacing in Patients with Preserved Ejection Fraction: A 3-Year Follow-Up Study [Speaker] Sung Soo KIM / Chosun Univ., Korea
14:15-14:25 No.203 [K2026F-0248]	Overall Survival in Patients with Implantable Cardioverter-Defibrillator for Brugada Syndrome, Early Repolarization Syndrome, or Idiopathic Ventricular Fibrillation: Two Decades Follow-Up [Speaker] Jaehan Kim / Ulsan Univ., Korea
14:25-14:35 No.204 [K2026F-0160]	Shensong Yangxin Reduces Transmural Dispersion of Repolarization and Prevents Ventricular Arrhythmias in an Ex-Vivo Model of Brugada Syndrome [Speaker] Hoyoung Son / Chonnam National Univ., Korea
14:35-14:45 No.205 [K2026F-0179]	One-Day Versus Extended-duration Electrocardiographic Patch Monitoring for Atrial Fibrillation Detection: A Prospective Multicenter Randomized Trial in Patients at High Risk of Stroke [Speaker] Juntae Kim / Dankuk Univ., Yonsei Univ., Korea
14:45-14:55 No.206 [K2026F-0277]	Pacing Burden Progression and Physiologic Pacing Strategies in Cardiac Amyloidosis Patients Undergoing CIED Implantation [Speaker] Heeyoung Park / Sungkyunkwan Univ., Korea

a CAD 4

Oral

a CAD 4

Oct. 17 (Sat.) 13:45-15:00, Grand 5

13:45-13:55 No.207 [K2026F-0029]	Clinical Outcomes of Potent P2Y12 Inhibitors Versus Clopidogrel in Patients with Achieved LDL-C Target after Acute Myocardial Infarction: From KAMIR-NIH-LIPID Registry [Speaker] Gyu Tae Park / Chung-Ang Univ., Korea
13:55-14:05 No.208 [K2026F-0184]	Long-Term Clopidogrel versus Aspirin Monotherapy After Drug-Eluting Stent Implantation: A Nationwide Real-World Comparative Study [Speaker] Eun Jin Park / Korea Univ., Korea
14:05-14:15 No.209 [K2026F-0142]	Residual Inflammatory Risk Versus Residual Cholesterol Risk for Long-Term Outcomes After Acute Myocardial Infarction: A 12-Month Landmark Analysis from the KAMIR Registry [Speaker] Yong Kyun Kim / Chungnam National Univ., Korea
14:15-14:25 No.210 [K2026F-0152]	CKM syndrome staging with metabolic risk stratification in patients with chest pain undergoing elective coronary angiography [Speaker] Ha Young Yu / Korea Univ., Korea
14:25-14:35 No.211 [K2026F-0089]	Arterial Stiffness Index and Platelet Reactivity Phenotype to Predict Ischemic and Bleeding Events After Percutaneous Coronary Intervention [Speaker] Byung Sik KIM / Hanyang Univ., Korea
14:35-14:45 No.212 [K2026F-0047]	Coronary artery calcium score elevation after statin use and cardiovascular outcomes [Speaker] Dong WOO SUH / Yonsei Univ., Korea
14:45-14:55 No.213 [K2026F-0099]	Clinical Impact of Thrombocytopenia and Platelet Reactivity on Bleeding and Ischemic Events After Drug-Eluting Stent Implantation [Speaker] Gyu Tae Park / Chung-Ang Univ., Korea

a Heart Failure 4

Oral

a Heart Failure 4

Oct. 17 (Sat.) 13:45-15:00, Grand 6

13:45-13:55 No.214 [K2026F-0114]	Sex and Age at Onset Across Genotypes of Dilated Cardiomyopathy in an Asian Cohort [Speaker] Jooyeon Lee / Yonsei Univ., Korea
13:55-14:05 No.215 [K2026F-0244]	Impact of Clinical Inertia in Acute Hospitalized Heart Failure with Reduced Ejection Fraction. [Speaker] Jung-Woo SON / Yonsei Wonju Univ., Korea
14:05-14:15 No.216 [K2026F-0241]	Prognostic Value of Discharge Blood Pressure in Acute HFrEF According to Discharge GDMT Status [Speaker] Jung-Woo SON / Yonsei Wonju Univ., Korea
14:15-14:25 No.217 [K2026F-0177]	Serum Proteomic Profiling Reveals Pathogenic Mechanisms of Post-Transplant Non-Melanoma Skin Cancer in Heart Transplant Recipients [Speaker] Minsook Oh / Catholic Univ., Korea
14:25-14:35 No.218 [K2026F-0117]	Peak oxygen uptake and ventilatory efficiency for identifying heart failure during combined exercise stress echocardiography and cardiopulmonary testing [Speaker] Seweon KIM / Yonsei Univ., Korea
14:35-14:45 No.219 [K2026F-0168]	Exploring the Patient Journey and Disease Burden in Korean ATTRv Amyloidosis: Results from a Preliminary Qualitative Thematic Analysis [Speaker] Seongwon Yun / Yonsei University, Korea
14:45-14:55 No.220 [K2026F-0269]	A Male Shift in Heart Failure Epidemiology: Age-Specific Crossover of Prevalence from the 60s to the 80s in a Super-Aged Society (2002-2023) [Speaker] Chan Joo Lee / Yonsei Univ., Korea

10.18 - 20

09:00-17:00

E-poster

- No.1 [K2026F-0262]	Potential of MS-275 to Promote Re-endothelialization in Drug-Eluting Stents [Speaker] Mi Hyang Na / Chonnam National Univ., Korea
- No.2 [K2026F-0256]	Clopidogrel Enhances Endothelial Recovery and Reduces Macrophage Infiltration in Nicotine-Accelerated Early Atherosclerosis [Speaker] Yu Jeong Jin / Chonnam National Univ., Korea
- No.3 [K2026F-0252]	SECRETORY APURINIC/APYRIMIDINIC ENDONUCLEASE 1/REDOX FACTOR-1 ATTENUATES HYPOXIA-INDUCED MYOCARDIAL INJURY BY MODULATING OXIDATIVE STRESS AND APOPTOTIC SIGNALING [Speaker] Seon-Ah JIN / Chungnam National Univ., Korea
- No.4 [K2026F-0226]	Emricasan orchestrates AQP4 activity to protect against atrial fibrillation by curbing maladaptive remodeling and aberrant electrophysiology. [Speaker] Jieun Hong / Inha Univ., Korea
- No.5 [K2026F-0166]	LINC00657 regulates cardiac hypertrophy via the miR-125a-3p/RhoA axis [Speaker] Malgeum Park / Yonsei Univ., Korea
- No.6 [K2026F-0100]	Clinical Impact of Fibrinogen and Thrombogenicity on Cardiovascular Events After Percutaneous Coronary Intervention [Speaker] Gyu Tae Park / Chung-Ang Univ., Korea
- No.7 [K2026F-0069]	Long-Term Clinical Outcomes in Coronary Artery Spasm Patients with Mildly Reduced eGFR [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.8 [K2026F-0062]	Long-Term Clinical Outcomes according to Reference Vessel Diameter in Patients with Coronary Artery Spasm: A Propensity Score-Matched Analysis [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.9 [E2026F-0138]	Renal dysfunction as a factor of adverse clinical course in acute decompensation of chronic heart failure in elderly and very elderly patients [Speaker] Eliza Abdilazizova / Interstate educational organization of higher education Kyrgyz-Russian Slavic University named after the first President of the Russian Federation B.N. Yeltsin, Kyrgyzstan
- No.10 [E2026F-0098]	Prospective Multidisciplinary Heart Failure Management in HFrEF: Patients Aged 80+ vs. Under 80 [Speaker] Hsin I Wu / Chi Mei Hospital, Liouying, Taiwan
- No.11 [E2026F-0079]	Longitudinal Dynamics of Urinary NGAL and Albumin-to-Creatinine Ratio After PCI in HFrEF Patients on Contemporary Quadruple Therapy: A Six-Timepoint Prospective Pilot Study [Speaker] FangHsiu Kuo / National Sun Yat-sen University, Chi Mei Medical Center, Taiwan
- No.12 [E2026F-0062]	Pre-hospital Phase of Peripartum Cardiomyopathy: Diagnostic Delay, Treatment Patterns and Risk Factors in Real-World Clinical Practice [Speaker] Nilufar Shamsieva / Republican Specialized Scientific Practical Medical Center Of Cardiology, Tashkent, Uzbekistan
- No.13 [E2026F-0061]	Gender differences in demographic and clinical characteristics of patients with dilated cardiomyopathy in the uzbek population [Speaker] Nilufar Shamsieva / Republican Specialized Scientific Practical Medical Center Of Cardiology, Tashkent, Uzbekistan
- No.14 [E2026F-0060]	Gender-related differences in physiological and functional parameters in patients with dilated cardiomyopathy [Speaker] Nilufar Shamsieva / Republican Specialized Scientific Practical Medical Center Of Cardiology, Tashkent, Uzbekistan
- No.15 [E2026F-0059]	The impact of NT-proBNP in the Development of Cardiac Remodeling in Patients with Atherosclerotic Cardiovascular Disease [Speaker] Nilufar Shamsieva / Republican Specialized Scientific Practical Medical Center Of Cardiology, Tashkent, Uzbekistan
- No.16 [E2026F-0015]	The Effects of Dulaglutide injection on Blood Pressure and safety among those with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [Speaker] Perlas Jim albert / Cardinal Santos Medical Center, Philippines
- No.17 [K2026F-0214]	Perindopril versus Valsartan in AMI Patients with High Systemic Inflammation (NLR > 3) Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.18 [K2026F-0213]	Perindopril versus Ramipril in AMI Patients with High Systemic Inflammation (NLR > 3) Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.19 [K2026F-0211]	Perindopril versus No-RAS-Blocker Therapy in AMI Patients with High Systemic Inflammation (NLR > 3) Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.20 [K2026F-0210]	Perindopril versus Candesartan in AMI Patients with High Systemic Inflammation (NLR > 3) Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.21 [K2026F-0209]	Perindopril versus Angiotensin-Receptor Blockers in AMI Patients with High Systemic Inflammation (NLR > 3) Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.22 [K2026F-0208]	Perindopril versus Valsartan in Patients with Non-ST-Elevation Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.23 [K2026F-0207]	Perindopril versus Ramipril in Patients with Non-ST-Elevation Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.24 [K2026F-0205]	Perindopril versus No-RAS-Blocker Therapy in Patients with Non-ST-Elevation Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.25 [K2026F-0204]	Perindopril versus Candesartan in Patients with Non-ST-Elevation Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.26 [K2026F-0203]	Perindopril versus Angiotensin-Receptor Blockers in Patients with Non-ST-Elevation Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.27 [K2026F-0202]	Perindopril versus Valsartan in Patients with ST-Elevation Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.28 [K2026F-0201]	Perindopril versus Ramipril in Patients with ST-Elevation Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.29 [K2026F-0200]	Perindopril versus No-RAS-Blocker Therapy in Patients with ST-Elevation Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.30 [K2026F-0199]	Perindopril versus Candesartan in Patients with ST-Elevation Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.31 [K2026F-0198]	Perindopril versus Angiotensin-Receptor Blockers in Patients with ST-Elevation Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.32 [K2026F-0197]	Perindopril versus Valsartan in Patients with Acute Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.33 [K2026F-0196]	Perindopril versus Ramipril in Patients with Acute Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.34 [K2026F-0195]	Perindopril versus No-RAS-Blocker Therapy in Patients with Acute Myocardial Infarction Undergoing Successful Percutaneous Coronary InterventionPerindopril versus No-RAS-Blocker Therapy in Patients with Acute Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.35 [K2026F-0193]	Perindopril versus Candesartan in Patients with Acute Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.36 [K2026F-0192]	Perindopril versus Angiotensin-Receptor Blockers in Patients with Acute Myocardial Infarction Undergoing Successful Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.37 [K2026F-0164]	Long-term Clinical Outcomes of Beta-Blocker Therapy in Elderly Patients with Chronic Total Occlusion Lesion undergoing Percutaneous Coronary Intervention [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.38 [K2026F-0143]	Temporal Trends in Antiplatelet Strategies After PCI: A Nationwide Study by Presentation and Bleeding Risk [Speaker] Keehwan LEE / Ulsan Univ., Korea
- No.39 [K2026F-0068]	Comparative Clinical Outcomes of Nebivolol Versus Bisoprolol in Patients with STEMI After Primary PCI: A Propensity-Score Matched Analysis [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.40 [K2026F-0064]	Comparative Clinical Outcomes of Carvedilol Versus Bisoprolol in STEMI Survivors After Primary PCI: A Propensity-Score Matched Analysis [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.41 [K2026F-0063]	Prognostic Impact of Carvedilol Following Primary Percutaneous Coronary Intervention with Second-Generation Drug-Eluting Stents [Speaker] Seung-Woon RHA / Korea Univ., Korea
- No.42 [K2026F-0039]	Prognostic Impact of 1-Year Renal Trajectories After Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention [Speaker] Yu Jin Hwang / Chungnam National Univ., Korea
- No.43 [E2026F-0032]	A HIDDEN CULPRIT: LATE-ONSET ST-ELEVATION MYOCARDIAL INFARCTION REVEALING SPONTANEOUS DISSECTION OF DISTAL RIGHT CORONARY ARTERY AFTER AN EPISODE OF VENTRICULAR TACHYCARDIA [Speaker] Andre Fellino Muhammad Harahap / University of North Sumatera, Indonesia
- No.44 [E2026F-0142]	Diagnostic Yield and Age-Related Variations of Holter ECG in Routine Clinical Practice: A Real-World Cohort Study [Speaker] Ochgerel Tyeliman / Central military hospital, Mongolia
- No.45 [E2026F-0112]	Gender-Driven Heterogeneity in Ventricular Repolarization During Silent Myocardial Ischemia: Are Males More Vulnerable to Extreme QTc Prolongation? [Speaker] Ochgerel Tyeliman / Central military hospital, Mongolia
- No.46 [E2026F-0137]	Three-Dimensional Echocardiographic Assessment of the Right Ventricle in Children at Mid-Term Follow-Up After Tetralogy of Fallot Repair [Speaker] PHUC NANG VU / Tam Anh general hospital, Vietnam
- No.47 [E2026F-0077]	Severe Aortic Regurgitation from Rheumatic Heart Disease and Takayasu Arteritis: A Rare Dual Diagnosis [Speaker] Justine Presinede / University of the Philippines - Philippine General Hospital, Philippines
- No.48 [E2026F-0076]	AN UNUSUAL INTRACARDIAC INVASION BY LUNG SQUAMOUS CELL CARCINOMA PRESENTING AS A LEFT ATRIAL TUMOR THROMBUS (CASE REPORT) [Speaker] Fadlan Aufar Malik / Department of Cardiology, Faculty of Medicine, Universitas Sumatera Utara / RSUP Haji Adam Malik, Medan, Indonesia
- No.49 [E2026F-0057]	Age-related features of myocardial remodeling in patients with heart failure with preserved ejection fraction (HFpEF) and obesity [Speaker] Nilufar Shamsieva / Republican Specialized Scientific Practical Medical Center Of Cardiology, Tashkent, Uzbekistan
- No.50 [E2026F-0033]	Echocardiographic Cardiac Features in Hunter Syndrome [Speaker] Catherine Joy Go / University of the Philippines - Philippine General Hospital, Philippines
- No.51 [K2026F-0287]	Epicardial fat thickness is independently associated with subclinical cardiac dysfunction in patients with prominent pericardial fat on echocardiography [Speaker] Jihee SON / Chung-Ang Univ., Korea
- No.52 [E2026F-0038]	Silent Killer Unmasked: Coronary Artery Calcium Score in Predicting MACE Among Hypertensive Patients With Stable Coronary Artery Disease [Speaker] Azzahra Wiana Kartika Siregar / Cardiology and Vascular Medicine, University of North Sumatera, Indonesia
- No.53 [E2026F-0036]	CT-DERIVED CORONARY ANATOMY FOR GUIDING PERCUTANEOUS CORONARY INTERVENTION IN OBSTRUCTIVE CORONARY ARTERY DISEASE: A STRATEGY TO OPTIMIZE REVASCULARIZATION: A CASE REPORT [Speaker] Cut Putri Puspita Sari / Universty of north sumatera, Indonesia
- No.54 [E2026F-0021]	Interplay Between Frontal QRS?T Angle and Coronary Artery Calcium in Predicting Major Adverse Cardiovascular Events in Postmenopausal Women [Speaker] Dina Ardelia / Faculty of Medicine, Universitas Sumatera Utara, Indonesia
- No.55 [K2026F-0291]	Clinical Outcomes of Surgical Management for Tracheobronchomalacia and Vascular Airway Compression in Children with Accompanying Complex Congenital Anomalies [Speaker] Ji Hyun Bang / Seoul Univ., Korea
- No.56 [K2026F-0263]	Surgical Reconstruction of Anomalous Left Upper Pulmonary Vein Connection: A Single-Institution Experience Across the Spectrum of PAPVR and Mixed-Type TAPVR [Speaker] Ji Yun Han / Seoul Univ., Korea
- No.57 [K2026F-0190]	Early Total Repair versus Staged Palliation for Pulmonary Atresia with Ventricular Septal Defect: A Nationwide Population-Based Cohort Study [Speaker] Chanki Kim / Jeonbuk National Univ., Korea
- No.58 [K2026F-0147]	Factors Associated With the Need for Shunt Flow Adjustment Following Systemic-to-Pulmonary Shunt [Speaker] Youngkwan SONG / Ulsan Univ., Korea
- No.59 [E2026F-0051]	Epidemiological survey of Congenital Heart Disease in Yanbian area [Speaker] Fenglin Jiang / the Affiliated Hospital of Yanbian University (Yanbian Hospital), China
- No.60 [K2026F-0081]	Long-term Safety and Effectiveness of Transcatheter versus Surgical Aortic Valve Replacement: A Pilot Study [Speaker] Yiju Park / Yonsei University, Korea

Detailed Program

Detailed Program

Intervention 1

ENG Echocardiography 1

Cardiogenic Shock 1

Main 1

ENG Main 2

ENG a Arrhythmia 1

ENG a Hypertension

ENG a Heart Failure 1

Pediatric Cardiology 1

Intervention 2

ENG Echocardiography 2

Cardiogenic Shock 2

ENG Arrhythmia 1

ENG Epidemiology 1

ENG a CAD 1

ENG a Vascular Research

ENG a Heart Failure 2

Pediatric Cardiology 2

Main 3

KSPH-KSC Joint Session

Myocardial Infarction 1

Main 4

ENG Epidemiology 2

a Arrhythmia 2

ENG a Intervention 1

ENG a Cardiovascular Imaging

Pediatric Cardiology 3

Main 5

Women Heart Disease 1

Myocardial Infarction 2

Arrhythmia 2

ENG Case 1

ENG Case 2

ENG Case 3

ENG ESC-KSC Joint Session

Women Heart Disease 2

Cardiometabolic Syndrome 1

Arrhythmia 3

Cardiovascular Imaging

ENG Young Investigator award Competition 1 1-6

ENG Young Investigator award Competition 2 7-12

ENG a Epidemiology 1

Adult Congenital Heart Disease 1

ENG Intervention 3

ENG ACC-KSC Joint Session

Cardiometabolic Syndrome 2

Main 6

ENG Cardio-Oncology

ENG Young Investigator award Competition 3 13-18

ENG Young Investigator award Competition 4 19-24

a Epidemiology 2

Adult Congenital Heart Disease 2

Intervention 4

ENG Echocardiography 3

Hypertension 1

Arrhythmia 4

Lipid & Atherosclerosis 1

a Cardiogenic Shock

ENG a Basic Research 1

ENG a Pediatric Cardiology 1

Insurance Issues 1

ENG Intervention 5

Echocardiography 4

Hypertension 2

Arrhythmia 5

Lipid & Atherosclerosis 2

ENG a CAD 2

a Basic Research 2

ENG a Pediatric Cardiology 2

Insurance Issues 2

Scientific Session [Daiichisankyo/Daewoong]

ENG Main 7

Echocardiography 5

ENG APSC-KSC Joint Session

Main 8

Main 9

ENG Case 4

ENG Case 5

ENG Young Investigator award Competition 1
1-6

ENG Young Investigator award Competition 2
7-12

ENG Young Investigator award Competition 3
13-18

ENG Young Investigator award Competition 4
19-24

Scientific Session
[Daiichisankyo/Daewoong]

Scientific Session
[Chong Kun Dang]

Ethics Workshop
12:20-14:20
[필수교육]